EP2655587B1 - Liquid surfactant preparation containing lipase and phosphonate - Google Patents
Liquid surfactant preparation containing lipase and phosphonate Download PDFInfo
- Publication number
- EP2655587B1 EP2655587B1 EP11805804.9A EP11805804A EP2655587B1 EP 2655587 B1 EP2655587 B1 EP 2655587B1 EP 11805804 A EP11805804 A EP 11805804A EP 2655587 B1 EP2655587 B1 EP 2655587B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- lipase
- acid
- surfactant preparation
- phosphonate
- surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004094 surface-active agent Substances 0.000 title claims description 131
- 108090001060 Lipase Proteins 0.000 title claims description 127
- 102000004882 Lipase Human genes 0.000 title claims description 127
- 239000004367 Lipase Substances 0.000 title claims description 126
- 235000019421 lipase Nutrition 0.000 title claims description 126
- 238000002360 preparation method Methods 0.000 title claims description 119
- 239000007788 liquid Substances 0.000 title claims description 35
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 title claims description 31
- 239000000203 mixture Substances 0.000 claims description 49
- 238000004140 cleaning Methods 0.000 claims description 46
- -1 DETPMP or DTPNT) Chemical compound 0.000 claims description 40
- 102000004190 Enzymes Human genes 0.000 claims description 38
- 108090000790 Enzymes Proteins 0.000 claims description 38
- 229940088598 enzyme Drugs 0.000 claims description 38
- 239000000126 substance Substances 0.000 claims description 38
- 238000005406 washing Methods 0.000 claims description 33
- YDONNITUKPKTIG-UHFFFAOYSA-N [Nitrilotris(methylene)]trisphosphonic acid Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CP(O)(O)=O YDONNITUKPKTIG-UHFFFAOYSA-N 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 29
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 claims description 26
- 244000005700 microbiome Species 0.000 claims description 26
- 150000003839 salts Chemical class 0.000 claims description 25
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 21
- 239000002253 acid Substances 0.000 claims description 20
- 150000001875 compounds Chemical class 0.000 claims description 20
- 239000004615 ingredient Substances 0.000 claims description 18
- 240000005384 Rhizopus oryzae Species 0.000 claims description 17
- 229940120146 EDTMP Drugs 0.000 claims description 16
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 235000013752 Rhizopus oryzae Nutrition 0.000 claims description 15
- 102000004169 proteins and genes Human genes 0.000 claims description 15
- 241000498617 Mucor javanicus Species 0.000 claims description 14
- 239000007844 bleaching agent Substances 0.000 claims description 14
- 108010059892 Cellulase Proteins 0.000 claims description 13
- 239000000645 desinfectant Substances 0.000 claims description 13
- 239000002562 thickening agent Substances 0.000 claims description 13
- 108091005804 Peptidases Proteins 0.000 claims description 12
- 230000000249 desinfective effect Effects 0.000 claims description 12
- 239000004365 Protease Substances 0.000 claims description 11
- 238000004659 sterilization and disinfection Methods 0.000 claims description 11
- 102000004316 Oxidoreductases Human genes 0.000 claims description 9
- 108090000854 Oxidoreductases Proteins 0.000 claims description 9
- 239000004744 fabric Substances 0.000 claims description 9
- 230000002366 lipolytic effect Effects 0.000 claims description 9
- DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000012190 activator Substances 0.000 claims description 7
- 229940090960 diethylenetriamine pentamethylene phosphonic acid Drugs 0.000 claims description 7
- 108010065511 Amylases Proteins 0.000 claims description 6
- 102000013142 Amylases Human genes 0.000 claims description 6
- 235000019418 amylase Nutrition 0.000 claims description 6
- 125000000129 anionic group Chemical group 0.000 claims description 6
- 229940106157 cellulase Drugs 0.000 claims description 6
- 239000012459 cleaning agent Substances 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 239000002689 soil Substances 0.000 claims description 6
- 102100032487 Beta-mannosidase Human genes 0.000 claims description 5
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 claims description 5
- 108010055059 beta-Mannosidase Proteins 0.000 claims description 5
- 108010059820 Polygalacturonase Proteins 0.000 claims description 4
- 239000003125 aqueous solvent Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 4
- 108010002430 hemicellulase Proteins 0.000 claims description 4
- 239000004382 Amylase Substances 0.000 claims description 3
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 3
- 125000002091 cationic group Chemical group 0.000 claims description 3
- 229940059442 hemicellulase Drugs 0.000 claims description 2
- 108010038851 tannase Proteins 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 108010047754 beta-Glucosidase Proteins 0.000 claims 1
- 102000006995 beta-Glucosidase Human genes 0.000 claims 1
- 239000003599 detergent Substances 0.000 description 37
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 30
- 235000002639 sodium chloride Nutrition 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 239000000047 product Substances 0.000 description 20
- 239000004753 textile Substances 0.000 description 19
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 18
- 238000009472 formulation Methods 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 229920002125 SokalanĀ® Polymers 0.000 description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 229920000742 Cotton Polymers 0.000 description 13
- 150000007513 acids Chemical class 0.000 description 13
- 150000002191 fatty alcohols Chemical class 0.000 description 13
- 125000000217 alkyl group Chemical group 0.000 description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 12
- 229920000642 polymer Polymers 0.000 description 12
- 102000035195 Peptidases Human genes 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 239000002736 nonionic surfactant Substances 0.000 description 11
- 150000007523 nucleic acids Chemical group 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 10
- 239000003945 anionic surfactant Substances 0.000 description 10
- 239000006229 carbon black Substances 0.000 description 10
- 229920001577 copolymer Polymers 0.000 description 10
- 108010084185 Cellulases Proteins 0.000 description 9
- 102000005575 Cellulases Human genes 0.000 description 9
- 150000004665 fatty acids Chemical class 0.000 description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 159000000000 sodium salts Chemical class 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 7
- 108010056079 Subtilisins Proteins 0.000 description 7
- 102000005158 Subtilisins Human genes 0.000 description 7
- 150000001298 alcohols Chemical class 0.000 description 7
- 229910052783 alkali metal Inorganic materials 0.000 description 7
- 125000003118 aryl group Chemical group 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 239000000178 monomer Substances 0.000 description 7
- 108020004707 nucleic acids Proteins 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 229920005646 polycarboxylate Polymers 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- 101100097467 Arabidopsis thaliana SYD gene Proteins 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 101100495925 Schizosaccharomyces pombe (strain 972 / ATCC 24843) chr3 gene Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 6
- 108090000637 alpha-Amylases Proteins 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 125000000623 heterocyclic group Chemical group 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000004006 olive oil Substances 0.000 description 6
- 235000008390 olive oil Nutrition 0.000 description 6
- 239000000049 pigment Substances 0.000 description 6
- 235000019419 proteases Nutrition 0.000 description 6
- 210000002374 sebum Anatomy 0.000 description 6
- 229920001285 xanthan gum Polymers 0.000 description 6
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 5
- SZHQPBJEOCHCKM-UHFFFAOYSA-N 2-phosphonobutane-1,2,4-tricarboxylic acid Chemical compound OC(=O)CCC(P(O)(O)=O)(C(O)=O)CC(O)=O SZHQPBJEOCHCKM-UHFFFAOYSA-N 0.000 description 5
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 5
- 244000060011 Cocos nucifera Species 0.000 description 5
- 235000013162 Cocos nucifera Nutrition 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 125000003342 alkenyl group Chemical group 0.000 description 5
- 102000004139 alpha-Amylases Human genes 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 235000015165 citric acid Nutrition 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 230000002255 enzymatic effect Effects 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 229920000058 polyacrylate Polymers 0.000 description 5
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 5
- 239000000344 soap Substances 0.000 description 5
- 239000003760 tallow Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229910052723 transition metal Inorganic materials 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
- 125000002877 alkyl aryl group Chemical group 0.000 description 4
- 229940024171 alpha-amylase Drugs 0.000 description 4
- 229940025131 amylases Drugs 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 150000004820 halides Chemical group 0.000 description 4
- 239000002480 mineral oil Substances 0.000 description 4
- 235000010446 mineral oil Nutrition 0.000 description 4
- 238000002887 multiple sequence alignment Methods 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 3
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000001361 adipic acid Substances 0.000 description 3
- 235000011037 adipic acid Nutrition 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 238000004061 bleaching Methods 0.000 description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 239000008139 complexing agent Substances 0.000 description 3
- 108010005400 cutinase Proteins 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 230000002070 germicidal effect Effects 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 235000019626 lipase activity Nutrition 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 239000010677 tea tree oil Substances 0.000 description 3
- 229940111630 tea tree oil Drugs 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 150000003624 transition metals Chemical class 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 2
- ZGZHWIAQICBGKN-UHFFFAOYSA-N 1-nonanoylpyrrolidine-2,5-dione Chemical compound CCCCCCCCC(=O)N1C(=O)CCC1=O ZGZHWIAQICBGKN-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- CIEZZGWIJBXOTE-UHFFFAOYSA-N 2-[bis(carboxymethyl)amino]propanoic acid Chemical compound OC(=O)C(C)N(CC(O)=O)CC(O)=O CIEZZGWIJBXOTE-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 2
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241001328119 Bacillus gibsonii Species 0.000 description 2
- 241000193422 Bacillus lentus Species 0.000 description 2
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- 108091005658 Basic proteases Proteins 0.000 description 2
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 241001480714 Humicola insolens Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000183011 Melanocarpus Species 0.000 description 2
- 241001480490 Mucoraceae Species 0.000 description 2
- 241000235388 Mucorales Species 0.000 description 2
- 241000219926 Myrtaceae Species 0.000 description 2
- 239000004435 Oxo alcohol Substances 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 101000966369 Rhizopus oryzae Lipase Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- MOYAFQVGZZPNRA-UHFFFAOYSA-N Terpinolene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 description 2
- BGRWYDHXPHLNKA-UHFFFAOYSA-N Tetraacetylethylenediamine Chemical compound CC(=O)N(C(C)=O)CCN(C(C)=O)C(C)=O BGRWYDHXPHLNKA-UHFFFAOYSA-N 0.000 description 2
- 241000223258 Thermomyces lanuginosus Species 0.000 description 2
- UAOKXEHOENRFMP-ZJIFWQFVSA-N [(2r,3r,4s,5r)-2,3,4,5-tetraacetyloxy-6-oxohexyl] acetate Chemical compound CC(=O)OC[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)C=O UAOKXEHOENRFMP-ZJIFWQFVSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 125000006193 alkinyl group Chemical group 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- AFYNADDZULBEJA-UHFFFAOYSA-N bicinchoninic acid Chemical compound C1=CC=CC2=NC(C=3C=C(C4=CC=CC=C4N=3)C(=O)O)=CC(C(O)=O)=C21 AFYNADDZULBEJA-UHFFFAOYSA-N 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000004851 dishwashing Methods 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical class CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000009969 flowable effect Effects 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 150000002357 guanidines Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 230000004130 lipolysis Effects 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 238000010297 mechanical methods and process Methods 0.000 description 2
- 230000005226 mechanical processes and functions Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229920000172 poly(styrenesulfonic acid) Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000004071 soot Substances 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 150000003871 sulfonates Chemical class 0.000 description 2
- 238000006277 sulfonation reaction Methods 0.000 description 2
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 108010075550 termamyl Proteins 0.000 description 2
- 125000004299 tetrazol-5-yl group Chemical group [H]N1N=NC(*)=N1 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 230000003253 viricidal effect Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- YHQGMYUVUMAZJR-UHFFFAOYSA-N Ī±-terpinene Chemical compound CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- FFLHFURRPPIZTQ-UHFFFAOYSA-N (5-acetyloxy-2,5-dihydrofuran-2-yl) acetate Chemical compound CC(=O)OC1OC(OC(C)=O)C=C1 FFLHFURRPPIZTQ-UHFFFAOYSA-N 0.000 description 1
- ZQEOKONOFKQRIR-NUEKZKHPSA-N (5R,6R,7R)-3,5,6-triacetyl-3,5,6,7-tetrahydroxy-7-(hydroxymethyl)nonane-2,4,8-trione Chemical compound C(C)(=O)[C@@]([C@]([C@@](C(C(O)(C(C)=O)C(C)=O)=O)(O)C(C)=O)(O)C(C)=O)(O)CO ZQEOKONOFKQRIR-NUEKZKHPSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- VUWCWMOCWKCZTA-UHFFFAOYSA-N 1,2-thiazol-4-one Chemical class O=C1CSN=C1 VUWCWMOCWKCZTA-UHFFFAOYSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- LYPVKWMHGFMDPD-UHFFFAOYSA-N 1,5-diacetyl-1,3,5-triazinane-2,4-dione Chemical compound CC(=O)N1CN(C(C)=O)C(=O)NC1=O LYPVKWMHGFMDPD-UHFFFAOYSA-N 0.000 description 1
- NPMRPDRLIHYOBW-UHFFFAOYSA-N 1-(2-butoxyethoxy)propan-2-ol Chemical compound CCCCOCCOCC(C)O NPMRPDRLIHYOBW-UHFFFAOYSA-N 0.000 description 1
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 1
- MITNMQMWBBEWFQ-UHFFFAOYSA-N 1-(4-chlorophenyl)-1-(3,4-dichlorophenyl)urea Chemical compound C=1C=C(Cl)C(Cl)=CC=1N(C(=O)N)C1=CC=C(Cl)C=C1 MITNMQMWBBEWFQ-UHFFFAOYSA-N 0.000 description 1
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N 1-Tetradecanol Natural products CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 1
- FEFQUIPMKBPKAR-UHFFFAOYSA-N 1-benzoylazepan-2-one Chemical compound C=1C=CC=CC=1C(=O)N1CCCCCC1=O FEFQUIPMKBPKAR-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- FENFUOGYJVOCRY-UHFFFAOYSA-N 1-propoxypropan-2-ol Chemical compound CCCOCC(C)O FENFUOGYJVOCRY-UHFFFAOYSA-N 0.000 description 1
- GQCZPFJGIXHZMB-UHFFFAOYSA-N 1-tert-Butoxy-2-propanol Chemical compound CC(O)COC(C)(C)C GQCZPFJGIXHZMB-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- COBPKKZHLDDMTB-UHFFFAOYSA-N 2-[2-(2-butoxyethoxy)ethoxy]ethanol Chemical compound CCCCOCCOCCOCCO COBPKKZHLDDMTB-UHFFFAOYSA-N 0.000 description 1
- WFSMVVDJSNMRAR-UHFFFAOYSA-N 2-[2-(2-ethoxyethoxy)ethoxy]ethanol Chemical compound CCOCCOCCOCCO WFSMVVDJSNMRAR-UHFFFAOYSA-N 0.000 description 1
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 1
- NCKMMSIFQUPKCK-UHFFFAOYSA-N 2-benzyl-4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1CC1=CC=CC=C1 NCKMMSIFQUPKCK-UHFFFAOYSA-N 0.000 description 1
- DHVLDKHFGIVEIP-UHFFFAOYSA-N 2-bromo-2-(bromomethyl)pentanedinitrile Chemical compound BrCC(Br)(C#N)CCC#N DHVLDKHFGIVEIP-UHFFFAOYSA-N 0.000 description 1
- ZIYRDJLAJYTELF-UHFFFAOYSA-N 2-bromo-4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1Br ZIYRDJLAJYTELF-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- XEEYSDHEOQHCDA-UHFFFAOYSA-N 2-methylprop-2-ene-1-sulfonic acid Chemical compound CC(=C)CS(O)(=O)=O XEEYSDHEOQHCDA-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- YEYKMVJDLWJFOA-UHFFFAOYSA-N 2-propoxyethanol Chemical compound CCCOCCO YEYKMVJDLWJFOA-UHFFFAOYSA-N 0.000 description 1
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- MFKRHJVUCZRDTF-UHFFFAOYSA-N 3-methoxy-3-methylbutan-1-ol Chemical compound COC(C)(C)CCO MFKRHJVUCZRDTF-UHFFFAOYSA-N 0.000 description 1
- GUUULVAMQJLDSY-UHFFFAOYSA-N 4,5-dihydro-1,2-thiazole Chemical class C1CC=NS1 GUUULVAMQJLDSY-UHFFFAOYSA-N 0.000 description 1
- XWWZJGOBESJRBC-UHFFFAOYSA-N 4,6,6-trimethyl-3-[4,6,6-trimethyl-3-(4,6,6-trimethyl-3-bicyclo[3.1.1]hept-4-enyl)-3-bicyclo[3.1.1]hept-4-enyl]bicyclo[3.1.1]hept-4-en-2-ol Chemical compound OC1C(C2)C(C)(C)C2=C(C)C1C1(C(=C2CC(C2(C)C)C1)C)C1CC(C2(C)C)CC2=C1C XWWZJGOBESJRBC-UHFFFAOYSA-N 0.000 description 1
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-M 4-nitrophenolate Chemical compound [O-]C1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-M 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 101000775727 Bacillus amyloliquefaciens Alpha-amylase Proteins 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 101000740449 Bacillus subtilis (strain 168) Biotin/lipoyl attachment protein Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 240000000113 Baeckea frutescens Species 0.000 description 1
- 235000004335 Baeckea frutescens Nutrition 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 101710130006 Beta-glucanase Proteins 0.000 description 1
- 108700038091 Beta-glucanases Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 108010073997 Bromide peroxidase Proteins 0.000 description 1
- 101100294115 Caenorhabditis elegans nhr-4 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 108010035722 Chloride peroxidase Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- 108010083608 Durazym Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000427940 Fusarium solani Species 0.000 description 1
- 102220644676 Galectin-related protein_D96L_mutation Human genes 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 241000223198 Humicola Species 0.000 description 1
- 241001514666 Kunzea Species 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241001514662 Leptospermum Species 0.000 description 1
- 244000011376 Leptospermum laevigatum Species 0.000 description 1
- 235000017865 Leptospermum laevigatum Nutrition 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 108010054320 Lignin peroxidase Proteins 0.000 description 1
- 108010048733 Lipozyme Proteins 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 108010059896 Manganese peroxidase Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 description 1
- 241000378467 Melaleuca Species 0.000 description 1
- 241000366182 Melaleuca alternifolia Species 0.000 description 1
- 241001184659 Melanocarpus albomyces Species 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108010029182 Pectin lyase Proteins 0.000 description 1
- SCKXCAADGDQQCS-UHFFFAOYSA-N Performic acid Chemical compound OOC=O SCKXCAADGDQQCS-UHFFFAOYSA-N 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589755 Pseudomonas mendocina Species 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 241001292348 Salipaludibacillus agaradhaerens Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 101710135785 Subtilisin-like protease Proteins 0.000 description 1
- 241001495429 Thielavia terrestris Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241000499912 Trichoderma reesei Species 0.000 description 1
- 241000223230 Trichosporon Species 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 150000001345 alkine derivatives Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000005263 alkylenediamine group Polymers 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- VUEDNLCYHKSELL-UHFFFAOYSA-N arsonium Chemical group [AsH4+] VUEDNLCYHKSELL-UHFFFAOYSA-N 0.000 description 1
- 150000005840 aryl radicals Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000002869 basic local alignment search tool Methods 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 150000003937 benzamidines Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 238000010352 biotechnological method Methods 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- DLEPCXYNAPUMDZ-UHFFFAOYSA-N butan-2-ylphosphonic acid Chemical compound CCC(C)P(O)(O)=O DLEPCXYNAPUMDZ-UHFFFAOYSA-N 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000007046 ethoxylation reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000002979 fabric softener Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 230000022244 formylation Effects 0.000 description 1
- 238000006170 formylation reaction Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 108010046301 glucose peroxidase Proteins 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 125000001046 glycoluril group Chemical group [H]C12N(*)C(=O)N(*)C1([H])N(*)C(=O)N2* 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Inorganic materials Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- MGFYSGNNHQQTJW-UHFFFAOYSA-N iodonium Chemical compound [IH2+] MGFYSGNNHQQTJW-UHFFFAOYSA-N 0.000 description 1
- 150000003854 isothiazoles Chemical class 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- ZGYKKZRFCQCGTB-UHFFFAOYSA-N methoxy-[6-(4-nitrophenyl)hexyl]phosphinic acid Chemical compound COP(O)(=O)CCCCCCC1=CC=C([N+]([O-])=O)C=C1 ZGYKKZRFCQCGTB-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 108010020132 microbial serine proteinases Proteins 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N n-hexadecyl alcohol Natural products CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- SMGTYJPMKXNQFY-UHFFFAOYSA-N octenidine dihydrochloride Chemical compound Cl.Cl.C1=CC(=NCCCCCCCC)C=CN1CCCCCCCCCCN1C=CC(=NCCCCCCCC)C=C1 SMGTYJPMKXNQFY-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 150000004967 organic peroxy acids Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108010087558 pectate lyase Proteins 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 108020004410 pectinesterase Proteins 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 125000000538 pentafluorophenyl group Chemical group FC1=C(F)C(F)=C(*)C(F)=C1F 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L persulfate group Chemical group S(=O)(=O)([O-])OOS(=O)(=O)[O-] JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- PATMLLNMTPIUSY-UHFFFAOYSA-N phenoxysulfonyl 7-methyloctanoate Chemical compound CC(C)CCCCCC(=O)OS(=O)(=O)OC1=CC=CC=C1 PATMLLNMTPIUSY-UHFFFAOYSA-N 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- AQSJGOWTSHOLKH-UHFFFAOYSA-N phosphite(3-) Chemical group [O-]P([O-])[O-] AQSJGOWTSHOLKH-UHFFFAOYSA-N 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical class NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical class C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 229920000083 poly(allylamine) Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920001444 polymaleic acid Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- USGIERNETOEMNR-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO.CCCO USGIERNETOEMNR-UHFFFAOYSA-N 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- YLQLIQIAXYRMDL-UHFFFAOYSA-N propylheptyl alcohol Chemical compound CCCCCC(CO)CCC YLQLIQIAXYRMDL-UHFFFAOYSA-N 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 125000005017 substituted alkenyl group Chemical group 0.000 description 1
- 125000004426 substituted alkynyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 1
- 229940086735 succinate Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical compound [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 1
- 150000003470 sulfuric acid monoesters Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229940116411 terpineol Drugs 0.000 description 1
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical class CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 108010031354 thermitase Proteins 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 238000012250 transgenic expression Methods 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- JLGLQAWTXXGVEM-UHFFFAOYSA-N triethylene glycol monomethyl ether Chemical compound COCCOCCOCCO JLGLQAWTXXGVEM-UHFFFAOYSA-N 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- JSPLKZUTYZBBKA-UHFFFAOYSA-N trioxidane Chemical compound OOO JSPLKZUTYZBBKA-UHFFFAOYSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 108010068608 xanthan lyase Proteins 0.000 description 1
- 108010083879 xyloglucan endo(1-4)-beta-D-glucanase Proteins 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06L—DRY-CLEANING, WASHING OR BLEACHING FIBRES, FILAMENTS, THREADS, YARNS, FABRICS, FEATHERS OR MADE-UP FIBROUS GOODS; BLEACHING LEATHER OR FURS
- D06L4/00—Bleaching fibres, filaments, threads, yarns, fabrics, feathers or made-up fibrous goods; Bleaching leather or furs
- D06L4/40—Bleaching fibres, filaments, threads, yarns, fabrics, feathers or made-up fibrous goods; Bleaching leather or furs using enzymes
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38627—Preparations containing enzymes, e.g. protease or amylase containing lipase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/78—Neutral esters of acids of phosphorus
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/36—Organic compounds containing phosphorus
- C11D3/361—Phosphonates, phosphinates or phosphonites
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/36—Organic compounds containing phosphorus
- C11D3/364—Organic compounds containing phosphorus containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/36—Organic compounds containing phosphorus
- C11D3/365—Organic compounds containing phosphorus containing carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
Definitions
- the invention is in the field of liquid enzyme-containing surfactant preparations, as used for example in washing, cleaning or disinfecting. More particularly, the invention relates to liquid enzyme-containing surfactant formulations containing defined lipases in combination with a phosphonate, and further proposes uses and methods in which such formulations are employed. The invention further relates to uses of defined lipases in liquid surfactant formulations containing a phosphonate.
- Surfactant preparations in particular in modern liquid detergents, but also in detergents or disinfectants, often contain phosphonates. They are used, for example, as complexing agents, to prevent precipitation or as a bleach stabilizer. As complexing agents they serve, for example, as water softeners. They can encase cations such as Ca 2+ in the solution and thus alter the chemical behavior of the cation. In the case of calcium, the property of water hardness disappears. Other cations can be complexed and thus protected against chemical reactions. They can also participate as corrosion inhibitors or serve as a stabilizer for peroxides, especially in bleaching agents.
- complexing agents serve, for example, as water softeners. They can encase cations such as Ca 2+ in the solution and thus alter the chemical behavior of the cation. In the case of calcium, the property of water hardness disappears. Other cations can be complexed and thus protected against chemical reactions. They can also participate as corrosion inhibitors or serve as a stabilizer for peroxides, especially in bleach
- lipase is increasingly used in surfactant preparations, in particular in detergents or cleaners.
- a lipase is an enzyme that catalyzes the hydrolysis of ester bonds in lipid substrates, especially in fats and oils. Lipases are therefore a group of esterases. Lipases are generally versatile enzymes that accept a variety of substrates, for example, aliphatic, alicyclic, bicyclic and aromatic esters, thioesters and activated amines. Lipases act against fat residues in the laundry to catalyze their hydrolysis (lipolysis).
- Lipases with broad substrate spectra are used in particular where inhomogeneous raw materials or substrate mixtures have to be reacted, for example in detergents and cleaners, since soiling may consist of differently structured fats and oils.
- the lipases used in the washing or cleaning agents known from the prior art are usually of microbial origin and are usually derived from bacteria or fungi, for example the genera Bacillus, Pseudomonas, Acinetobacter, Micrococcus, Humicola, Trichoderma or Trichosporon. Lipases are usually produced by biotechnological methods known per se by suitable microorganisms, for example by transgenic expression hosts of the genera Bacillus or by filamentous fungi.
- EP 443063 is, for example, intended for detergents and cleaners lipase from Pseudomonas sp. ATCC 21808, but not explicitly for use in a phosphonate-containing liquid formulation.
- JP 1225490 is a lipase from Rhizopus oryzae disclosed.
- this document also does not disclose a specific liquid surfactant preparation which necessarily contains a phosphonate in combination with a Rhizopus oryzae lipase.
- WO037097780 discloses combinations of certain lipases with transition metal bleach catalysts to increase cleaning performance.
- WO2005 / 124012 discloses an enzymatic bleaching system containing phosphonate, at least one oxidase and at least one perhydrolase, and their use in various care and cleaning agents.
- lipases from Rhizopus oryzae or Mucor javanicus are not mentioned in either document.
- WO2004 / 053039 discloses detergent compositions containing a combination of an endoglucanase and a Rhizopus oryzae lipase. However, these detergent compositions do not contain phosphonates.
- DE 102007003143 discloses alkaline proteases from Bacillus gibsonii, and their use in detergents and cleaners, as well as their combination with lipases.
- a liquid surfactant preparation containing a phosphonate in combination with a lipase from Rhizopus oryzae or Mucor javanicus is also not apparent from this document.
- lipases are suitable for use in liquid surfactant preparations. Many lipases do not show sufficient catalytic performance or stability in such formulations. In phosphonate-containing liquid surfactant preparations, this problem is even more serious, for example due to the complex-forming properties of the phosphonates or due to unfavorable interactions between the phosphonate and the lipase.
- lipase-containing liquid surfactant preparations of the prior art in particular those containing phosphonates, have the disadvantage that they often do not have satisfactory lipolytic activity and therefore the surfactant preparation does not show optimal cleaning performance on lipase-sensitive soils.
- the object of the present invention is to overcome the mentioned disadvantage and to provide a phosphonate-containing liquid surfactant preparation which has a beneficial lipolytic activity.
- An object of the invention is a liquid surfactant preparation comprising a phosphonate and a lipase which is naturally present in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucorjavanicus.
- a liquid surfactant preparation which contains the combination of such a lipase with a phosphonate has advantageous cleaning performance on lipase-sensitive soiling.
- a surfactant preparation exhibits an improved cleaning performance on at least one, preferably on several lipase-sensitive stains, in particular on textiles and / or hard surfaces.
- a surfactant preparation according to the invention is also advantageously storage-stable.
- inventive surfactant formulations show an advantageous cleaning performance with respect to at least one lipase-sensitive soiling at temperatures between 10 Ā° C and 80 Ā° C, preferably also at low temperatures, for example between 10 Ā° C and 50 Ā° C, between 10 Ā° C and 40 Ā° C or between 20 Ā° C and 40 Ā° C.
- the present invention is therefore a particularly advantageous selection of a lipase for a phosphonate-containing liquid surfactant preparation.
- cleaning performance is understood to mean the whitening performance of one or more soiling, in particular laundry soiling or scrape dirt, which are sensitive to degradation by the lipase.
- soiling in particular laundry soiling or scrape dirt
- examples of such stains are carbon black / mineral oil, carbon black / olive oil, pigment / oil or skin fat (sebum) / carbon black, in each case for example on cotton fabric, in particular as indicated below.
- both the surfactant preparation which comprises the lipase or the washing or cleaning liquor formed by this surfactant preparation, and the lipase itself have a respective cleaning performance.
- the cleaning performance of the lipase thus contributes to the cleaning performance of the surfactant preparation or the washing or cleaning liquor formed by the surfactant preparation.
- the cleaning performance is preferably determined as indicated below.
- Washing or cleaning liquor is understood as meaning the use solution containing the surfactant preparation which acts on textiles or fabrics (wash liquor) or hard surfaces (cleaning liquor) and thus comes into contact with the soiling present on textiles or fabrics or hard surfaces.
- the washing or cleaning liquor arises when the washing or cleaning process begins and the surfactant preparation, in particular the detergent or cleaning agent, for example, in a washing machine, dishwasher or other suitable container is diluted with water.
- a lipase contained in a surfactant preparation according to the invention has a lipolytic activity, that is, it is capable of hydrolysis (lipolysis) of lipids such as glycerides or cholesterol esters.
- the lipase contained in a surfactant preparation according to the invention is naturally present in a microorganism of the species Rhizopus oryzae or Mucor javanicus. Naturally present in this context means that the lipase is a separate enzyme of the microorganism.
- the lipase can thus be expressed in the microorganism from a nucleic acid sequence which is part of the chromosomal DNA of the microorganism in its wild-type form.
- nucleic acid sequence is therefore present in the wild-type form of the microorganism and / or can be isolated from the wild-type form of the microorganism from this.
- a lipase or the nucleic acid sequence coding for it in the microorganism would be incorporated into the microorganism by means of genetic engineering have been deliberately introduced so that the microorganism would have been enriched to the lipase or the coding for them nucleic acid sequence.
- a lipase naturally present in a microorganism of the genus Rhizopus oryzae or Mucor javanicus may well have been produced recombinantly from another organism.
- the fungus Rhizopus oryzae belongs to the class of Zygomycetes (subclass Incertae sedis), herein to the order Mucorales and here again to the family Mucoraceae and the genus Rhizopus.
- the fungus Mucorjavanicus also belongs to the class of Zygomycetes (subclass Incertae sedis), herein to the order Mucorales and here again to the family Mucoraceae, then herein to the genus Mucor.
- the names Rhizopus oryzae and Mucorjavanicus are the biological species names within the respective genus.
- Phosphonates are salts and organic compounds, especially esters, of phosphonic acid.
- M' stands for a monovalent metal.
- inorganic phosphonates are also referred to as primary and secondary phosphites, respectively.
- Inorganic phosphonates are formed, for example, by reaction of phosphonic acid HP (O) (OH) 2 , in particular the stable tautomeric form of phosphorous acid with a (primary) or two (secondary) equivalents of base, for example alkali metal hydroxide.
- organic P-substituted phosphonates which have a phosphorus-carbon bond (phosphorus-organic compounds).
- Organic P-substituted phosphonates are formed, for example, by the Michaelis-Arbusov reaction. Many of these phosphonates are soluble in water. Some technically important phosphonates also carry amino group (s). Some of these aminophosphonates have structural similarities to complexing agents such as EDTA, NTA or DTPA and have a similar function.
- Particularly preferred phosphonates in the context of the present invention are 1-hydroxyethane-1,1-diphosphonic acid (HEDP), aminotrimethylenephosphonic acid (ATMP), nitrilotrimethylenephosphonic acid (NTMP), diethylenetriaminepentamethylenephosphonic acid (DTPMP, DETPMP or DTPNT), ethylenediamine tetramethylenephosphonic acid (EDTMP) and 2-phosphonobutane.
- HEDP 1-hydroxyethane-1,1-diphosphonic acid
- ATMP aminotrimethylenephosphonic acid
- NTMP nitrilotrimethylenephosphonic acid
- DTPMP diethylenetriaminepentamethylenephosphonic acid
- DETPMP DETPMP or DTPNT
- ETMP ethylenediamine tetramethylenephosphonic acid
- 2-phosphonobutane 2-phosphonobutane.
- 1,2,4-tricarboxylic acid PBS-AM, also referred to as 3-carboxy-3-phosphonoadipic acid
- DTPMP diethylenetriaminepentamethylenephosphonic acid sodium
- HEDP 1-hydroxyethane-1,1-diphosphonic acid
- Such phosphonates are available, for example, under the trade names DequestĀ® 2066 and DequestĀ® 2010 (each from Thermphos).
- the surfactant preparation is characterized in that the lipase has an amino acid sequence which corresponds to the amino acid sequence shown in SEQ ID NO. 1 amino acid sequence is at least 80% identical. More preferably, the amino acid sequence is at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95% %, 96%, 97%, 98%, 99% and most preferably 100% identical to that shown in SEQ ID NO. 1 indicated amino acid sequence.
- SEQ ID NO. 1 is the sequence of a mature (mature) lipase from Rhizopus oryzae.
- Lipases which are very particularly preferred according to the invention are the lipase enzymes obtainable from the company Amano Pharmaceuticals under the names Lipase M-AP10Ā®, Lipase LEĀ® and Lipase FĀ® (also Lipase JVĀ®).
- the Lipase FĀ® is naturally present in Rhizopus oryzae.
- the lipase M-AP10Ā® is naturally present in Mucor javanicus.
- a lipase to a liquid surfactant preparation which comprises a phosphonate, in particular one as described above, provides a particularly advantageous lipolytic activity in this preparation.
- surfactant preparations are sufficiently stable on storage, in particular with regard to their remaining lipolytic activity after storage, in particular after a storage period of 1 to 5 weeks, 1 to 4 weeks, 1.5 to 3 weeks and particularly preferably after 2 weeks.
- nucleic acid or amino acid sequences is determined by a sequence comparison. Such a comparison is made by assigning similar sequences in the nucleotide sequences or amino acid sequences to each other. This sequence comparison is preferably carried out based on the BLAST algorithm established and commonly used in the prior art (cf., for example, US Pat Altschul, SF, Gish, W., Miller, W., Myers, EW & Lipman, DJ (1990) "Basic local alignment search tool.ā J. Mol. Biol. 215: 403-410 , and Altschul, Stephan F., Thomas L. Madden, Alejandro A. Schaffer, Jinghui Zhang, Hheng Zhang, Webb Miller, and David J.
- T-Coffee cf., for example Notredame et al. (2000): T-Coffee: A novel method for multiple sequence alignments. J. Mol. Biol. 302, 205-217 ) or programs based on these programs or algorithms.
- Clustal cf., for example, Chenna et al. (2003): Multiple sequence alignment with the Clustal series of programs.
- T-Coffee cf., for example Notredame et al. (2000): T-Coffee: A novel method for multiple sequence alignments. J. Mol. Biol.
- sequence comparisons and alignments are preferably created with the computer program Vector NTIĀ® Suite 10.3 (Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, California, USA) with the default parameters specified.
- nucleic acid or amino acid sequence can be small and comprise only a few nucleotides or amino acids. Often, such small regions exert essential functions for the overall activity of the protein. It may therefore be useful to relate sequence matches only to individual, possibly small areas. Unless stated otherwise, identity or homology information in the present application, however, refers to the total length of the respectively indicated nucleic acid or amino acid sequence.
- the detergent for the washing system is a liquid detergent composed as follows (all figures in weight percent): 0.3-0.5% xanthan gum, 0.2-0.4% anti-foaming agent, 6-7% glycerol, 0.3-0.5% ethanol, 4-7% FAEOS (fatty alcohol ether sulfate), 24-28% nonionic surfactants, 1% boric acid, 1-2% sodium citrate (dihydrate), 2-4% soda , 14-16% coconut fatty acids, 0.5% HEDP (1-hydroxyethane-1,1-diphosphonic acid), 0-0.4% PVP (polyvinylpyrrolidone), 0-0.05% optical brightener, 0-0.001% Dye, remainder demineralized water.
- the lipase is used in this regard in a concentration of 0.0001-0.06 wt .-%, preferably from 0.001 to 0.006 wt .-%, in the detergent, based on active protein.
- the dosage of the liquid detergent is between 2.0 and 9.0, preferably between 2.5 and 8.0, between 3.0 and 7.0 and more preferably 3.5 grams per liter of wash liquor. Washing takes place in a pH range between pH 8 and pH 10.5, preferably between pH 8 and pH 9.
- the lipase activity in the wash liquor is not equal to zero at the start of washing.
- the degree of whiteness i. the brightening of the stains, as a measure of the cleaning performance is determined by optical measurement methods, preferably photometrically.
- a suitable device for this purpose is for example the spectrometer Minolta CM508d.
- the devices used for the measurement are previously calibrated with a white standard, preferably a supplied white standard.
- the activity-like use of the respective lipase ensures that even if the ratio of active substance to total protein (the values of the specific activity) diverge, the respective enzymatic properties, for example the cleaning performance of certain soils, are compared. In general, a low specific activity can be compensated by adding a larger amount of protein.
- the lipase activity is determined in a customary manner, preferably as described in Bruno Stellmach, "Methods of determination enzymes for pharmacy, food chemistry, engineering, biochemistry, biology, medicineā (Steinkopff Verlag Darmstadt, 1988, p 172ff).
- lipase-containing samples are added to an olive oil emulsion in emulsifier-containing water and incubated at 30 Ā° C and pH 9.0. This fatty acids are released. These will be with an autotitrator over 20min. titrated continuously with 0.01 N sodium hydroxide solution so that the pH remains constant (āpH-stat titration"). Based on the sodium hydroxide consumption, the determination of the lipase activity takes place by reference to a reference lipase sample.
- lipases are formed as so-called pre-proteins, ie together with a propeptide and / or a signal peptide. Often the prodrug and / or signal peptide are N-terminal sequences. In the course of the folding and / or secretion process of the protein Cleaved signal and / or propeptide, so that after the cleavage of the pro- and / or signal peptide, the then mature lipase exerts its catalytic activity without the originally present N-terminal amino acids.
- the mature (mature) lipases ie the enzymes processed after their preparation, are preferred over the preproteins.
- the lipases may also be modified by the cells producing them after production of the polypeptide chain, for example, by attachment of sugar molecules, formylations, aminations, etc. Such modifications are post-translational modifications and may, but do not, have an effect on the function of the lipase.
- the lipase contained in a surfactant preparation according to the invention may be adsorbed to carriers and / or embedded in encapsulating substances in order to protect them against premature inactivation. In the washing or cleaning liquor, ie under conditions of use, the lipase is then released and can develop their lipolytic action.
- the surfactant preparation is characterized in that the phosphonate is contained in an amount of 0.01 to 4 wt .-%. Further preferred amounts of the phosphonate contained in the surfactant preparation are from 0.01 to 3% by weight, from 0.01 to 2.5% by weight, from 0.02 to 2.4% by weight, from 0, 02 to 2 wt .-%, from 0.03 to 1.5 wt .-% or from 0.05 to 1 wt .-%.
- the lipase is preferably contained in a surfactant preparation according to the invention in each case in an amount of from 1 ā 10 -8 to 5% by weight, based on active protein. More preferably, the lipase is in an amount of 1 x 10 -7 -3 wt .-%, from 0.00001 to 1 wt .-%, from 0.0002 to 0.8% wt .-% and particularly preferably from 0 , 0008-0.4% wt .-% in a surfactant preparations according to the invention, based on active protein.
- the protein concentration can be determined by known methods, for example the BCA method (bicinchoninic acid, 2,2'-biquinolyl-4,4'-dicarboxylic acid) or the biuret method ( Gornall AG, CS Bardawill and MM David, J. Biol. Chem., 177 (1948), pp. 751-766 ).
- the Aktivenzymproteinehalt can by means of "Active Siteā titration of the lipase preparation according to Rotticci et al .: "An active-site titration method for lipasesā (Biochim Biophys Acta 1483 (1), pages 132-140 ).
- a surfactant preparation is to be understood as meaning any type of composition which comprises at least one surfactant.
- a composition contains a surfactant as described below.
- liquid or flowable administration forms can serve as liquid surfactant preparations.
- "Flowable" in the context of the present application are preparations which are pourable and can have viscosities of up to several tens of thousands of mPas. The viscosity can be measured by conventional standard methods (for example, Brookfield LVT-II viscosimeter at 20 rpm and 20 Ā° C., spindle 3) and is preferably in the range from 5 to 10,000 mPas.
- Preferred surfactant formulations have viscosities of 10 to 8000 mPas, with values between 120 to 3000 mPas being particularly preferred.
- a liquid surfactant preparation in the context of the present invention can therefore also be gelatinous or paste-like, it can be in the form of a homogeneous solution or suspension, and can be sprayed or packaged in other conventional dosage forms, for example.
- a liquid surfactant preparation according to the invention can be used as such or after dilution with water, in particular for the cleaning of textiles and / or hard surfaces.
- Such dilution can be readily made by diluting a measured amount of the surfactant preparation in a further amount of water in certain weight ratios of surfactant preparation: water and optionally shaking this dilution to ensure uniform distribution of the surfactant formulation in the water.
- Possible weight or volume ratios of the dilutions are from 1: 0 surfactant preparation: water to 1: 10,000 or 1: 20000 surfactant preparation: water, preferably from 1:10 to 1: 2000 surfactant preparation: water.
- a surfactant preparation in the sense of the present invention can therefore also be the washing or cleaning liquor itself.
- the surfactant preparation is a washing, cleaning or disinfecting agent.
- the detergents include all conceivable types of detergents, in particular detergents for textiles, carpets or natural fibers. They can be provided for manual and / or machine application.
- the detergents also include washing aids, which are added to the actual detergent in the manual or machine textile washing, in order to achieve a further effect.
- Detergents include all agents for cleaning and / or disinfecting hard surfaces also found in all of the above dosage forms, manual and automatic dishwashing detergents, carpet cleaners, abrasives, glass cleaners, toilet scavengers, etc.
- Textile pre- and post-treatment agent Finally, on the one hand are such means with which the laundry is brought into contact before the actual laundry, for example, for solving stubborn dirt, on the other hand, those in one of the actual textile laundry downstream step the laundry further desirable properties such as pleasant handle , Give crease-free or low static charge.
- the fabric softeners are calculated. Disinfectants are, for example, hand disinfectants, surface disinfectants and instrument disinfectants, which may also occur in the mentioned dosage forms.
- a disinfectant preferably causes a germ reduction by a factor of at least 10 4 , that is to say that of originally 10,000 proliferating germs (so-called colony-forming units - CFU) survived no more than a single, with viruses in this regard are not considered as germs, since they have no cytoplasm and have no own metabolism.
- Preferred disinfectants cause a germ reduction by a factor of at least 10 5 .
- surfactant (s) it is possible to use anionic, nonionic, zwitterionic and / or amphoteric surfactants. From an application point of view, preference is given to mixtures of anionic and nonionic surfactants.
- the total surfactant content of the liquid surfactant preparation is preferably below 60% by weight, and more preferably below 45% by weight, based on the total liquid surfactant formulation.
- Suitable nonionic surfactants include alkoxylated fatty alcohols, alkoxylated fatty acid alkyl esters, fatty acid amides, alkoxylated fatty acid amides, polyhydroxy fatty acid amides, alkylphenol polyglycol ethers, amine oxides, alkyl polyglucosides, and mixtures thereof.
- the nonionic surfactants used are preferably alkoxylated, advantageously ethoxylated, in particular primary, alcohols having preferably 8 to 18 carbon atoms and on average 1 to 12 moles of ethylene oxide (EO) per mole of alcohol, in which the alcohol radical can be linear or preferably methyl-branched in the 2-position or linear and methyl-branched radicals in the mixture can contain, as they are usually present in Oxoalkoholresten.
- alcohol ethoxylates with linear radicals of alcohols of native origin having 12 to 18 carbon atoms, for example of coconut, palm, tallow or oleyl alcohol, and on average 2 to 8 EO per mole of alcohol are preferred.
- Preferred ethoxylated alcohols include, for example, C12-14 alcohols containing 3 EO, 7 EO or 4 EO, C9-11 alcohol containing 7 EO, C 13-5 alcohols containing 3 EO, 5 EO, 7 EO or 8 EO, C 12-18 -alcohols with 3 EO, 5 EO or 7 EO and mixtures of these, such as mixtures of C 12-14 -alcohol with 3 EO and C 12-18 -alcohol with 7 EO.
- the degrees of ethoxylation given represent statistical means which, for a particular product, may be an integer or a fractional number.
- Preferred alcohol ethoxylates have a narrowed Homolog distribution (narrow range ethoxylates, NRE).
- fatty alcohols with more than 12 EO can also be used. Examples include tallow fatty alcohol with 14 EO, 25 EO, 30 EO or 40 EO.
- Nonionic surfactants containing EO and PO groups together in the molecule can also be used according to the invention. Also suitable are also a mixture of a (more) branched ethoxylated fatty alcohol and an unbranched ethoxylated fatty alcohol, such as a mixture of a C 16-18 fatty alcohol with 7 EO and 2-propylheptanol with 7 EO.
- the surfactant preparation contains a C 12-18 fatty alcohol with 7 EO or a C 13-15 oxo alcohol with 7 EO as nonionic surfactant.
- the content of nonionic surfactants is preferably 3 to 40 wt .-%, preferably 5 to 30 wt .-% and in particular 7 to 20 wt .-%, each based on the total surfactant.
- the surfactant preparation may also contain anionic surfactants.
- the anionic surfactant used is preferably sulfonates, sulfates, soaps, alkyl phosphates, anionic silicone surfactants and mixtures thereof.
- the surfactants of the sulfonate type are preferably C 9-13 -alkylbenzenesulfonates, olefinsulfonates, ie mixtures of alkene and hydroxyalkanesulfonates and disulfonates, as are obtained, for example, from C 12-18 -monoolefins having terminal or internal double bonds by sulfonation with gaseous sulfur trioxide and subsequent alkaline or acid hydrolysis of the sulfonation products into consideration.
- esters of ā -sulfo fatty acids for example the ā -sulfonated methyl esters of hydrogenated coconut, palm kernel or tallow fatty acids.
- Alk (en) ylsulfates are the alkali metal salts and in particular the sodium salts of the sulfuric monoesters of C 12 -C 18 fatty alcohols, for example coconut fatty alcohol, tallow fatty alcohol, lauryl, myristyl, cetyl or stearyl alcohol or the C 10 -C 20 oxo alcohols and those half-esters of secondary alcohols of these chain lengths are preferred.
- the C 12 -C 16 alkyl sulfates and C 12 -C 15 alkyl sulfates and C 14 -C 15 alkyl sulfates are preferred.
- 2,3-alkyl sulfates are also suitable anionic surfactants.
- EO ethylene oxide
- Fatty alcohols with 1 to 4 EO are suitable.
- anionic surfactants are soaps.
- Suitable are saturated and unsaturated fatty acid soaps, such as the salts of lauric acid, myristic acid, palmitic acid, stearic acid, (hydrogenated) erucic acid and behenic acid and, in particular, soap mixtures derived from natural fatty acids, for example coconut, palm kernel, olive oil or tallow fatty acids.
- the anionic surfactants including the soaps may be in the form of their sodium, potassium or magnesium or ammonium salts.
- the anionic surfactants are in the form of their sodium salts.
- Further preferred counterions for the anionic surfactants are also the protonated forms of choline, triethylamine or methylethylamine.
- the content of a surfactant preparation of anionic surfactants can be from 1 to 40% by weight, preferably from 5 to 30% by weight and very particularly preferably from 10 to 25% by weight, based in each case on the total surfactant preparation.
- surfactant preparations in particular of liquid detergents or cleaners containing a lipase, in particular such as described above, in particular at a temperature between 10 Ā° C and 80 Ā° C and preferably at comparatively low temperatures, in particular between 10 Ā° C and 50 Ā° C, between 10 Ā° C and 40 Ā° C, between 10 Ā° C and 30 Ā° C and / or between 20 Ā° C and 40 Ā° C.
- the substances indicated are anionic or polyanionic substances, ie these substances carry at least one and preferably several negative charges. It is preferably a polymer having at least one negatively charged monomer, preferably having a plurality of negatively charged monomers. According to the invention, this polymer is therefore a negatively charged polymer.
- polymers of organic acids or their salts in particular polyacrylates and / or poly-sugar acids and / or polyarcylate copolymers and / or poly-sugar copolymers, are preferred.
- further preferred compounds are polyacrylic sulfonates or polycarboxylates and their salts, copolymers or salts of the copolymers.
- Acusol 587D polyacrylic sulfonate, Rohm & Haas / Dow Chemical Company
- Acusol 445N polycarboxylate sodium salt, Rohm & Haas / Dow Chemical Company
- Acusol 590 polyacrylate copolymer; Rohm & Haas / Dow Chemical
- Acusol 916 polyarcrylate sodium salt, Rohm & Haas / Dow Chemical Company
- Sokalan CP42 modified polycarboxylate sodium salt, BASF Company
- Sokalan PA 30CL polycarboxylate sodium salt, BASF Company
- Dequest P 9000 polymaleic acid, Thermphos Company
- alginic acid Poly-2-acrylamido-2-methyl-1-propane-sulfonic acid, poly-4-styrene sulfonic acid-co-maleic acid sodium salt, poly-acrylamido-co-acrylic acid sodium salt, poly-me
- the substances indicated are cationic or polycationic substances, i. these substances carry at least one and preferably several positive charges. It is preferably a polymer having at least one positively charged monomer, preferably having a plurality of positively charged monomers. According to the invention, this polymer is therefore a positively charged polymer.
- preferred compounds in this regard are salts of polyamines, polyethylene imines or their copolymers, salts of polyallylamines, salts of Polydiallyldimethylammonium compounds or poly (acrylamide-co-diallyldimethylammonium compounds.
- under iii. specified substances are substances which have at least one hydroxyl and / or polyhydroxyl group and preferably more hydroxyl and / or polyhydroxyl groups.
- Preferred in this regard are, for example, polyvinyl alcohols, for example those which are available under the trade name Mowiol (Kremer Pigmente GmbH & Co. KG).
- a specific substance to one or more of the above groups i. to iii. may be associated.
- it may be an anionic polymer having one or more hydroxyl and / or polyhydroxyl group (s).
- Such a substance is then associated with the groups i. and iii.
- the surfactant preparation is characterized by further comprising at least one other ingredient selected from the group consisting of builder, peroxygen compound, bleach activator, nonaqueous solvent, acid, water soluble salt, thickener, disinfecting ingredient, and the like Combinations thereof.
- the addition of one or more of the further ingredient (s) proves to be advantageous, as this further improved cleaning performance and / or disinfection is achieved.
- the improved cleaning performance and / or disinfection is based on a synergistic interaction of at least two ingredients.
- Builders which may be present in the surfactant preparation include, in particular, silicates, aluminum silicates (in particular zeolites), carbonates, salts of organic di- and polycarboxylic acids and mixtures of these substances.
- Organic builders which may be present in the surfactant preparation are, for example, the polycarboxylic acids which can be used in the form of their sodium salts, polycarboxylic acids meaning those carboxylic acids which carry more than one acid function. These are, for example, citric acid, adipic acid, succinic acid, glutaric acid, malic acid, tartaric acid, maleic acid, fumaric acid, sugar acids, aminocarboxylic acids, nitrilotriacetic acid (NTA), methylglycine diacetic acid (MGDA) and derivatives thereof and mixtures thereof.
- Preferred salts are the salts of polycarboxylic acids such as citric acid, adipic acid, succinic acid, glutaric acid, tartaric acid, sugar acids and mixtures thereof.
- polymeric polycarboxylates are suitable. These are, for example, the alkali metal salts of polyacrylic acid or polymethacrylic acid, for example, those having a molecular weight of 600 to 750,000 g / mol.
- Suitable polymers are in particular polyacrylates, which preferably have a molecular weight of from 1,000 to 15,000 g / mol. Because of their superior solubility, the short-chain polyacrylates, which have molecular weights of from 1,000 to 10,000 g / mol, and particularly preferably from 1,000 to 5,000 g / mol, may again be preferred from this group.
- copolymeric polycarboxylates in particular those of acrylic acid with methacrylic acid and of acrylic acid or methacrylic acid with maleic acid.
- the polymers may also contain allylsulfonic acids, such as allyloxybenzenesulfonic acid and methallylsulfonic acid, as a monomer.
- soluble builders such as, for example, citric acid, or acrylic polymers having a molar mass of from 1,000 to 5,000 g / mol, preferably in the liquid surfactant preparation.
- the molecular weights stated for polymeric polycarboxylates are weight-average molecular weights M w of the particular acid form, which were determined in principle by means of gel permeation chromatography (GPC), a UV detector being used. The measurement was carried out against an external polyacrylic acid standard, which provides realistic molecular weight values due to its structural relationship with the polymers investigated. These data differ significantly from the molecular weight data in which Polystyrene sulfonic acids are used as standard. The molar masses measured against polystyrenesulfonic acids are generally significantly higher than the molecular weights specified in this document.
- organic builder substances may be present in amounts of up to 40% by weight, in particular up to 25% by weight and preferably from 1% by weight to 8% by weight. Amounts close to the stated upper limit are preferably used in paste-form or liquid, in particular water-containing, surfactant preparations.
- Peroxygen compounds which are suitable for use in surfactant preparations according to the invention are, in particular, organic peracids or persalts of organic acids, such as phthalimidopercaproic acid, perbenzoic acid or salts of diperdodecanedioic acid, hydrogen peroxide and inorganic salts which release hydrogen peroxide under the washing conditions, such as perborate, percarbonate, persilicate and / or persulphate Caroat belong into consideration. If a preparation contains peroxygen compounds, they are present in amounts of preferably up to 50% by weight, especially from 5% to 30% by weight. The addition of small amounts of known bleach stabilizers such as phosphonates, borates or metaborates and metasilicates and magnesium salts such as magnesium sulfate may be useful.
- organic peracids or persalts of organic acids such as phthalimidopercaproic acid, perbenzoic acid or salts of diperdodecanedioic acid, hydrogen
- bleach activators it is possible to use compounds which, under perhydrolysis conditions, give aliphatic peroxycarboxylic acids having preferably 1 to 10 C atoms, in particular 2 to 4 C atoms, and / or optionally substituted perbenzoic acid.
- Suitable substances are those which carry O- and / or N-acyl groups of the stated C atom number and / or optionally substituted benzoyl groups.
- polyacylated alkylenediamines in particular tetraacetylethylenediamine (TAED), acylated triazine derivatives, in particular 1,5-diacetyl-2,4-dioxohexahydro-1,3,5-triazine (DADHT), acylated glycolurils, in particular tetraacetylglycoluril (TAGU), N- Acylimides, in particular N-nonanoylsuccinimide (NOSI), acylated phenolsulfonates, in particular n-nonanoyl or isononanoyloxybenzenesulfonate (n- or iso-NOBS), carboxylic anhydrides, in particular phthalic anhydride, acylated polyhydric alcohols, in particular triacetin, ethylene glycol diacetate, 2,5-diacetoxy- 2,5-dihydrofuran and enol esters
- TAED
- the hydrophilic substituted acyl acetals and the acyl lactams are also preferably used.
- combinations of conventional bleach activators can be used.
- Such bleach activators can, in particular in the presence of the abovementioned hydrogen peroxide-producing bleach, in the usual amount range, preferably in amounts of from 0.5 wt .-% to 10 wt .-%, in particular 1 wt .-% to 8 wt .-%, based on However, the total surfactant preparation, be contained when using percarboxylic acid as the sole bleach, but preferably completely.
- sulfone imines and / or bleach-enhancing transition metal salts or transition metal complexes may also be present as so-called bleach catalysts.
- the surfactant preparations according to the invention are liquid and preferably contain water as the main solvent.
- non-aqueous solvents may be added to the surfactant preparation. Suitable non-aqueous solvents include mono- or polyhydric alcohols, alkanolamines or glycol ethers, provided that they are miscible with water in the specified concentration range.
- the solvents are selected from ethanol, n-propanol, i-propanol, butanols, glycol, propanediol, butanediol, glycerol, diglycol, propyldiglycol, butyldiglycol, hexylene glycol, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol propyl ether, ethylene glycol mono-n-butyl ether, diethylene glycol methyl ether, diethylene glycol ethyl ether, Propylene glycol methyl ether, propylene glycol ethyl ether, propylene glycol propyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, diisopropylene glycol monomethyl ether, di-isopropylene glycol monoethyl ether, methoxytriglycol, ethoxytriglycol
- the surfactant formulation contain a polyol as a nonaqueous solvent.
- the polyol may in particular comprise glycerol, 1,2-propanediol, 1,3-propanediol, ethylene glycol, diethylene glycol and / or dipropylene glycol.
- the surfactant formulation contains a mixture of a polyol and a monohydric alcohol.
- Non-aqueous solvents may be used in the surfactant preparation in amounts of between 0.5 and 15% by weight, but preferably below 12% by weight.
- the surfactant formulation s systemic and environmentally acceptable acids, especially citric acid, acetic acid, tartaric acid, malic acid, lactic acid, glycolic acid, succinic acid, glutaric acid and / or adipic acid, but also, mineral acids, in particular sulfuric acid, or bases, in particular ammonium or alkali metal hydroxides.
- Such pH regulators are present in the surfactant preparations in amounts of preferably not more than 20% by weight, in particular from 1.2% by weight to 17% by weight.
- a surfactant preparation according to the invention may further contain one or more water-soluble salts which serve, for example, for adjusting the viscosity.
- These may be inorganic and / or organic salts.
- Useful inorganic salts are preferably selected from the group consisting of colorless water-soluble halides, sulfates, sulfites, carbonates, bicarbonates, nitrates, nitrites, phosphates and / or oxides of the alkali metals, alkaline earth metals, aluminum and / or transition metals; Furthermore, ammonium salts can be used.
- the inorganic salt is selected from the group comprising sodium chloride, potassium chloride, sodium sulfate, potassium sulfate and mixtures thereof.
- Useful organic salts are, for example, colorless water-soluble alkali metal, alkaline earth metal, ammonium, aluminum and / or transition metal salts of the carboxylic acids.
- the salts are selected from the group comprising formate, acetate, propionate, citrate, malate, tartrate, succinate, malonate, oxalate, lactate and mixtures thereof.
- a surfactant preparation according to the invention may contain one or more thickeners.
- the thickener is selected from the group comprising xanthan, guar, carrageenan, agar-agar, gellan, pectin, locust bean gum and mixtures thereof. These compounds are effective thickeners even in the presence of inorganic salts.
- the surfactant formulation contains xanthan gum as a thickener because xanthan effectively thickened even in the presence of high salt concentrations and prevents macroscopic separation of the continuous phase.
- the thickener stabilizes the continuous, low surfactant phase and prevents macroscopic phase separation.
- acrylic and methacrylic (co) polymers include, for example, the high molecular weight homopolymers of acrylic acid crosslinked with a polyalkenyl polyether, in particular an allyl ether of sucrose, pentaerythritol or propylene (INCI name according to "International Dictionary of Cosmetic Ingredientsā of "The Cosmetic, Toiletry and Fragrance Association (CTFA) ": carbomer), also referred to as carboxyvinyl polymers.
- CFA Cosmetic, Toiletry and Fragrance Association
- Such polyacrylic acids are available, inter alia, under the trade names PolygelĀ® and CarbopolĀ®.
- acrylic acid copolymers are suitable: (i) copolymers of two or more monomers from the group of acrylic acid, methacrylic acid and their simple, preferably formed with C 1-4 alkanols, esters (INCI acrylates copolymer), for example, among the Trade names AculynĀ®, AcusolĀ® or TegoĀ® Polymer are available; (ii) crosslinked high molecular weight acrylic acid copolymers, such as those crosslinked with an allyl ether of sucrose or pentaerythritol copolymers of C 10-30 alkyl acrylates with one or more Monomers from the group of acrylic acid, methacrylic acid and their simple, preferably with C 1-4 alkanols formed ester (INCI acrylates / C 10-30 alkyl acrylate crosspolymer) include and are available, for example, under the trade name CarbopolĀ®.
- Other suitable polymers are (meth) acrylic acid (co) polymers of the SokalanĀ® type.
- the surfactant preparation according to the invention contains a (meth) acrylic acid (co) polymer in combination with a further thickener, preferably xanthan.
- the surfactant preparation can contain from 0.05 to 1.5% by weight and preferably from 0.1 to 1% by weight, based in each case on the total surfactant preparation, of thickening agent.
- the amount of thickener used depends on the type of thickener and the desired degree of thickening.
- ingredients which have an antimicrobial or antiviral activity are understood to be a disinfectant ingredient.
- the germicidal effect is dependent on the content of the disinfecting ingredient in the surfactant preparation, wherein the germicidal effect decreases with decreasing content of disinfecting ingredient or increasing dilution of the surfactant preparation.
- a preferred disinfecting ingredient is ethanol or propanol. These monohydric alcohols are commonly used in disinfectants and detergents because of their solvent properties and their germicidal activity.
- the term "propanolā includes both the 1-propanol (n-propanol) and the 2-propanol ("isopropanolā).
- Ethanol and / or propanol for example, in an amount of from 10 to 65 wt .-%, preferably 25 to 55 wt .-% in the surfactant preparation.
- Another preferred disinfecting ingredient is tea tree oil.
- the tea tree oil is obtained by steam distillation from the leaves and branch tips of these trees and is a mixture of about 100 substances; its main constituents include (+) - terpinene-4-ol, ā -terpinene, terpinolene, terpineol, pinene, myrcene, phellandrene, p-cymene, limonene and 1,8-cineole.
- Tea tree oil is contained, for example, in an amount of 0.05 to 10% by weight, preferably 0.1 to 5.0% by weight, in the virucidal treatment solution.
- Another preferred disinfecting ingredient is lactic acid.
- the lactic acid or 2-hydroxypropionic acid is a fermentation product produced by various microorganisms. She is weakly active in antibiotics. Lactic acid is for example, in amounts of up to 10 wt .-%, preferably 0.2 to 5.0 wt .-% in the surfactant preparation.
- disinfectant ingredients are, for example, active compounds from the groups of alcohols, aldehydes, antimicrobial acids or their salts, carboxylic esters, acid amides, phenols, phenol derivatives, diphenyls, diphenylalkanes, urea derivatives, oxygen, nitrogen acetals and formals, benzamidines, isothiazoles and derivatives thereof such as isothiazolines and isothiazolinones, phthalimide derivatives, pyridine derivatives, antimicrobial surface active compounds, guanidines, antimicrobial amphoteric compounds, quinolines, 1,2-dibromo-2,4-dicyanobutane, iodo-2-propynyl-butyl-carbamate, iodine, iodophores and peroxides.
- active compounds from the groups of alcohols, aldehydes, antimicrobial acids or their salts, carboxylic esters, acid amides, phenols,
- preferred active ingredients are selected from the group comprising 1,3-butanediol, phenoxyethanol, 1,2-propylene glycol, glycerol, undecylenic acid, citric acid, lactic acid, benzoic acid, salicylic acid, thymol, 2-benzyl-4-chlorophenol, 2,2 '.
- Preferred quaternary surface active compounds contain an ammonium, sulfonium, phosphonium, iodonium or arsonium group.
- disinfectant essential oils can be used, which at the same time provide for a scenting of the virucidal treatment solution.
- particularly preferred active compounds are selected from the group comprising salicylic acid, quaternary surfactants, in particular benzalkonium chloride, peroxo compounds, in particular hydrogen peroxide, alkali metal hypochlorite and mixtures thereof.
- Such another disinfecting ingredient is, for example, in an amount of 0.01 to 1 wt .-%, preferably 0.02 to 0.8 wt .-%, in particular 0.05 to 0.5 wt .-%, particularly preferably 0 , 1 to 0.3 wt .-%, most preferably 0.2 wt .-% in the surfactant preparation.
- Liquid surfactant preparations according to the invention in the form of customary solvent-containing solutions are generally prepared by simply mixing the ingredients, which can be added in bulk or as a solution in an automatic mixer.
- Surfactant preparations according to the invention may contain as enzymatic constituents exclusively a lipase as described. Alternatively, they may also contain other hydrolytic enzymes or other enzymes in a concentration useful for the effectiveness of the surfactant formulation. In a further embodiment of the invention, therefore, the surfactant preparation comprises at least one further enzyme. In principle, all the enzymes established in the prior art for this purpose can be used in this regard.
- Preferred as further enzymes all enzymes which can develop a catalytic activity in a surfactant preparation according to the invention can be used, in particular a protease, amylase, cellulase, hemicellulase, mannanase, pectinase, tannase, xylanase, xanthanase, .beta.-glucosidase, carrageenase, perhydrolase, oxidase, oxidoreductase or another Lipase, as well as their mixtures.
- a protease amylase, cellulase, hemicellulase, mannanase, pectinase, tannase, xylanase, xanthanase, .beta.-glucosidase, carrageenase, perhydrolase, oxidase, oxidoreducta
- each further enzyme is in an amount of 1 x 10 -7 -3 wt%, from 0.00001 to 1 wt%, from 0.00005 to 0.5 wt%, from 0.0001 to 0.1 wt .-% and particularly preferably from 0.0001 to 0.05 wt .-% in inventive surfactant preparations, based on active protein.
- the enzymes show synergistic cleaning performance against certain stains or stains, ie the enzymes contained in the surfactant preparation support each other in their cleaning performance.
- subtilisin type those of the subtilisin type are preferable.
- subtilisins BPN 'and Carlsberg the protease PB92, the subtilisins 147 and 309, the alkaline protease from Bacillus lentus, subtilisin DY and the enzymes thermitase, proteinase K and the subtilases, but not the subtilisins in the narrower sense Proteases TW3 and TW7.
- Subtilisin Carlsberg is available in a further developed form under the trade name AlcalaseĀ® from Novozymes A / S, Bagsvaard, Denmark.
- subtilisins 147 and 309 are sold under the trade names EsperaseĀ®, and SavinaseĀ® by the company Novozymes. From the protease from Bacillus lentus DSM 5483 derived under the name BLAPĀ® protease variants derived.
- proteases are, for example, those under the trade names DurazymĀ®, RelaseĀ®, EverlaseĀ®, NafizymĀ®, NatalaseĀ®, KannaseĀ® and OvozymeĀ® from Novozymes, which are available under the trade names, PurafectĀ®, PurafectĀ® OxP, PurafectĀ® Prime, ExcellaseĀ® and ProperaseĀ® from Genencor, sold under the trade name ProtosolĀ® by Advanced Biochemicals Ltd., Thane, India, under the trade name WuxiĀ® by Wuxi Snyder Bioproducts Ltd., China, under the trade names Proleather Ā® and Protease PĀ® from Amano Pharmaceuticals Ltd., Nagoya, Japan, and the enzyme available under the name Proteinase K-16 from Kao Corp., Tokyo, Japan.
- the proteases are also used with particular preference Bacillus gibsonii and Bacillus pumilus disclosed in international patent applications WO2008 / 086916 and WO2007 / 131656 ,
- Amylases which can be synthesized according to the invention are, for example, the ā -amylases from Bacillus licheniformis, from Bacillus amyloliquefaciens or from Bacillus stearothermophilus, and in particular also their further developments improved for use in detergents or cleaners.
- the enzyme from Bacillus licheniformis is available from the company Novozymes under the name TermamylĀ® and from the company Danisco / Genencor under the name PurastarĀ®ST.
- this ā -amylase is available from the company Novozymes under the trade name DuramylĀ® and TermamylĀ®ultra, from the company Danisco / Genencor under the name PurastarĀ®OxAm and from the company Daiwa Seiko Inc., Tokyo, Japan, as KeistaseĀ®.
- the Bacillus amyloliquefaciens ā -amylase is sold by the company Novozymes under the name BANĀ®, and variants derived from the Bacillus stearothermophilus ā -amylase under the names BSGĀ® and NovamylĀ®, also from the company Novozymes. Furthermore, for this purpose, the ā -amylase from Bacillus sp.
- a 7-7 (DSM 12368) and cyclodextrin glucanotransferase (CGTase) from Bacillus agaradherens (DSM 9948).
- CCTase cyclodextrin glucanotransferase
- fusion products of all the molecules mentioned can be used.
- the further developments of the ā -amylase from Aspergillus niger and A. oryzae available under the trade name FungamylĀ® from the company Novozymes are suitable.
- Further advantageously usable commercial products are, for example, the amylase-LTĀ® and StainzymeĀ® or Stainzyme ultraĀ® or Stainzyme plusĀ®, the latter also from the company Novozymes.
- variants of these enzymes obtainable by point mutations can be used according to the invention.
- amylases are disclosed in International Publications WO 00/60060 . WO 03/002711 . WO 03/054177 and WO07 / 079938 , whose disclosure is therefore expressly referred to, or whose disclosure in this regard is therefore expressly incorporated into the present patent application. Further, amylases which can be synthesized according to the invention are preferably .alpha.-amylases.
- lipases or cutinases which can be synthesized according to the invention, which are contained in particular because of their triglyceride-cleaving activities, but also in order to generate in situ peracids from suitable precursors, are the lipases which are originally obtainable from Humicola lanuginosa (Thermomyces lanuginosus) or further developed, in particular those with the amino acid exchange D96L. They are sold for example by the company Novozymes under the trade names LipolaseĀ®, LipolaseĀ®Ultra, LipoPrimeĀ®, LipozymeĀ® and LipexĀ®. Furthermore, for example, the cutinases can be used, which were originally isolated from Fusarium solani pisi and Humicola insolens.
- the lipases or cutinases can be used whose initial enzymes were originally isolated from Pseudomonas mendocina and Fusarium solanii.
- Other important commercial products are the preparations M1 Lipase.RTM. And Lipomax.RTM.
- Lipase MY-30Ā®, Lipase OFĀ® and Lipase PLĀ® to mention also the product LumafastĀ® from the company Genencor.
- Detergents or cleaning agents according to the invention may also contain cellulases, depending on the purpose, as pure enzymes, as enzyme preparations or in the form of mixtures in which the individual components advantageously supplement each other in terms of their various performance aspects.
- These performance aspects include, in particular, contributions to the primary washing performance, the secondary washing performance of the composition (anti-redeposition effect or graying inhibition) and softening (fabric effect), up to the exercise of a "stone washed" effect.
- Cellulases (endoglucanases, EG) which can be synthesized according to the invention comprise, for example, the fungal cellulase preparation rich in endoglucanase (EG) or its further developments, which is offered by the company Novozymes under the trade name CelluzymeĀ®. EndolaseĀ® and CarezymeĀ®, also available from Novozymes, are based on the 50 kD EG or 43 kD EG from Humicola insolens DSM 1800. Further commercial products of this company are CellusoftĀ®, RenozymeĀ® and CellucleanĀ®.
- cellulases available from the company AB Enzymes, Finland, under the trade names EcostoneĀ® and BiotouchĀ®, which are based, at least in part, on the 20 kD-EG of melanocarpus.
- Other cellulases from AB Enzymes are EconaseĀ® and EcopulpĀ®.
- Other suitable cellulases are from Bacillus sp. CBS 670.93 and CBS 669.93, those derived from Bacillus sp. CBS 670.93 is available from the company Danisco / Genencor under the trade name PuradaxĀ®.
- Other usable commercial products of the company Danisco / Genencor are "Genencor detergent cellulase L" and IndiAgeĀ®Neutra.
- cellulases are Thielavia terrestris cellulase variants described in International Publication WO 98/12307 Cellulases from Melanocarpus, in particular Melanocarpus albomyces, disclosed in the international publication WO 97/14804 Cellulases of the EGIII type from Trichoderma reesei disclosed in the European patent application EP 1 305 432 and variations obtainable therefrom, in particular those disclosed in the European patent applications EP 1240525 and EP 1305432 , as well as cellulases, which are disclosed in international publications WO 1992006165 .
- WO 96/29397 and WO 02/099091 On their respective disclosure is therefore expressly referenced or their disclosure in this regard is therefore expressly included in the present patent application.
- Suitable enzymes for this purpose are available, for example, under the name GamanaseĀ® and Pektinex ARĀ® from Novozymes, under the name RohapecĀ® B1L from AB Enzymes and under the name PyrolaseĀ® from Diversa Corp., San Diego, CA, USA ,
- the ā -glucanase obtained from Bacillus subtilis is available under the name CerefloĀ® from Novozymes.
- Hemicellulases which are particularly preferred according to the invention are mannanases which are sold, for example, under the trade names MannawayĀ® by the company Novozymes or PurabriteĀ® by the company Genencor.
- a surfactant preparation according to the invention may also contain oxidoreductases, for example oxidases, oxygenases, catalases (which react as peroxidase at low H 2 O 2 concentrations), peroxidases, such as halo-, chloro-, bromo-, lignin-, glucose- or manganese peroxidases, dioxygenases or laccases (phenol oxidases, polyphenol oxidases).
- Suitable commercial products are DeniliteĀ® 1 and 2 from Novozymes.
- advantageous systems for enzymatic perhydrolysis can be applied to the applications WO 98/45398 A1 .
- WO 2005/056782 A2 such as WO 2004/058961 A1 directed.
- a combined enzymatic bleaching system comprising an oxidase and a perhydrolase describes the application WO 2005/124012 .
- organic, particularly preferably aromatic, compounds which interact with the enzymes in order to enhance the activity of the relevant oxidoreductases (enhancers) or to ensure the flow of electrons (mediators) at greatly varying redox potentials between the oxidizing enzymes and the soils.
- the enzymes to be used according to the invention may also be formulated together with accompanying substances, for example from the fermentation, or with stabilizers and incorporated in such a formulation in a surfactant preparation according to the invention.
- a further subject of the invention is the use of a surfactant preparation according to the invention for the removal of stains, in particular of lipase-sensitive stains, on textiles or hard surfaces, ie for the cleaning of textiles or of hard surfaces.
- surfactant preparations according to the invention may be used, in particular because of the combination of phosphonate and lipase, advantageously in order to remove impurities from textiles or from hard surfaces.
- Embodiments of this subject invention include, for example, hand washing, manual removal of stains from textiles or hard surfaces, or use in conjunction with a machine process.
- a further subject of the invention is a process for the cleaning of textiles or hard surfaces or for disinfection, wherein in at least one process step a surfactant preparation according to the invention is used.
- the invention furthermore relates to a process, in particular a washing, cleaning or disinfecting process, in which a wash liquor which comprises a phosphonate and a lipase which is naturally present in a microorganism, the microorganism being Rhizopus oryzae or Mucorjavanicus, is contacted with a lipase-sensitive soil or germ on a textile or hard surface.
- a wash liquor which comprises a phosphonate and a lipase which is naturally present in a microorganism, the microorganism being Rhizopus oryzae or Mucorjavanicus
- Processes for cleaning textiles are generally characterized in that one or more cleaning-active substances are applied to the items to be cleaned and washed off after the action time.
- the cleaning product is treated with the surfactant preparation or the wash liquor formed by it, preferably for a certain minimum duration, for example 5, 10, 15, 20, 25, 30, 40, 50 or 60 minutes.
- the germ to be killed is brought into contact with the surfactant preparation or the wash liquor formed by it, preferably for a certain minimum duration, for example 5, 10, 15, 20, 25, 30, 40, 50 or 60 minutes.
- a method according to the invention is characterized in that the lipase is present in the wash liquor in a concentration of 0.0000003 to 0.0004 wt .-%, preferably from 0.0000005 to 0.0003 wt .-%, wherein the Details are based on active protein in the wash liquor.
- a method according to the invention is characterized in that it is carried out at a temperature between 10 Ā° C and 80 Ā° C, preferably between 10 Ā° C and 70 Ā° C and more preferably between 20 Ā° C and 60 Ā° C.
- Lipases provided according to the invention are advantageously usable in surfactant preparations according to the invention and processes, in particular washing, cleaning or disinfection processes. They can therefore be used advantageously to provide lipolytic activity in corresponding preparations.
- Another object of the invention is the use of a lipase naturally present in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucorjavanicus, for providing a lipolytic activity in a liquid surfactant preparation further comprising a phosphonate.
- Another object of the invention is the use of a lipase, which is naturally present in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucor javanicus, for the removal of lipase-sensitive stains on textiles or hard surfaces or for disinfection in a wash liquor, which further comprises a phosphonate.
- the detergent base formulation used was a phosphonate-containing liquid detergent of the following composition (all figures in percent by weight): 0.3-0.5% xanthan gum, 0.2-0.4% anti-foaming agent, 6-7% glycerol, 0 , 3-0.5% ethanol, 4-7% FAEOS (fatty alcohol ether sulfate), 24-28% nonionic surfactants, 1% boric acid, 1-2% sodium citrate (dihydrate), 2-4% soda, 14-16% coconut oil.
- This detergent base formulation was added to the following series of lipases for the various series of experiments in an activity-identical manner to 0.35% by weight of Lipex 100L (lipase preparation from Novozymes (batch 4 as reference): Lipase M-AP10Ā® (batch 1), Lipase LE Ā® (batch 2) and Lipase FĀ® (also Lipase JVĀ®, batch 3), all available from Amano Pharmaceuticals.
Description
Die Erfindung liegt auf dem Gebiet der flĆ¼ssigen enzymhaltigen Tensidzubereitungen, wie sie zum Beispiel beim Waschen, Reinigen oder Desinfizieren Verwendung finden. Die Erfindung betrifft insbesondere flĆ¼ssige enzymhaltige Tensidzubereitungen, die definierte Lipasen in Kombination mit einem Phosphonat enthalten, und schlƤgt ferner Verwendungen und Verfahren vor, in denen solche Zubereitungen angewendet werden. Die Erfindung betrifft ferner Verwendungen definierter Lipasen in flĆ¼ssigen Tensidzubereitungen, die ein Phosphonat enthalten.The invention is in the field of liquid enzyme-containing surfactant preparations, as used for example in washing, cleaning or disinfecting. More particularly, the invention relates to liquid enzyme-containing surfactant formulations containing defined lipases in combination with a phosphonate, and further proposes uses and methods in which such formulations are employed. The invention further relates to uses of defined lipases in liquid surfactant formulations containing a phosphonate.
In Tensidzubereitungen, insbesondere in modernen FlĆ¼ssigwaschmitteln, aber auch in Reinigungs-oder Desinfektionsmitteln, sind oftmals Phosphonate enthalten. Sie werden beispielsweise als Komplexbildner, zur Verhinderung von AusfƤllungen oder als Bleichmittelstabilisator eingesetzt. Als Komplexbildner dienen sie beispielsweise als WasserenthƤrter. Sie kƶnnen Kationen wie Ca2+ in der Lƶsung ummanteln und damit das chemische Verhalten des Kations verƤndern. Im Fall von Calcium verschwindet die Eigenschaft WasserhƤrte zu bilden. Auch andere Kationen kƶnnen komplexiert und damit vor chemischen Reaktionen geschĆ¼tzt werden. Sie kƶnnen ferner als Korrosionsinhibitoren mitwirken oder als Stabilisator fĆ¼r Peroxide, insbesondere in Bleichmitteln, dienen.Surfactant preparations, in particular in modern liquid detergents, but also in detergents or disinfectants, often contain phosphonates. They are used, for example, as complexing agents, to prevent precipitation or as a bleach stabilizer. As complexing agents they serve, for example, as water softeners. They can encase cations such as Ca 2+ in the solution and thus alter the chemical behavior of the cation. In the case of calcium, the property of water hardness disappears. Other cations can be complexed and thus protected against chemical reactions. They can also participate as corrosion inhibitors or serve as a stabilizer for peroxides, especially in bleaching agents.
Ferner werden in Tensidzubereitungen, insbesondere in Wasch- oder Reinigungsmitteln, zunehmend Lipasen eingesetzt. Eine Lipase ist ein Enzym, das die Hydrolyse von Esterbindungen in Lipid-Substraten, insbesondere in Fetten und Ćlen, katalysiert. Lipasen stellen daher eine Gruppe der Esterasen dar. Lipasen sind im Allgemeinen vielseitige Enzyme, die eine Vielzahl an Substraten akzeptieren, beispielsweise aliphatische, alizyklische, bizyklische und aromatische Ester, Thioester und aktivierte Amine. Lipasen wirken gegen FettrĆ¼ckstƤnde in der WƤsche katalysieren deren Hydrolyse (Lipolyse). Lipasen mit breiten Substratspektren werden insbesondere dort verwendet, wo inhomogene Rohstoffe oder Substratgemische umgesetzt werden mĆ¼ssen, also beispielsweise in Wasch- und Reinigungsmitteln, da Verschmutzungen aus unterschiedlich aufgebauten Fetten und Ćlen bestehen kƶnnen. Die in den aus dem Stand der Technik bekannten Wasch- oder Reinigungsmitteln eingesetzten Lipasen sind Ć¼blicherweise mikrobiellen Ursprungs und stammen in der Regel aus Bakterien oder Pilzen, beispielsweise der Gattungen Bacillus, Pseudomonas, Acinetobacter, Micrococcus, Humicola, Trichoderma oder Trichosporon. Lipasen werden Ć¼blicherweise nach an sich bekannten biotechnologischen Verfahren durch geeignete Mikroorganismen produziert, beispielsweise durch transgene Expressionswirte der Gattungen Bacillus oder durch filamentƶse Pilze.Furthermore, lipase is increasingly used in surfactant preparations, in particular in detergents or cleaners. A lipase is an enzyme that catalyzes the hydrolysis of ester bonds in lipid substrates, especially in fats and oils. Lipases are therefore a group of esterases. Lipases are generally versatile enzymes that accept a variety of substrates, for example, aliphatic, alicyclic, bicyclic and aromatic esters, thioesters and activated amines. Lipases act against fat residues in the laundry to catalyze their hydrolysis (lipolysis). Lipases with broad substrate spectra are used in particular where inhomogeneous raw materials or substrate mixtures have to be reacted, for example in detergents and cleaners, since soiling may consist of differently structured fats and oils. The lipases used in the washing or cleaning agents known from the prior art are usually of microbial origin and are usually derived from bacteria or fungi, for example the genera Bacillus, Pseudomonas, Acinetobacter, Micrococcus, Humicola, Trichoderma or Trichosporon. Lipases are usually produced by biotechnological methods known per se by suitable microorganisms, for example by transgenic expression hosts of the genera Bacillus or by filamentous fungi.
In der europƤischen Patentanmeldung
Generell sind nur ausgewƤhlte Lipasen fĆ¼r den Einsatz in flĆ¼ssigen Tensidzubereitungen Ć¼berhaupt geeignet. Viele Lipasen zeigen in derartigen Zubereitungen keine ausreichende katalytische Leistung oder StabilitƤt. In Phosphonat-haltigen flĆ¼ssigen Tensidzubereitungen ist diese Problematik noch gravierender, beispielsweise auf Grund der komplexbildenden Eigenschaften der Phosphonate oder auf Grund von unvorteilhaften Wechselwirkungen zwischen dem Phosphonat und der Lipase.In general, only selected lipases are suitable for use in liquid surfactant preparations. Many lipases do not show sufficient catalytic performance or stability in such formulations. In phosphonate-containing liquid surfactant preparations, this problem is even more serious, for example due to the complex-forming properties of the phosphonates or due to unfavorable interactions between the phosphonate and the lipase.
Folglich haben lipasehaltige flĆ¼ssige Tensidzubereitungen aus dem Stand der Technik, insbesondere solche mit Phosphonaten, den Nachteil, dass sie oftmals keine zufriedenstellende lipolytische AktivitƤt aufweisen und die Tensidzubereitung daher keine optimale Reinigungsleistung an lipase-sensitiven Anschmutzungen zeigt.Consequently, lipase-containing liquid surfactant preparations of the prior art, in particular those containing phosphonates, have the disadvantage that they often do not have satisfactory lipolytic activity and therefore the surfactant preparation does not show optimal cleaning performance on lipase-sensitive soils.
Der vorliegenden Erfindung liegt die Aufgabe zugrunde, den genannten Nachteil zu Ć¼berwinden und eine Phosphonat-haltige flĆ¼ssige Tensidzubereitung bereitzustellen, die eine vorteilhafte lipolytische AktivitƤt aufweist.The object of the present invention is to overcome the mentioned disadvantage and to provide a phosphonate-containing liquid surfactant preparation which has a beneficial lipolytic activity.
Ein Gegenstand der Erfindung ist eine flĆ¼ssige Tensidzubereitung umfassend ein Phosphonat und eine Lipase, die natĆ¼rlicherweise in einem Mikroorganismus vorhanden ist, wobei der Mikroorganismus Rhizopus oryzae oder Mucorjavanicus ist.An object of the invention is a liquid surfactant preparation comprising a phosphonate and a lipase which is naturally present in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucorjavanicus.
Ćberraschenderweise wurde festgestellt, dass eine flĆ¼ssige Tensidzubereitung, welche die Kombination einer derartigen Lipase mit einem Phosphonat enthƤlt, vorteilhafte Reinigungsleistungen an lipase-sensitiven Anschmutzungen aufweist. Vorteilhafterweise zeigt eine derartige Tensidzubereitung eine verbesserte Reinigungsleistung an mindestens einer, vorzugsweise an mehreren lipase-sensitiven Anschmutzungen, insbesondere auf Textilien und/oder harten OberflƤchen. In einer bevorzugten Ausgestaltung ist eine erfindungsgemƤĆe Tensidzubereitung zudem vorteilhaft lagerstabil. Weitere bevorzugte AusfĆ¼hrungsformen erfindungsgemƤĆer Tensidzubereitungen zeigen eine vorteilhafte Reinigungsleistung hinsichtlich mindestens einer lipase-sensitiven Anschmutzung bei Temperaturen zwischen 10Ā°C und 80Ā°C, vorzugsweise auch bei niedrigen Temperaturen, beispielsweise zwischen 10Ā°C und 50Ā°C, zwischen 10Ā°C und 40Ā°C oder zwischen 20Ā°C und 40Ā°C. Hinsichtlich des einleitend erwƤhnten Standes der Technik handelt es bei der vorliegenden Erfindung daher um eine besonders vorteilhafte Auswahl von einer Lipase fĆ¼r eine Phosphonat-haltige flĆ¼ssige Tensidzubereitung.Surprisingly, it has been found that a liquid surfactant preparation which contains the combination of such a lipase with a phosphonate has advantageous cleaning performance on lipase-sensitive soiling. Advantageously, such a surfactant preparation exhibits an improved cleaning performance on at least one, preferably on several lipase-sensitive stains, in particular on textiles and / or hard surfaces. In a preferred embodiment, a surfactant preparation according to the invention is also advantageously storage-stable. Further preferred embodiments of inventive surfactant formulations show an advantageous cleaning performance with respect to at least one lipase-sensitive soiling at temperatures between 10 Ā° C and 80 Ā° C, preferably also at low temperatures, for example between 10 Ā° C and 50 Ā° C, between 10 Ā° C and 40 Ā° C or between 20 Ā° C and 40 Ā° C. With regard to the prior art mentioned in the introduction, the present invention is therefore a particularly advantageous selection of a lipase for a phosphonate-containing liquid surfactant preparation.
Unter Reinigungsleistung wird im Rahmen der Erfindung die Aufhellungsleistung an einer oder mehreren Anschmutzungen, insbesondere WƤscheanschmutzungen oder Geschirranschmutzungen, verstanden, die sensitiv sind fĆ¼r den Abbau durch die Lipase. Beispiele fĆ¼r solche Anschmutzungen sind RuĆ/Mineralƶl, RuĆ/Olivenƶl, Pigment/ĆI oder Hautfett (Sebum)/Kohlenschwarz, jeweils beispielsweise auf Baumwollgewebe, insbesondere derart wie weiter unten angegeben. Im Rahmen der Erfindung weist sowohl die Tensidzubereitung, welche die Lipase umfasst bzw. die durch diese Tensidzubereitung gebildete Wasch- bzw. Reinigungsflotte, als auch die Lipase selbst eine jeweilige Reinigungsleistung auf. Die Reinigungsleistung der Lipase trƤgt somit zur Reinigungsleistung der Tensidzubereitung bzw. der durch die Tensidzubereitung gebildeten Wasch- bzw. Reinigungsflotte bei. Die Reinigungsleistung wird bevorzugt ermittelt wie weiter unten angegeben.In the context of the invention, cleaning performance is understood to mean the whitening performance of one or more soiling, in particular laundry soiling or scrape dirt, which are sensitive to degradation by the lipase. Examples of such stains are carbon black / mineral oil, carbon black / olive oil, pigment / oil or skin fat (sebum) / carbon black, in each case for example on cotton fabric, in particular as indicated below. In the context of the invention, both the surfactant preparation, which comprises the lipase or the washing or cleaning liquor formed by this surfactant preparation, and the lipase itself have a respective cleaning performance. The cleaning performance of the lipase thus contributes to the cleaning performance of the surfactant preparation or the washing or cleaning liquor formed by the surfactant preparation. The cleaning performance is preferably determined as indicated below.
Unter Wasch- bzw. Reinigungsflotte wird diejenige die Tensidzubereitung enthaltende Gebrauchslƶsung verstanden, die auf Textilien oder Gewebe (Waschflotte) bzw. harte OberflƤchen (Reinigungsflotte) einwirkt und damit mit den auf Textilien bzw. Geweben oder harten OberflƤchen vorhandenen Anschmutzungen in Kontakt kommt. Ćblicherweise entsteht die Wasch- bzw. Reinigungsflotte, wenn der Wasch- oder Reinigungsvorgang beginnt und die Tensidzubereitung, insbesondere das Wasch- oder Reinigungsmittel, beispielsweise in einer Waschmaschine, GeschirrspĆ¼lmaschine oder in einem anderen geeigneten BehƤltnis mit Wasser verdĆ¼nnt wird.Washing or cleaning liquor is understood as meaning the use solution containing the surfactant preparation which acts on textiles or fabrics (wash liquor) or hard surfaces (cleaning liquor) and thus comes into contact with the soiling present on textiles or fabrics or hard surfaces. Usually, the washing or cleaning liquor arises when the washing or cleaning process begins and the surfactant preparation, in particular the detergent or cleaning agent, for example, in a washing machine, dishwasher or other suitable container is diluted with water.
Eine in einer erfindungsgemƤĆen Tensidzubereitung enthaltene Lipase weist eine lipolytische AktivitƤt auf, das heiĆt, sie ist zur Hydrolyse (Lipolyse) von Lipiden wie Glyceriden oder Cholesterinestern befƤhigt. Ferner ist die in einer erfindungsgemƤĆen Tensidzubereitung enthaltene Lipase natĆ¼rlicherweise in einem Mikroorganismus der Art Rhizopus oryzae oder Mucor javanicus vorhanden. NatĆ¼rlicherweise vorhanden bedeutet in diesem Zusammenhang, dass die Lipase ein eigenes Enzym des Mikroorganismus ist. Die Lipase kann folglich in dem Mikroorganismus von einer NukleinsƤuresequenz exprimiert werden, die Teil der chromosomalen DNA des Mikroorganismus in seiner Wildtyp-Form ist. Sie bzw. die fĆ¼r sie codierende NukleinsƤuresequenz ist folglich in der Wildtyp-Form des Mikroorganismus vorhanden und/oder kann aus der Wildtyp-Form des Mikroorganismus aus diesem isoliert werden. Im Gegensatz hierzu wƤre eine nicht natĆ¼rlicherweise in dem Mikroorganismus vorhandene Lipase bzw. die fĆ¼r sie codierende NukleinsƤuresequenz mit Hilfe gentechnischer Verfahren in den Mikroorganismus gezielt eingebracht worden, so dass der Mikroorganismus um die Lipase bzw. die fĆ¼r sie codierende NukleinsƤuresequenz bereichert worden wƤre. Jedoch kann eine Lipase, die natĆ¼rlicherweise in einem Mikroorganismus der Art Rhizopus oryzae oder Mucor javanicus vorhanden ist, aber durchaus rekombinant von einem anderen Organismus hergestellt worden sein.A lipase contained in a surfactant preparation according to the invention has a lipolytic activity, that is, it is capable of hydrolysis (lipolysis) of lipids such as glycerides or cholesterol esters. Furthermore, the lipase contained in a surfactant preparation according to the invention is naturally present in a microorganism of the species Rhizopus oryzae or Mucor javanicus. Naturally present in this context means that the lipase is a separate enzyme of the microorganism. The lipase can thus be expressed in the microorganism from a nucleic acid sequence which is part of the chromosomal DNA of the microorganism in its wild-type form. It or the coding for them nucleic acid sequence is therefore present in the wild-type form of the microorganism and / or can be isolated from the wild-type form of the microorganism from this. In contrast to this, a lipase or the nucleic acid sequence coding for it in the microorganism would be incorporated into the microorganism by means of genetic engineering have been deliberately introduced so that the microorganism would have been enriched to the lipase or the coding for them nucleic acid sequence. However, a lipase naturally present in a microorganism of the genus Rhizopus oryzae or Mucor javanicus may well have been produced recombinantly from another organism.
Der Pilz Rhizopus oryzae zƤhlt zur Klasse der Zygomyceten (Unterklasse Incertae sedis), hierin zur Ordnung Mucorales und hierin wiederum zur Familie Mucoraceae und der Gattung Rhizopus. Der Pilz Mucorjavanicus zƤhlt ebenfalls zur Klasse der Zygomyceten (Unterklasse Incertae sedis), hierin zur Ordnung Mucorales und hierin wiederum zur Familie Mucoraceae, hierin dann zur Gattung Mucor. Die Bezeichnungen Rhizopus oryzae und Mucorjavanicus sind die biologischen Artbezeichnungen innerhalb der jeweiligen Gattung.The fungus Rhizopus oryzae belongs to the class of Zygomycetes (subclass Incertae sedis), herein to the order Mucorales and here again to the family Mucoraceae and the genus Rhizopus. The fungus Mucorjavanicus also belongs to the class of Zygomycetes (subclass Incertae sedis), herein to the order Mucorales and here again to the family Mucoraceae, then herein to the genus Mucor. The names Rhizopus oryzae and Mucorjavanicus are the biological species names within the respective genus.
Phosphonate sind Salze und organische Verbindungen, insbesondere Ester, der PhosphonsƤure. Als Salze existieren primƤre (M'H2PO3 bzw. HP(O)(OH)(OM')) und sekundƤre (M'2HPO3 bzw. HP(O)(OM')2) Phosphonate, wobei M' fĆ¼r ein einwertiges Metall steht. Diese anorganischen Phosphonate werden auch als primƤre bzw. sekundƤre Phosphite bezeichnet. Anorganische Phosphonate entstehen beispielsweise durch Umsetzung von PhosphonsƤure HP(O)(OH)2, insbesondere der stabilen tautomeren Form der PhosphorigsƤure mit einem (primƤre) oder zwei (sekundƤre) Ćquivalenten Base, beispielsweise Alkalimetallhydroxid.Phosphonates are salts and organic compounds, especially esters, of phosphonic acid. As salts there exist primary (M'H 2 PO 3 or HP (O) (OH) (OM ')) and secondary (M' 2 HPO 3 or HP (O) (OM ') 2 ) phosphonates, where M' stands for a monovalent metal. These inorganic phosphonates are also referred to as primary and secondary phosphites, respectively. Inorganic phosphonates are formed, for example, by reaction of phosphonic acid HP (O) (OH) 2 , in particular the stable tautomeric form of phosphorous acid with a (primary) or two (secondary) equivalents of base, for example alkali metal hydroxide.
Im Rahmen der vorliegenden Erfindung bevorzugt sind organisch P-substituierte Phosphonate, die eine Phosphor-Kohlenstoff-Bindung aufweisen (Phosphor-organische Verbindungen). Ihre allgemeine Struktur ist R1 P(O)(OR2)2, mit R1 und/oder R2 = Alkyl, Aryl oder H, wobei die Alkyl- bzw. Arylreste weitere Substitutionen aufweisen oder weitere chemische Gruppen tragen kƶnnen. Organisch P-substituierte Phosphonate entstehen beispielsweise durch Michaelis-Arbusov-Reaktion. Viele dieser Phosphonate sind lƶslich in Wasser. Einige technisch wichtige Phosphonate tragen ferner Amino-Gruppe(n). Einige diese Aminophosphonate haben strukturelle Ćhnlichkeiten mit Komplexbildnern wie EDTA, NTA oder DTPA und haben eine Ƥhnliche Funktion.In the context of the present invention, preference is given to organic P-substituted phosphonates which have a phosphorus-carbon bond (phosphorus-organic compounds). Their general structure is R1P (O) (OR2) 2 , with R1 and / or R2 = alkyl, aryl or H, where the alkyl or aryl radicals can have further substitutions or carry further chemical groups. Organic P-substituted phosphonates are formed, for example, by the Michaelis-Arbusov reaction. Many of these phosphonates are soluble in water. Some technically important phosphonates also carry amino group (s). Some of these aminophosphonates have structural similarities to complexing agents such as EDTA, NTA or DTPA and have a similar function.
Besonders bevorzugte Phosphonate im Rahmen der vorliegenden Erfindung sind 1-Hydroxyethan-1,1-diphosphonsƤure (HEDP), AminotrimethylenphosphonsƤure (ATMP), NitrilotrimethylenphosphonsƤure (NTMP), DiethylentriaminpentamethylenphosphonsƤure (DTPMP, DETPMP oder DTPNT), EthylendiamintetramethylenphosphonsƤure (EDTMP) sowie 2-Phosphonobutan-1,2,4-tricarbonsƤure (PBS-AM, auch bezeichnet als 3-Carboxy-3-phosphonoadipinsƤure), die zumeist in Form ihrer Ammonium- oder Alkalimetallsalze eingesetzt werden. Ferner kƶnnen Kombinationen der Phosphonate eingesetzt werden.Particularly preferred phosphonates in the context of the present invention are 1-hydroxyethane-1,1-diphosphonic acid (HEDP), aminotrimethylenephosphonic acid (ATMP), nitrilotrimethylenephosphonic acid (NTMP), diethylenetriaminepentamethylenephosphonic acid (DTPMP, DETPMP or DTPNT), ethylenediamine tetramethylenephosphonic acid (EDTMP) and 2-phosphonobutane. 1,2,4-tricarboxylic acid (PBS-AM, also referred to as 3-carboxy-3-phosphonoadipic acid), which are usually used in the form of their ammonium or alkali metal salts. Furthermore, combinations of the phosphonates can be used.
Besonders bevorzugt sind DiethylentriaminpentamethylenphosphonsƤure-Natrium (DTPMP), insbesondere fĆ¼r erfindungsgemƤĆe Tensidzubereitungen, die Waschmittel darstellen, und/oder 1-Hydroxyethan-1,1-diphosphonsƤure (HEDP), insbesondere fĆ¼r erfindungsgemƤĆe Tensidzubereitungen, die Wasch- oder GeschirrspĆ¼lmittel, insbesondere maschinelle GeschirrspĆ¼lmittel, darstellen. Derartige Phosphonate sind beispielsweise unter den Handelsnamen DequestĀ® 2066 und DequestĀ® 2010 (jeweils Firma Thermphos) erhƤltlich.Particular preference is given to diethylenetriaminepentamethylenephosphonic acid sodium (DTPMP), in particular for surfactant preparations according to the invention which are detergents, and / or 1-hydroxyethane-1,1-diphosphonic acid (HEDP), in particular for surfactant preparations according to the invention which contain washing or dishwashing detergents, in particular automatic dishwasher detergents, represent. Such phosphonates are available, for example, under the trade names DequestĀ® 2066 and DequestĀ® 2010 (each from Thermphos).
In einerweiteren AusfĆ¼hrungsform der Erfindung ist die Tensidzubereitung dadurch gekennzeichnet, dass die Lipase eine AminosƤuresequenz aufweist, die zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz zu mindestens 80% identisch ist. Zunehmend bevorzugt ist die AminosƤuresequenz zu mindestens 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% und ganz besonders bevorzugt zu 100% identisch zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz. SEQ ID NO. 1 ist die Sequenz einer reifen (maturen) Lipase aus Rhizopus oryzae.In a further embodiment of the invention, the surfactant preparation is characterized in that the lipase has an amino acid sequence which corresponds to the amino acid sequence shown in SEQ ID NO. 1 amino acid sequence is at least 80% identical. More preferably, the amino acid sequence is at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95% %, 96%, 97%, 98%, 99% and most preferably 100% identical to that shown in SEQ ID NO. 1 indicated amino acid sequence. SEQ ID NO. 1 is the sequence of a mature (mature) lipase from Rhizopus oryzae.
ErfindungsgemĆ¤Ć ganz besonders bevorzugte Lipasen sind die von dem Unternehmen Amano Pharmaceuticals unter den Bezeichnungen Lipase M-AP10Ā®, Lipase LEĀ® und Lipase FĀ® (auch Lipase JVĀ®) erhƤltlichen Lipaseenzyme. Die Lipase FĀ® ist beispielsweise natĆ¼rlicherweise in Rhizopus oryzae vorhanden. Die Lipase M-AP10Ā® ist beispielsweise natĆ¼rlicherweise in Mucor javanicus vorhanden.Lipases which are very particularly preferred according to the invention are the lipase enzymes obtainable from the company Amano Pharmaceuticals under the names Lipase M-AP10Ā®, Lipase LEĀ® and Lipase FĀ® (also Lipase JVĀ®). For example, the Lipase FĀ® is naturally present in Rhizopus oryzae. For example, the lipase M-AP10Ā® is naturally present in Mucor javanicus.
ErfindungsgemĆ¤Ć hat sich gezeigt, dass durch den Zusatz einer derartigen Lipase zu einer flĆ¼ssigen Tensidzubereitung, welche ein Phosphonat enthƤlt, insbesondere eines wie vorstehend beschrieben, eine besonders vorteilhafte lipolytische AktivitƤt in dieser Zubereitung bereitgestellt wird. Ferner sind derartige Tensidzubereitungen ausreichend lagerstabil, insbesondere hinsichtlich deren verbleibender lipolytischer AktivitƤt nach Lagerung, insbesondere nach einer Lagerdauer von 1 bis 5 Wochen, 1 bis 4 Wochen, 1,5 bis 3 Wochen und besonders bevorzugt nach 2 Wochen.According to the invention, it has been found that the addition of such a lipase to a liquid surfactant preparation which comprises a phosphonate, in particular one as described above, provides a particularly advantageous lipolytic activity in this preparation. Furthermore, such surfactant preparations are sufficiently stable on storage, in particular with regard to their remaining lipolytic activity after storage, in particular after a storage period of 1 to 5 weeks, 1 to 4 weeks, 1.5 to 3 weeks and particularly preferably after 2 weeks.
Besonders bevorzugte Kombinationen von Lipase und Phosphonat in erfindungsgemƤĆen Tensidzubereitungen sind:
- Lipase, die eine AminosƤuresequenz aufweist, die zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz zu mindestens 80% und zunehmend bevorzugt zu mindestens 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% und ganz besonders bevorzugt zu 100% identisch ist in Kombination mit 1-Hydroxyethan-1,1-diphosphonsƤure (HEDP);
- Lipase, die eine AminosƤuresequenz aufweist, die zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz zu mindestens 80% und zunehmend bevorzugt zu mindestens 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% und ganz besonders bevorzugt zu 100% identisch ist in Kombination mit AminotrimethylenphosphonsƤure (ATMP);
- Lipase, die eine AminosƤuresequenz aufweist, die zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz zu mindestens 80% und zunehmend bevorzugt zu mindestens 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% und ganz besonders bevorzugt zu 100% identisch ist in Kombination mit NitrilotrimethylenphosphonsƤure (NTMP);
- Lipase, die eine AminosƤuresequenz aufweist, die zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz zu mindestens 80% und zunehmend bevorzugt zu mindestens 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% und ganz besonders bevorzugt zu 100% identisch ist in Kombination mit DiethylentriaminpentamethylenphosphonsƤure (DTPMP);
- Lipase, die eine AminosƤuresequenz aufweist, die zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz zu mindestens 80% und zunehmend bevorzugt zu mindestens 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% und ganz besonders bevorzugt zu 100% identisch ist in Kombination mit EthylendiamintetramethylenphosphonsƤure (EDTMP);
- Lipase, die eine AminosƤuresequenz aufweist, die zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz zu mindestens 80% und zunehmend bevorzugt zu mindestens 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% und ganz besonders bevorzugt zu 100% identisch ist in Kombination mit 2-Phosphonobutan-1,2,4-tricarbonsƤure (PBS-AM);
- Lipase M-AP10Ā® in Kombination mit 1-Hydroxyethan-1,1-diphosphonsƤure (HEDP) oder AminotrimethylenphosphonsƤure (ATMP) oder NitrilotrimethylenphosphonsƤure (NTMP) oder DiethylentriaminpentamethylenphosphonsƤure (DTPMP) oder EthylendiamintetramethylenphosphonsƤure (EDTMP) oder 2-Phosphonobutan-1,2,4-tricarbonsƤure (PBS-AM);
- Lipase LEĀ® in Kombination mit 1-Hydroxyethan-1,1-diphosphonsƤure (HEDP) oder AminotrimethylenphosphonsƤure (ATMP) oder NitrilotrimethylenphosphonsƤure (NTMP) oder DiethylentriaminpentamethylenphosphonsƤure (DTPMP) oder EthylendiamintetramethylenphosphonsƤure (EDTMP) oder 2-Phosphonobutan-1,2,4-tricarbonsƤure (PBS-AM);
- Lipase FĀ® in Kombination mit 1-Hydroxyethan-1,1-diphosphonsƤure (HEDP) oder AminotrimethylenphosphonsƤure (ATMP) oder NitrilotrimethylenphosphonsƤure (NTMP) oder DiethylentriaminpentamethylenphosphonsƤure (DTPMP) oder EthylendiamintetramethylenphosphonsƤure (EDTMP) oder 2-Phosphonobutan-1,2,4-tricarbonsƤure (PBS-AM).
- Lipase having an amino acid sequence corresponding to that shown in SEQ ID NO. At least 80% and more preferably at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93% , 94%, 95%, 96%, 97%, 98%, 99%, and most preferably 100% identical in combination with 1-hydroxyethane-1,1-diphosphonic acid (HEDP);
- Lipase having an amino acid sequence corresponding to that shown in SEQ ID NO. At least 80% and more preferably at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93% , 94%, 95%, 96%, 97%, 98%, 99%, and most preferably 100% identical in combination with aminotrimethylene phosphonic acid (ATMP);
- Lipase having an amino acid sequence corresponding to that shown in SEQ ID NO. At least 80% and more preferably at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93% , 94%, 95%, 96%, 97%, 98%, 99% and most preferably 100% identical in combination with nitrilotrimethylene phosphonic acid (NTMP);
- Lipase having an amino acid sequence corresponding to that shown in SEQ ID NO. At least 80% and more preferably at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93% , 94%, 95%, 96%, 97%, 98%, 99%, and most preferably 100% identical in combination with diethylenetriaminepentamethylenephosphonic acid (DTPMP);
- Lipase having an amino acid sequence corresponding to that shown in SEQ ID NO. At least 80% and more preferably at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93% , 94%, 95%, 96%, 97%, 98%, 99% and most preferably 100% identical in combination with ethylenediamine tetramethylene phosphonic acid (EDTMP);
- Lipase having an amino acid sequence corresponding to that shown in SEQ ID NO. At least 80% and more preferably at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93% , 94%, 95%, 96%, 97%, 98%, 99%, and most preferably 100% identical in combination with 2-phosphonobutane-1,2,4-tricarboxylic acid (PBS-AM);
- Lipase M-AP10Ā® in combination with 1-hydroxyethane-1,1-diphosphonic acid (HEDP) or aminotrimethylenephosphonic acid (ATMP) or nitrilotrimethylenephosphonic acid (NTMP) or diethylenetriaminepentamethylenephosphonic acid (DTPMP) or ethylenediamine tetramethylene phosphonic acid (EDTMP) or 2-phosphonobutane-1,2,4 tricarboxylic acid (PBS-AM);
- Lipase LEĀ® in combination with 1-hydroxyethane-1,1-diphosphonic acid (HEDP) or aminotrimethylenephosphonic acid (ATMP) or nitrilotrimethylenephosphonic acid (NTMP) or diethylenetriaminepentamethylenephosphonic acid (DTPMP) or ethylenediamine tetramethylenephosphonic acid (EDTMP) or 2-phosphonobutane-1,2,4-tricarboxylic acid (PBS-AM);
- Lipase FĀ® in combination with 1-hydroxyethane-1,1-diphosphonic acid (HEDP) or aminotrimethylenephosphonic acid (ATMP) or nitrilotrimethylenephosphonic acid (NTMP) or Diethylenetriaminepentamethylenephosphonic acid (DTPMP) or ethylenediamine tetramethylene phosphonic acid (EDTMP) or 2-phosphonobutane-1,2,4-tricarboxylic acid (PBS-AM).
Die Bestimmung der IdentitƤt von NukleinsƤure- oder AminosƤuresequenzen erfolgt durch einen Sequenzvergleich. Solch ein Vergleich erfolgt dadurch, dass Ƥhnliche Abfolgen in den Nukleotidsequenzen oder AminosƤuresequenzen einander zugeordnet werden. Dieser Sequenzvergleich erfolgt vorzugsweise basierend auf dem im Stand der Technik etablierten und Ć¼blicherweise genutzten BLAST-Algorithmus (vgl. beispielsweise
Solch ein Vergleich erlaubt eine Aussage Ć¼ber die Ćhnlichkeit der verglichenen Sequenzen zueinander. Sie wird Ć¼blicherweise in Prozent IdentitƤt, das heiĆt dem Anteil der identischen Nukleotide oder AminosƤurereste an denselben bzw. in einem Alignment einander entsprechenden Positionen angegeben. Der weiter gefasste Begriff der Homologie bezieht bei AminosƤuresequenzen konservierte AminosƤure-Austausche in die Betrachtung mit ein, also AminosƤuren mit Ƥhnlicher chemischer AktivitƤt, da diese innerhalb des Proteins meist Ƥhnliche chemische AktivitƤten ausĆ¼ben. Daher kann die Ćhnlichkeit der verglichenen Sequenzen auch Prozent Homologie oder Prozent Ćhnlichkeit angegeben sein. IdentitƤts- und/oder Homologieangaben kƶnnen Ć¼ber ganze Polypeptide oder Gene oder nur Ć¼ber einzelne Bereiche getroffen werden. Homologe bzw. identische Bereiche von verschiedenen NukleinsƤure- oder AminosƤuresequenzen sind daher durch Ćbereinstimmungen in den Sequenzen definiert. Solche Bereiche weisen oftmals identische Funktionen auf. Sie kƶnnen klein sein und nur wenige Nukleotide bzw. AminosƤuren umfassen. Oftmals Ć¼ben solche kleinen Bereiche fĆ¼r die GesamtaktivitƤt des Proteins essentielle Funktionen aus. Es kann daher sinnvoll sein, SequenzĆ¼bereinstimmungen nur auf einzelne, gegebenenfalls kleine Bereiche zu beziehen. Soweit nicht anders angegeben beziehen sich IdentitƤts- bzw. Homologieangaben in der vorliegenden Anmeldung aber auf die GesamtlƤnge der jeweils angegebenen NukleinsƤure- oder AminosƤuresƤuresequenz.Such a comparison allows a statement about the similarity of the compared sequences to each other. It is usually given in percent identity, that is, the proportion of identical nucleotides or amino acid residues at the same or in an alignment corresponding positions. The broader concept of homology involves conserved amino acid substitutions in amino acids, such as amino acids similar chemical activity, as they usually carry out similar chemical activities within the protein. Therefore, the similarity of the sequences compared may also be stated as percent homology or percent similarity. Identity and / or homology information can be made about whole polypeptides or genes or only over individual regions. Homologous or identical regions of different nucleic acid or amino acid sequences are therefore defined by matches in the sequences. Such areas often have identical functions. They can be small and comprise only a few nucleotides or amino acids. Often, such small regions exert essential functions for the overall activity of the protein. It may therefore be useful to relate sequence matches only to individual, possibly small areas. Unless stated otherwise, identity or homology information in the present application, however, refers to the total length of the respectively indicated nucleic acid or amino acid sequence.
In einerweiteren AusfĆ¼hrungsform der Erfindung ist eine erfindungsgemƤĆe Tensidzubereitung ferner dadurch gekennzeichnet, dass ihre Reinigungsleistung mindestens derjenigen einer Tensidzubereitung entspricht, die eine Lipase beinhaltet, die eine AminosƤuresequenz gemĆ¤Ć SEQ ID NO. 1 aufweist, wobei die Reinigungsleistung in einem Waschsystem bestimmt wird, das ein Waschmittel in einer Dosierung zwischen 2,0 und 9,0 Gramm pro Liter Waschflotte sowie die Lipase enthƤlt, wobei die zu vergleichenden Lipasen aktivitƤtsgleich eingesetzt sind und die Reinigungsleistung gegenĆ¼ber einer oder mehrerer der Anschmutzungen RuĆ/Mineralƶl auf Baumwolle, RuĆ/Olivenƶl auf Baumwolle, Pigment/ĆI auf Baumwolle oder Hautfett (Sebum)/Kohlenschwarz,auf Baumwolle, insbesondere gegenĆ¼ber einer oder mehrerer der Anschmutzungen
- RuĆ/Mineralƶl auf Baumwolle: Produkt Nr. C-01 erhƤltlich von CFT (Center For Testmaterials) B.V. Vlaardingen, Niederlande
- RuĆ/Olivenƶl auf Baumwolle: Produkt Nr. C-02 erhƤltlich von CFT (Center For Testmaterials) B.V. Vlaardingen, Niederlande
- Pigment/Ćl auf Baumwolle: Produkt Nr. C-09 erhƤltlich von CFT (Center For Testmaterials) B.V. Vlaardingen, Niederlande
- Hautfett (Sebum)/Kohlenschwarz,auf Baumwolle: Produkt Nr. C-S-32 erhƤltlich von CFT (Center For Testmaterials) B.V. Vlaardingen, Niederlande,
- Carbon black / mineral oil on cotton: Product No. C-01 available from CFT (Center For Test Materials) BV Vlaardingen, The Netherlands
- Carbon black / olive oil on cotton: Product No. C-02 available from CFT (Center For Test Materials) BV Vlaardingen, The Netherlands
- Pigment / Oil on cotton: Product No. C-09 available from CFT (Center For Test Materials) BV Vlaardingen, The Netherlands
- Skin fat (sebum) / carbon black, on cotton: Product No. CS-32 available from CFT (Center For Test Materials) BV Vlaardingen, The Netherlands,
Das Waschmittel fĆ¼r das Waschsystem ist ein flĆ¼ssiges Waschmittel, das wie folgt zusammengesetzt (alle Angaben in Gewichts-Prozent): 0,3-0,5% Xanthan, 0,2-0,4% AntiSchaummittel, 6-7% Glycerin, 0,3-0,5% Ethanol, 4-7% FAEOS (Fettalkoholethersulfat), 24-28% nichtionische Tenside, 1% BorsƤure, 1-2% Natriumcitrat (Dihydrat), 2-4% Soda, 14-16% Kokosnuss-FettsƤuren, 0,5% HEDP (1-Hydroxyethan-1,1-diphosphonsƤure), 0-0,4% PVP (Polyvinylpyrrolidon), 0-0,05% optischer Aufheller, 0-0,001% Farbstoff, Rest demineralisiertes Wasser. Die Lipase wird diesbezĆ¼glich in einer Konzentration von 0,0001-0,06 Gew.-%, vorzugsweise von 0,001 bis 0,006 Gew.-%, in dem Waschmittel eingesetzt, bezogen auf aktives Protein. Die Dosierung des flĆ¼ssigen Waschmittels betrƤgt zwischen 2,0 und 9,0, vorzugsweise zwischen 2,5 und 8,0, zwischen 3,0 und 7,0 und besonders bevorzugt 3,5 Gramm pro Liter Waschflotte. Gewaschen wird in einem pH-Wertebereich zwischen pH 8 und pH 10,5, bevorzugt zwischen pH 8 und pH 9. Die LipaseaktivitƤt in der Waschflotte ist zu Waschbeginn nicht gleich Null.The detergent for the washing system is a liquid detergent composed as follows (all figures in weight percent): 0.3-0.5% xanthan gum, 0.2-0.4% anti-foaming agent, 6-7% glycerol, 0.3-0.5% ethanol, 4-7% FAEOS (fatty alcohol ether sulfate), 24-28% nonionic surfactants, 1% boric acid, 1-2% sodium citrate (dihydrate), 2-4% soda , 14-16% coconut fatty acids, 0.5% HEDP (1-hydroxyethane-1,1-diphosphonic acid), 0-0.4% PVP (polyvinylpyrrolidone), 0-0.05% optical brightener, 0-0.001% Dye, remainder demineralized water. The lipase is used in this regard in a concentration of 0.0001-0.06 wt .-%, preferably from 0.001 to 0.006 wt .-%, in the detergent, based on active protein. The dosage of the liquid detergent is between 2.0 and 9.0, preferably between 2.5 and 8.0, between 3.0 and 7.0 and more preferably 3.5 grams per liter of wash liquor. Washing takes place in a pH range between pH 8 and pH 10.5, preferably between pH 8 and pH 9. The lipase activity in the wash liquor is not equal to zero at the start of washing.
Der WeiĆheitsgrad, d.h. die Aufhellung der Anschmutzungen, als MaĆ fĆ¼r die Reinigungsleistung wird mit optischen Messverfahren bestimmt, bevorzugt photometrisch. Ein hierfĆ¼r geeignetes GerƤt ist beispielsweise das Spektrometer Minolta CM508d. Ćblicherweise werden die fĆ¼r die Messung eingesetzten GerƤte zuvor mit einem WeiĆstandard, bevorzugt einem mitgelieferten WeiĆstandard, kalibriert.The degree of whiteness, i. the brightening of the stains, as a measure of the cleaning performance is determined by optical measurement methods, preferably photometrically. A suitable device for this purpose is for example the spectrometer Minolta CM508d. Usually, the devices used for the measurement are previously calibrated with a white standard, preferably a supplied white standard.
Durch den aktivitƤtsgleichen Einsatz der jeweiligen Lipase wird sichergestellt, dass auch bei einem etwaigen Auseinanderklaffen des VerhƤltnisses von Aktivsubstanz zu Gesamtprotein (die Werte der spezifischen AktivitƤt) die jeweiligen enzymatischen Eigenschaften, also beispielsweise die Reinigungsleistung an bestimmten Anschmutzungen, verglichen werden. Generell gilt, dass eine niedrige spezifische AktivitƤt durch Zugabe einer grƶĆeren Proteinmenge ausgeglichen werden kann.The activity-like use of the respective lipase ensures that even if the ratio of active substance to total protein (the values of the specific activity) diverge, the respective enzymatic properties, for example the cleaning performance of certain soils, are compared. In general, a low specific activity can be compensated by adding a larger amount of protein.
Die LipaseaktivitƤt wird in fachĆ¼blicher Weise bestimmt, und zwar vorzugsweise wie beschrieben in Bruno Stellmach, "Bestimmungsmethoden Enzyme fĆ¼r Pharmazie, Lebensmittelchemie, Technik, Biochemie, Biologie, Medizin" (Steinkopff Verlag Darmstadt, 1988, S. 172ff). Hierbei werden Lipase-haltige Proben zu einer Olivenƶlemulsion in emulgatorhaltigem Wasser gegeben und bei 30Ā°C und pH 9,0 inkubiert. Dabei werden FettsƤuren freigesetzt. Diese werden mit einem Autotitrator Ć¼ber 20min. laufend mit 0,01 N Natronlauge titriert, so dass der pH-Wert konstant bleibt ("pH-stat-Titration"). Anhand des Natronlauge-Verbrauchs erfolgt mittels Bezug auf eine Referenzlipaseprobe die Bestimmung der LipaseaktivitƤt.The lipase activity is determined in a customary manner, preferably as described in Bruno Stellmach, "Methods of determination enzymes for pharmacy, food chemistry, engineering, biochemistry, biology, medicine" (Steinkopff Verlag Darmstadt, 1988, p 172ff). In this case, lipase-containing samples are added to an olive oil emulsion in emulsifier-containing water and incubated at 30 Ā° C and pH 9.0. This fatty acids are released. These will be with an autotitrator over 20min. titrated continuously with 0.01 N sodium hydroxide solution so that the pH remains constant ("pH-stat titration"). Based on the sodium hydroxide consumption, the determination of the lipase activity takes place by reference to a reference lipase sample.
Zahlreiche Lipasen werden als sogenannte PrƤproteine, also zusammen mit einem Propeptid und/oder einem Signalpeptid gebildet. HƤufig handelt es sich bei Pro- und/oder Signalpeptid um N-terminale Sequenzen. Im Zuge des Faltungs- und/oder Sekretionsprozesses des Proteins werden Signal- und/oder Propeptid abgespalten, so dass nach der Abspaltung des Pro- und /oder Signalpeptids die dann reife (mature) Lipase ihre katalytische AktivitƤt ohne die ursprĆ¼nglich vorhandenen N-terminalen AminosƤuren ausĆ¼bt. FĆ¼r technische Anwendungen allgemein und insbesondere im Rahmen der Erfindung sind die reifen (maturen) Lipasen, d.h. die nach ihrer Herstellung prozessierten Enzyme, gegenĆ¼ber den PrƤproteinen bevorzugt. Die Lipasen kƶnnen ferner von den sie produzierenden Zellen nach der Herstellung der Polypeptidkette modifiziert werden, beispielsweise durch AnknĆ¼pfung von ZuckermolekĆ¼len, Formylierungen, Aminierungen, usw. Solche Modifikationen sind posttranslationale Modifikationen und kƶnnen, mĆ¼ssen jedoch nicht einen Einfluss auf die Funktion der Lipase ausĆ¼ben.Numerous lipases are formed as so-called pre-proteins, ie together with a propeptide and / or a signal peptide. Often the prodrug and / or signal peptide are N-terminal sequences. In the course of the folding and / or secretion process of the protein Cleaved signal and / or propeptide, so that after the cleavage of the pro- and / or signal peptide, the then mature lipase exerts its catalytic activity without the originally present N-terminal amino acids. For technical applications in general, and in particular in the context of the invention, the mature (mature) lipases, ie the enzymes processed after their preparation, are preferred over the preproteins. The lipases may also be modified by the cells producing them after production of the polypeptide chain, for example, by attachment of sugar molecules, formylations, aminations, etc. Such modifications are post-translational modifications and may, but do not, have an effect on the function of the lipase.
Ferner kann die in einer erfindungsgemƤĆen Tensidzubereitung enthaltene Lipase an TrƤgerstoffe adsorbiert und/oder in HĆ¼llsubstanzen eingebettet sein, um sie gegen vorzeitige Inaktivierung zu schĆ¼tzen. In der Wasch- bzw. Reinigungsflotte, also unter Anwendungsbedingungen, wird die Lipase dann freigesetzt und kann ihre lipolytische Wirkung entfalten.Furthermore, the lipase contained in a surfactant preparation according to the invention may be adsorbed to carriers and / or embedded in encapsulating substances in order to protect them against premature inactivation. In the washing or cleaning liquor, ie under conditions of use, the lipase is then released and can develop their lipolytic action.
In einer bevorzugten AusfĆ¼hrungsform der Erfindung ist die Tensidzubereitung dadurch gekennzeichnet, dass das Phosphonat in einer Menge von 0,01 bis 4 Gew.-% enthalten ist. Weitere bevorzugte Mengen des in der Tensidzubereitung enthaltenen Phosphonats sind von 0,01 bis 3 Gew.-%, von 0,01 bis 2,5 Gew.-%, von 0,02 bis 2,4 Gew.-%, von 0,02 bis 2 Gew.-%, von 0,03 bis 1,5 Gew.-% oder von 0,05 bis 1 Gew.-%.In a preferred embodiment of the invention, the surfactant preparation is characterized in that the phosphonate is contained in an amount of 0.01 to 4 wt .-%. Further preferred amounts of the phosphonate contained in the surfactant preparation are from 0.01 to 3% by weight, from 0.01 to 2.5% by weight, from 0.02 to 2.4% by weight, from 0, 02 to 2 wt .-%, from 0.03 to 1.5 wt .-% or from 0.05 to 1 wt .-%.
Die Lipase ist in einer erfindungsgemƤĆen Tensidzubereitung vorzugsweise jeweils in einer Menge von 1 x 10-8 bis 5 Gew.-% bezogen auf aktives Protein enthalten. Zunehmend bevorzugt ist die Lipase in einer Menge von 1 x 10-7 -3 Gew.-%, von 0,00001-1 Gew.-%, von 0,0002-0,8% Gew.-% und besonders bevorzugt von 0,0008-0,4% Gew.-% in einer erfindungsgemƤĆen Tensidzubereitungen enthalten, bezogen auf aktives Protein. Die Proteinkonzentration kann mit Hilfe bekannter Methoden, zum Beispiel dem BCA-Verfahren (BicinchoninsƤure; 2,2'-Bichinolyl-4,4'-dicarbonsƤure) oder dem Biuret-Verfahren (
Unter einer Tensidzubereitung ist im Rahmen der vorliegenden Erfindung jegliche Art von Zusammensetzung zu verstehen, die mindestens ein Tensid enthƤlt. Vorzugsweise enthƤlt eine derartige Zusammensetzung ein Tensid wie weiter unten beschrieben.For the purposes of the present invention, a surfactant preparation is to be understood as meaning any type of composition which comprises at least one surfactant. Preferably, such a composition contains a surfactant as described below.
Als flĆ¼ssige Tensidzubereitungen kƶnnen hierbei alle flĆ¼ssigen bzw. flieĆfƤhigen Darreichungsformen dienen. "FlieĆfƤhig" im Sinne der vorliegenden Anmeldung sind dabei Zubereitungen, welche gieĆbar sind und ViskositƤten bis hin zu mehreren 10.000 mPas aufweisen kƶnnen. Die ViskositƤt kann mit Ć¼blichen Standardmethoden (beispielsweise Brookfield-Viskosimeter LVT-II bei 20 U/min und 20Ā°C, Spindel 3) gemessen werden und liegt vorzugsweise im Bereich von 5 bis 10000 mPas. Bevorzugte Tensidzubereitungen haben ViskositƤten von 10 bis 8000 mPas, wobei Werte zwischen 120 bis 3000 mPas besonders bevorzugt sind. Eine flĆ¼ssige Tensidzubereitung im Rahmen der vorliegenden Erfindung kann daher auch gelfƶrmig oder pastenfƶrmig sein, sie kann als homogene Lƶsung oder Suspension vorliegen, sowie beispielsweise versprĆ¼hbar oder in sonstigen Ć¼blichen Darreichungsformen konfektioniert sein.In this case, all liquid or flowable administration forms can serve as liquid surfactant preparations. "Flowable" in the context of the present application are preparations which are pourable and can have viscosities of up to several tens of thousands of mPas. The viscosity can be measured by conventional standard methods (for example, Brookfield LVT-II viscosimeter at 20 rpm and 20 Ā° C., spindle 3) and is preferably in the range from 5 to 10,000 mPas. Preferred surfactant formulations have viscosities of 10 to 8000 mPas, with values between 120 to 3000 mPas being particularly preferred. A liquid surfactant preparation in the context of the present invention can therefore also be gelatinous or paste-like, it can be in the form of a homogeneous solution or suspension, and can be sprayed or packaged in other conventional dosage forms, for example.
Eine erfindungsgemƤĆe flĆ¼ssige Tensidzubereitung kann als solche oder nach VerdĆ¼nnen mit Wasser eingesetzt werden, insbesondere zur Reinigung von Textilien und/oder harten OberflƤchen. Eine solche VerdĆ¼nnung kann leicht hergestellt werden, indem eine abgemessene Menge der Tensidzubereitung in einer weiteren Menge Wasser verdĆ¼nnt wird in bestimmten GewichtsverhƤltnissen von Tensidzubereitung : Wasser und optional diese VerdĆ¼nnung geschĆ¼ttelt wird, um eine gleichmƤĆige Verteilung der Tensidzubereitung im Wasser sicherzustellen. Mƶgliche Gewichts- oder VolumenverhƤltnisse der VerdĆ¼nnungen sind von 1:0 Tensidzubereitung : Wasser bis 1:10000 oder 1:20000 Tensidzubereitung : Wasser, vorzugsweise von 1:10 bis 1:2000 Tensidzubereitung : Wasser.A liquid surfactant preparation according to the invention can be used as such or after dilution with water, in particular for the cleaning of textiles and / or hard surfaces. Such dilution can be readily made by diluting a measured amount of the surfactant preparation in a further amount of water in certain weight ratios of surfactant preparation: water and optionally shaking this dilution to ensure uniform distribution of the surfactant formulation in the water. Possible weight or volume ratios of the dilutions are from 1: 0 surfactant preparation: water to 1: 10,000 or 1: 20000 surfactant preparation: water, preferably from 1:10 to 1: 2000 surfactant preparation: water.
Eine Tensidzubereitung im Sinne der vorliegenden Erfindung kann daher auch die Wasch- bzw. Reinigungsflotte selbst sein.A surfactant preparation in the sense of the present invention can therefore also be the washing or cleaning liquor itself.
In einer bevorzugten AusfĆ¼hrungsform ist die Tensidzubereitung ein Wasch-, Reinigungs- oder Desinfektionsmittel. Zu den Waschmitteln zƤhlen alle denkbaren Waschmittelarten, insbesondere Waschmittel fĆ¼r Textilien, Teppiche oder Naturfasern. Sie kƶnnen fĆ¼r die manuelle und/oder auch die maschinelle Anwendung vorgesehen sein. Zu den Waschmitteln zƤhlen ferner Waschhilfsmittel, die bei der manuellen oder maschinellen TextilwƤsche zum eigentlichen Waschmittel hinzudosiert werden, um eine weitere Wirkung zu erzielen. Zu den Reinigungsmitteln werden alle, ebenfalls in sƤmtlichen genannten Darreichungsformen vorkommenden Mittel zur Reinigung und/oder Desinfektion harter OberflƤchen, manuelle und maschinelle GeschirrspĆ¼lmittel, Teppichreiniger, Scheuermittel, Glasreiniger, WC-DuftspĆ¼ler, usw. gezƤhlt. Textilvor- und Nachbehandlungsmittel sind schlieĆlich auf der einen Seite solche Mittel, mit denen das WƤschestĆ¼ck vor der eigentlichen WƤsche in Kontakt gebracht wird, beispielsweise zum Anlƶsen hartnƤckiger Verschmutzungen, auf der anderen Seite solche, die in einem der eigentlichen TextilwƤsche nachgeschalteten Schritt dem Waschgut weitere wĆ¼nschenswerte Eigenschaften wie angenehmen Griff, Knitterfreiheit oder geringe statische Aufladung verleihen. Zu letztgenannten Mittel werden u.a. die WeichspĆ¼ler gerechnet. Desinfektionsmittel sind beispielsweise HƤndedesinfektionsmittel, FlƤchendesinfektionsmittel und Instrumentendesinfektionsmittel, die ebenfalls in den genannten Darreichungsformen vorkommen kƶnnen. Ein Desinfektionsmittel bewirkt vorzugsweise eine Keimreduktion um einen Faktor von mindestens 104, das heiĆt dass von ursprĆ¼nglich 10.000 vermehrungsfƤhigen Keimen (so genannte koloniebildende Einheiten - KBE) nicht mehr als ein Einziger Ć¼berlebt, wobei Viren diesbezĆ¼glich nicht als Keime gelten, da sie kein Zytoplasma und keinen eigenen Stoffwechsel aufweisen. Bevorzugte Desinfektionsmittel bewirken eine Keimreduktion um einen Faktor von mindestens 105.In a preferred embodiment, the surfactant preparation is a washing, cleaning or disinfecting agent. The detergents include all conceivable types of detergents, in particular detergents for textiles, carpets or natural fibers. They can be provided for manual and / or machine application. The detergents also include washing aids, which are added to the actual detergent in the manual or machine textile washing, in order to achieve a further effect. Detergents include all agents for cleaning and / or disinfecting hard surfaces also found in all of the above dosage forms, manual and automatic dishwashing detergents, carpet cleaners, abrasives, glass cleaners, toilet scavengers, etc. Textile pre- and post-treatment agent Finally, on the one hand are such means with which the laundry is brought into contact before the actual laundry, for example, for solving stubborn dirt, on the other hand, those in one of the actual textile laundry downstream step the laundry further desirable properties such as pleasant handle , Give crease-free or low static charge. Amongst others, the fabric softeners are calculated. Disinfectants are, for example, hand disinfectants, surface disinfectants and instrument disinfectants, which may also occur in the mentioned dosage forms. A disinfectant preferably causes a germ reduction by a factor of at least 10 4 , that is to say that of originally 10,000 proliferating germs (so-called colony-forming units - CFU) survived no more than a single, with viruses in this regard are not considered as germs, since they have no cytoplasm and have no own metabolism. Preferred disinfectants cause a germ reduction by a factor of at least 10 5 .
Als Tensid(e) kƶnnen anionische, nichtionische, zwitterionische und/oder amphotere Tenside eingesetzt werden. Bevorzugt sind aus anwendungstechnischer Sicht Mischungen aus anionischen und nichtionischen Tensiden. Der Gesamttensidgehalt der flĆ¼ssigen Tensidzubereitung liegt vorzugsweise unterhalb von 60 Gew.-% und besonders bevorzugt unterhalb von 45 Gew.-%, bezogen auf die gesamte flĆ¼ssige Tensidzubereitung.As surfactant (s) it is possible to use anionic, nonionic, zwitterionic and / or amphoteric surfactants. From an application point of view, preference is given to mixtures of anionic and nonionic surfactants. The total surfactant content of the liquid surfactant preparation is preferably below 60% by weight, and more preferably below 45% by weight, based on the total liquid surfactant formulation.
Geeignete nichtionische Tenside umfassen alkoxylierte Fettalkohole, alkoxylierte FettsƤurealkylester, FettsƤureamide, alkoxylierte FettsƤureamide, PolyhydroxyfettsƤureamide, Alkylphenolpolyglycolether, Aminoxide, Alkylpolyglucoside und Mischungen daraus.Suitable nonionic surfactants include alkoxylated fatty alcohols, alkoxylated fatty acid alkyl esters, fatty acid amides, alkoxylated fatty acid amides, polyhydroxy fatty acid amides, alkylphenol polyglycol ethers, amine oxides, alkyl polyglucosides, and mixtures thereof.
Als nichtionische Tenside werden vorzugsweise alkoxylierte, vorteilhafterweise ethoxylierte, insbesondere primƤre Alkohole mit vorzugsweise 8 bis 18 C-Atomen und durchschnittlich 1 bis 12 Mol Ethylenoxid (EO) pro Mol Alkohol eingesetzt, in denen der Alkoholrest linear oder bevorzugt in 2-Stellung methylverzweigt sein kann bzw. lineare und methylverzweigte Reste im Gemisch enthalten kann, so wie sie Ć¼blicherweise in Oxoalkoholresten vorliegen. Insbesondere sind jedoch Alkoholethoxylate mit linearen Resten aus Alkoholen nativen Ursprungs mit 12 bis 18 C-Atomen, zum Beispiel aus Kokos-, Palm-, Talgfett- oder Oleylalkohol, und durchschnittlich 2 bis 8 EO pro Mol Alkohol bevorzugt. Zu den bevorzugten ethoxylierten Alkoholen gehƶren beispielsweise C12-14-Alkohole mit 3 EO, 4 EO oder 7 EO, C9-11-Alkohol mit 7 EO, C13-5-Alkohole mit 3 EO, 5 EO, 7 EO oder 8 EO, C12-18-Alkohole mit 3 EO, 5 EO oder 7 EO und Mischungen aus diesen, wie Mischungen aus C12-14-Alkohol mit 3 EO und C12-18-Alkohol mit 7 EO. Die angegebenen Ethoxylierungsgrade stellen statistische Mittelwerte dar, die fĆ¼r ein spezielles Produkt eine ganze oder eine gebrochene Zahl sein kƶnnen. Bevorzugte Alkoholethoxylate weisen eine eingeengte Homologenverteilung auf (narrow range ethoxylates, NRE). ZusƤtzlich zu diesen nichtionischen Tensiden kƶnnen auch Fettalkohole mit mehr als 12 EO eingesetzt werden. Beispiele hierfĆ¼r sind Talgfettalkohol mit 14 EO, 25 EO, 30 EO oder 40 EO. Auch nichtionische Tenside, die EO- und PO-Gruppen zusammen im MolekĆ¼l enthalten, sind erfindungsgemĆ¤Ć einsetzbar. Geeignet sind ferner auch eine Mischung aus einem (stƤrker) verzweigten ethoxylierten Fettalkohol und einem unverzweigten ethoxylierten Fettalkohol, wie beispielsweise eine Mischung aus einem C16-18-Fettalkohol mit 7 EO und 2-Propylheptanol mit 7 EO. Insbesondere bevorzugt enthƤlt die Tensidzubereitung einen C12-18-Fettalkohol mit 7 EO oder einen C13-15-Oxoalkohol mit 7 EO als nichtionisches Tensid.The nonionic surfactants used are preferably alkoxylated, advantageously ethoxylated, in particular primary, alcohols having preferably 8 to 18 carbon atoms and on average 1 to 12 moles of ethylene oxide (EO) per mole of alcohol, in which the alcohol radical can be linear or preferably methyl-branched in the 2-position or linear and methyl-branched radicals in the mixture can contain, as they are usually present in Oxoalkoholresten. In particular, however, alcohol ethoxylates with linear radicals of alcohols of native origin having 12 to 18 carbon atoms, for example of coconut, palm, tallow or oleyl alcohol, and on average 2 to 8 EO per mole of alcohol are preferred. Preferred ethoxylated alcohols include, for example, C12-14 alcohols containing 3 EO, 7 EO or 4 EO, C9-11 alcohol containing 7 EO, C 13-5 alcohols containing 3 EO, 5 EO, 7 EO or 8 EO, C 12-18 -alcohols with 3 EO, 5 EO or 7 EO and mixtures of these, such as mixtures of C 12-14 -alcohol with 3 EO and C 12-18 -alcohol with 7 EO. The degrees of ethoxylation given represent statistical means which, for a particular product, may be an integer or a fractional number. Preferred alcohol ethoxylates have a narrowed Homolog distribution (narrow range ethoxylates, NRE). In addition to these nonionic surfactants, fatty alcohols with more than 12 EO can also be used. Examples include tallow fatty alcohol with 14 EO, 25 EO, 30 EO or 40 EO. Nonionic surfactants containing EO and PO groups together in the molecule can also be used according to the invention. Also suitable are also a mixture of a (more) branched ethoxylated fatty alcohol and an unbranched ethoxylated fatty alcohol, such as a mixture of a C 16-18 fatty alcohol with 7 EO and 2-propylheptanol with 7 EO. Particularly preferably, the surfactant preparation contains a C 12-18 fatty alcohol with 7 EO or a C 13-15 oxo alcohol with 7 EO as nonionic surfactant.
Der Gehalt an nichtionischen Tensiden betrƤgt bevorzugt 3 bis 40 Gew.-%, vorzugsweise 5 bis 30 Gew.-% und insbesondere 7 bis 20 Gew.-%, jeweils bezogen auf die gesamte Tensidzubereitung.The content of nonionic surfactants is preferably 3 to 40 wt .-%, preferably 5 to 30 wt .-% and in particular 7 to 20 wt .-%, each based on the total surfactant.
Neben den nichtionischen Tensiden kann die Tensidzubereitung auch anionische Tenside enthalten. Als anionisches Tensid werden vorzugsweise Sulfonate, Sulfate, Seifen, Alkylphosphate, anionische Silikontenside und Mischungen daraus eingesetzt.In addition to the nonionic surfactants, the surfactant preparation may also contain anionic surfactants. The anionic surfactant used is preferably sulfonates, sulfates, soaps, alkyl phosphates, anionic silicone surfactants and mixtures thereof.
Als Tenside vom Sulfonat-Typ kommen dabei vorzugsweise C9-13-Alkylbenzolsulfonate, Olefinsulfonate, d.h. Gemische aus Alken- und Hydroxyalkansulfonaten sowie Disulfonaten, wie man sie beispielsweise aus C12-18-Monoolefinen mit end- oder innenstƤndiger Doppelbindung durch Sulfonieren mit gasfƶrmigem Schwefeltrioxid und anschlieĆende alkalische oder saure Hydrolyse der Sulfonierungsprodukte erhƤlt, in Betracht. Geeignet sind auch C12-18-Alkansulfonate und die Ester von Ī±-SulfofettsƤuren (Estersulfonate), zum Beispiel die Ī±-sulfonierten Methylester der hydrierten Kokos-, Palmkern- oder TalgfettsƤuren.The surfactants of the sulfonate type are preferably C 9-13 -alkylbenzenesulfonates, olefinsulfonates, ie mixtures of alkene and hydroxyalkanesulfonates and disulfonates, as are obtained, for example, from C 12-18 -monoolefins having terminal or internal double bonds by sulfonation with gaseous sulfur trioxide and subsequent alkaline or acid hydrolysis of the sulfonation products into consideration. Also suitable are C 12-18 alkanesulfonates and the esters of Ī±-sulfo fatty acids (ester sulfonates), for example the Ī±-sulfonated methyl esters of hydrogenated coconut, palm kernel or tallow fatty acids.
Als Alk(en)ylsulfate werden die Alkali- und insbesondere die Natriumsalze der SchwefelsƤurehalbester der C12-C18-Fettalkohole, beispielsweise aus Kokosfettalkohol, Talgfettalkohol, Lauryl-, Myristyl-, Cetyl- oder Stearylalkohol oder der C10-C20-Oxoalkohole und diejenigen Halbester sekundƤrer Alkohole dieser KettenlƤngen bevorzugt. Aus waschtechnischem Interesse sind die C12-C16-Alkylsulfate und C12-C15-Alkylsulfate sowie C14-C15-Alkylsulfate bevorzugt. Auch 2,3-Alkylsulfate sind geeignete anionische Tenside.Alk (en) ylsulfates are the alkali metal salts and in particular the sodium salts of the sulfuric monoesters of C 12 -C 18 fatty alcohols, for example coconut fatty alcohol, tallow fatty alcohol, lauryl, myristyl, cetyl or stearyl alcohol or the C 10 -C 20 oxo alcohols and those half-esters of secondary alcohols of these chain lengths are preferred. Of washing technology interest, the C 12 -C 16 alkyl sulfates and C 12 -C 15 alkyl sulfates and C 14 -C 15 alkyl sulfates are preferred. 2,3-alkyl sulfates are also suitable anionic surfactants.
Auch die SchwefelsƤuremonoester der mit 1 bis 6 Mol Ethylenoxid ethoxylierten geradkettigen oder verzweigten C7-21-Alkohole, wie 2-Methyl-verzweigte C9-11-Alkohole mit im Durchschnitt 3,5 Mol Ethylenoxid (EO) oder C12-18-Fettalkohole mit 1 bis 4 EO, sind geeignet.The sulfuric acid monoesters of straight-chain or branched C 7-21 -alcohols ethoxylated with from 1 to 6 mol of ethylene oxide, such as 2-methyl-branched C 9-11- alcohols having on average 3.5 mol of ethylene oxide (EO) or C 12-18 . Fatty alcohols with 1 to 4 EO are suitable.
Auch bevorzugte anionische Tenside sind Seifen. Geeignet sind gesƤttigte und ungesƤttigte FettsƤureseifen, wie die Salze der LaurinsƤure, MyristinsƤure, PalmitinsƤure, StearinsƤure, (hydrierten) ErucasƤure und BehensƤure sowie insbesondere aus natĆ¼rlichen FettsƤuren, zum Beispiel Kokos-, Palmkern-, Olivenƶl- oder TalgfettsƤuren, abgeleitete Seifengemische.Also preferred anionic surfactants are soaps. Suitable are saturated and unsaturated fatty acid soaps, such as the salts of lauric acid, myristic acid, palmitic acid, stearic acid, (hydrogenated) erucic acid and behenic acid and, in particular, soap mixtures derived from natural fatty acids, for example coconut, palm kernel, olive oil or tallow fatty acids.
Die anionischen Tenside einschlieĆlich der Seifen kƶnnen in Form ihrer Natrium-, Kalium- oder Magnesium- oder Ammoniumsalze vorliegen. Vorzugsweise liegen die anionischen Tenside in Form ihrer Natriumsalze vor. Weitere bevorzugte Gegenionen fĆ¼r die anionischen Tenside sind auch die protonierten Formen von Cholin, Triethylamin oder Methylethylamin.The anionic surfactants including the soaps may be in the form of their sodium, potassium or magnesium or ammonium salts. Preferably, the anionic surfactants are in the form of their sodium salts. Further preferred counterions for the anionic surfactants are also the protonated forms of choline, triethylamine or methylethylamine.
Der Gehalt einer Tensidzubereitung an anionischen Tensiden kann 1 bis 40 Gew.-%, vorzugsweise 5 bis 30 Gew.-% und ganz besonders bevorzugt 10 bis 25 Gew.-%, jeweils bezogen auf die gesamte Tensidzubereitung, betragen.The content of a surfactant preparation of anionic surfactants can be from 1 to 40% by weight, preferably from 5 to 30% by weight and very particularly preferably from 10 to 25% by weight, based in each case on the total surfactant preparation.
In einerweiteren AusfĆ¼hrungsform der Erfindung ist die Tensidzubereitung dadurch gekennzeichnet, dass sie ferner eine Komponente umfasst, die ausgewƤhlt ist aus i
- i. anionische und/oder polyanionische Substanz, und/oder
- ii. kationische und/oder polykationische Substanz, und/oder
- iii. Hydroxyl- und/oder Polyhydroxyl-Gruppe(n) aufweisende Substanz.
- i. anionic and / or polyanionic substance, and / or
- ii. cationic and / or polycationic substance, and / or
- iii. Hydroxyl and / or polyhydroxyl group (s) having substance.
Es wurde festgestellt, dass der Zusatz solcher Substanzen die Reinigungsleistung von Tensidzubereitungen, insbesondere von flĆ¼ssigen Wasch- oder Reinigungsmitteln, welche eine Lipase enthalten, insbesondere eine solche wie vorstehend beschrieben, weiter verbessert, insbesondere bei einer Temperatur zwischen 10Ā°C und 80Ā°C und vorzugsweise bei vergleichsweise niedrigen Temperaturen, insbesondere zwischen 10Ā°C und 50Ā°C, zwischen 10Ā°C und 40Ā°C, zwischen 10Ā°C und 30Ā°C und/oder zwischen 20Ā°C und 40Ā°C.It has been found that the addition of such substances further improves the cleaning performance of surfactant preparations, in particular of liquid detergents or cleaners containing a lipase, in particular such as described above, in particular at a temperature between 10 Ā° C and 80 Ā° C and preferably at comparatively low temperatures, in particular between 10 Ā° C and 50 Ā° C, between 10 Ā° C and 40 Ā° C, between 10 Ā° C and 30 Ā° C and / or between 20 Ā° C and 40 Ā° C.
Bei den vorstehend unter i. angegebenen Substanzen handelt es sich um anionische oder polyanionische Substanzen, d.h. diese Substanzen tragen mindestens eine und bevorzugt mehrere negative Ladungen. Bevorzugt handelt es sich um ein Polymer mit mindestens einem negativ gelandenen Monomer, bevorzugt mit mehreren negativ geladenen Monomeren. ErfindungsgemĆ¤Ć bevorzugt ist dieses Polymer daher ein negativ geladenes Polymer. Bevorzugt sind beispielsweise Polymere organischer SƤuren bzw. deren Salze, insbesondere Polyacrylate und/oder Poly-ZuckersƤuren und/oder Polyarcylat-copolymere und/oder Poly-zucker-copolymere. DiesbezĆ¼glich weitere bevorzugte Verbindungen sind Polyacrylsulfonate oder Polycarboxylate und deren Salze, Copolymere oder Salze der Coploymere.In the case under i. The substances indicated are anionic or polyanionic substances, ie these substances carry at least one and preferably several negative charges. It is preferably a polymer having at least one negatively charged monomer, preferably having a plurality of negatively charged monomers. According to the invention, this polymer is therefore a negatively charged polymer. For example, polymers of organic acids or their salts, in particular polyacrylates and / or poly-sugar acids and / or polyarcylate copolymers and / or poly-sugar copolymers, are preferred. In this regard, further preferred compounds are polyacrylic sulfonates or polycarboxylates and their salts, copolymers or salts of the copolymers.
Beispiele fĆ¼r besonders bevorzugt einzusetzende Substanzen sind Acusol 587D (Polyacrylsulfonat; Unternehmen Rohm & Haas/Dow Chemical), Acusol 445N (Polycarboxylat Natriumsalz; Unternehmen Rohm & Haas/Dow Chemical), Acusol 590 (Polyarcrylat-copolymer; Unternehmen Rohm & Haas/Dow Chemical), Acusol 916 (Polyarcrylat Natriumsalz; Unternehmen Rohm & Haas/Dow Chemical), Sokalan CP42 (modifiziertes Polycarboxylat Natriumsalz; Unternehmen BASF), Sokalan PA 30CL (Polycarboxylat Natriumsalz; Unternehmen BASF), Dequest P 9000 (PolymaleinsƤure; Unternehmen Thermphos), AlginsƤure, Poly-2-acrylamido-2-methyl-1-propan-sulfonsƤure, Poly-4-styrol sulfonsƤure -co-maleinsƤure Natriumsalz, Poly-acrylamido-co-acrylsƤure Natriumsalz, Poly-methacrylsƤure Natriumsalz, Poly-methyl vinyl ether-alt maleinsƤure oder PolyvinylsulfonsƤure Natriumsalz.Examples of particularly preferable substances to be used are Acusol 587D (polyacrylic sulfonate, Rohm & Haas / Dow Chemical Company), Acusol 445N (polycarboxylate sodium salt, Rohm & Haas / Dow Chemical Company), Acusol 590 (polyacrylate copolymer; Rohm & Haas / Dow Chemical ), Acusol 916 (polyarcrylate sodium salt, Rohm & Haas / Dow Chemical Company), Sokalan CP42 (modified polycarboxylate sodium salt, BASF Company), Sokalan PA 30CL (polycarboxylate sodium salt, BASF Company), Dequest P 9000 (polymaleic acid, Thermphos Company), alginic acid , Poly-2-acrylamido-2-methyl-1-propane-sulfonic acid, poly-4-styrene sulfonic acid-co-maleic acid sodium salt, poly-acrylamido-co-acrylic acid sodium salt, poly-methacrylic acid sodium salt, poly-methyl vinyl ether-alt maleic acid or polyvinyl sulfonic acid sodium salt.
Bei den unter ii. angegebenen Substanzen handelt es sich kationische oder polykationische Substanzen, d.h. diese Substanzen tragen mindestens eine und bevorzugt mehrere positive Ladungen. Bevorzugt handelt es sich um ein Polymer mit mindestens einem positiv gelandenen Monomer, bevorzugt mit mehreren positiv geladenen Monomeren. ErfindungsgemĆ¤Ć bevorzugt ist dieses Polymer daher ein positiv geladenes Polymer. Beispiele fĆ¼r diesbezĆ¼glich bevorzugte Verbindungen sind Salze der Polyamine, Polyethyleneimine bzw. deren Copolymere, Salze der Polyallylamine, Salze der Polydiallyldimethylammonium-verbindungen oder Poly(acrylamide-co-diallyldimethylammonium-verbindungen.In the under ii. The substances indicated are cationic or polycationic substances, i. these substances carry at least one and preferably several positive charges. It is preferably a polymer having at least one positively charged monomer, preferably having a plurality of positively charged monomers. According to the invention, this polymer is therefore a positively charged polymer. Examples of preferred compounds in this regard are salts of polyamines, polyethylene imines or their copolymers, salts of polyallylamines, salts of Polydiallyldimethylammonium compounds or poly (acrylamide-co-diallyldimethylammonium compounds.
Bei den unter iii. angegebenen Substanzen handelt es sich um Substanzen, die mindestens eine Hydroxyl- und/oder Polyhydroxyl-Gruppe und bevorzugt mehrere Hydroxyl- und/oder Polyhydroxyl-Gruppen aufweisen. Bevorzugt sind diesbezĆ¼glich beispielsweise Polyvinylalkohole, beispielsweise solche, die unter dem Handelsnamen Mowiol verfĆ¼gbar sind (Unternehmen Kremer Pigmente GmbH & Co. KG).In the under iii. specified substances are substances which have at least one hydroxyl and / or polyhydroxyl group and preferably more hydroxyl and / or polyhydroxyl groups. Preferred in this regard are, for example, polyvinyl alcohols, for example those which are available under the trade name Mowiol (Kremer Pigmente GmbH & Co. KG).
Es wird an dieser Stelle ausdrĆ¼cklich darauf hingewiesen, dass eine konkrete Substanz zu einer oder mehreren der vorstehend genannten Gruppen i. bis iii. zugehƶrig sein kann. Beispielsweise kann es sich um ein anionisches Polymer handeln, welches eine oder mehrere Hydroxyl- und/oder Polyhydroxyl-Gruppe(n) aufweist. Eine solche Substanz ist dann zugehƶrig zu den Gruppen i. und iii. Ebenso ist ein kationisches Polymer, welches eine oder mehrere Hydroxyl- und/oder Polyhydroxyl-Gruppe(n) aufweist, zugehƶrig zu den Gruppen ii. und iii.It is expressly noted at this point that a specific substance to one or more of the above groups i. to iii. may be associated. For example, it may be an anionic polymer having one or more hydroxyl and / or polyhydroxyl group (s). Such a substance is then associated with the groups i. and iii. Likewise, a cationic polymer having one or more hydroxyl and / or polyhydroxyl group (s) belonging to the groups ii. and iii.
Im Rahmen der vorliegenden Erfindung ebenfalls einsetzbar sind Derivate der vorstehend als zugehƶrig zu i., ii. oder iii. genannten Substanzen. Unter einem Derivat wird im Sinne der vorliegenden Anmeldung eine solche Substanz verstanden, die ausgehend von einer der vorstehend genannten Substanzen chemisch modifiziert ist, beispielsweise durch die Umwandlung einer Seitenkette oder durch kovalente Bindung einer anderen Verbindung an die Substanz. Bei solch einer Verbindung kann es sich beispielsweise um niedrigmolekulare Verbindungen wie Lipide oder Mono-, Oligo- oder Polysaccharide oder Amine bzw. Aminverbindungen handeln. Ferner kann die Substanz glykosyliert, hydrolysiert, oxidiert, N-methyliert, N-formyliert, N-acetyliert sein oder Methyl, Formyl, Ethyl, Acetyl, t-Butyl, Anisyl, Benzyl, Trifluroacetyl, N-hydroxysuccinimide, t-Butyloxycarbonyl, Benzoyl, 4-Methylbenzyl, Thioanizyl, Thiocresyl, Benzyloxymethyl, 4-Nitrophenyl, Benzyloxycarbonyl, 2-Nitrobenzoyl, 2-Nitrophenylsulphenyl, 4-Toluenesulphonyl, Pentafluorophenyl, Diphenylmethyl, 2-Chlorobenzyloxycarbonyl, 2,4,5-trichlorophenyl, 2-bromobenzyloxycarbonyl, 9-Fluorenylmethyloxycarbonyl, Tripheylmethyl, 2,2,5,7,8-pentamethyl-chroman-6-sulphonyl enthalten. Ebenso ist unter einem Derivat die kovalente oder nichtkovalente Bindung der Substanz an einen makromolekularen TrƤger zu verstehen, genauso wie auch ein nichtkovalenter Einschluss in geeignete makromolekulare KƤfigstrukturen. Auch Kopplungen mit sonstigen makromolekularen Verbindungen, wie etwa Polyethylenglykol, kƶnnen vorgenommen sein. Weitere bevorzugte chemische Modifikationen sind die Modifikation von einer oder mehreren der chemischen Gruppen -COOH, -OH, =NH, -NH2 -SH zu -COOR, -OR, -NHR, -NR2, -NHR, -NR, -SR; wobei:
- R ist-CH=CH-R2, -Cā”C-R2, -C(R2)=CH2, -C(R2)=C(R3), -CH=NR2, -C(R2)=N-R3, ein 4-7 C-Ring System mit oder ohne Substitution, ein 4-7 Stickstoffheterozyklus mit oder ohne Substitution, oder eine C2 bis C8 Kette mit 1 bis 5 Doppel- oder Dreifachbindungen mit Substitutionen ausgewƤhlt aus R1, R2, oder R3, wobei
- -R1 ist H, -R, -NO2, -CN, Halogenidsubstituent, -N3, -C1-8 alkyl, -(CH2)nCO2R2, -C2-8 alkenyl-CO2R2, -O(CH2)nCO2R2, -C(O)NR2R3, -P(O)(OR2)2, alkyl substituiertes tetrazol-5-yl, -(CH2)nO(CH2)n aryl, -NR2R3, -(CH2)n OR2, -(CH2)n SR2, -N(R2)C(O)R3, -S(O2)NR2R3, -N(R2)S(O2)R3, -(CHR2)n NR2R3, -C(O)R3, (CH2)n N(R3)C(O)R3, -N(R2)CR2R3, substituiertes oder nicht substituiertes (CH2)n-zykloalkyl, substituiertes oder nicht substituiertes (CH2)n-phenyl, oder-zyklus; wobei n eine Zahl grƶĆer als 1 ist;
- -R2 ist H, Halogenidsubstituent, -alkyl, -halogenalkyl, -(CH2)n-phenyl, -(CH2)1-3-biphenyl, -(CH2)1-4-Ph-N(SO2-C1-2-alkyl)2, -CO(CHR1)n-OR1, -(CHR1)n-Heterozyklus, -(CHR1)n-NH-CO-R1, -(CHR1)n-NH-SO2R1, -(CHR1)n-Ph-N(SO2-C1-2-alkyl)2, -(CHR1)n-C(O)(CHR1)-NHR1, -(CHR1)n-C(S)(CHR1)-NHR1, -(CH2)nO(CH2)nCH3, -CF3, -C2-C5 acyl, -(CHR1)nOH, -(CHR1)nCO2R1, -(CHR1)n-O-alkyl, -(CHR1)n-O-(CH2)n-O-alkyl, -(CHR1)n-S-alkyl, -(CHR1)n-S(O)-alkyl, -(CHR1)n-S(O2)-alkyl, -(CHR1)n-S(O2)-NHR3, -(CHR3)n-N3, -(CHR3)nNHR4, eine C2 bis C8 Kette Alken-Kette mit 1 bis 5 Doppelbindungen, eine C2 bis C8 Kette Alkin-Kette mit 1 bis 5 Dreifachbindungen, substituierter oder nicht substituierter -(CHR3)n Heterozyklus, substituiertes oder nicht substituiertes gesƤttigtes oder nicht gesƤttigtes -(CHR3)n Zykloalkyl; wobei n eine Zahl grƶĆer als 1 ist und R1 und R3 gleich oder unterschiedlich sein kƶnnen;
- -R3 ist H, -OH, -CN, substituiertes Alkyl, - C2 bis C8 Alkenyl, substituiertes oder nicht substituiertes Zykloalkyl, -N(R1)R2, gesƤttigter oder nicht gesƤttigter C5 bis C7 Heterozyklus oder Heterobizyklus von 4 bis 7 C-Atomen, -NR1, -NR2, -NR1R2 bestehend aus einem gesƤttigten oder nicht gesƤttigten Heterozyklus oder einem Heterobizyklus von 4 bis 7 C-Atomen;
- -R4 ist H, -(CH2)nOH, -C(O)ORS, -C(O)SR5, -(CH2)n C(O)NR6R7, -O-C(O)-O-R6, eine AminosƤure oder ein Peptid; wobei n eine Zahl zwischen 0 und 4 ist;
- -R5 ist H,
- -R6 ist -C(R7)-(CH2)n-O-C(O)-R8, -(CH2)n-C(R7)-O-C(O)R8, -(CH2)n-C(R7)-O-C(O)-O-R8, oder-C(R7)-(CH2)n-O-C(O)-O-R8; wobei n eine Zahl zwischen 0 und 4 ist; und
- -R7 und R8 sind jeweils H, Alkyl, substituiertes Alkyl, Aryl, substituiertes Aryl, Alkenyl, substituiertes Alkenyl, Alkinyl, substituiertes Alkinyl, Heterozyklus, substituierter Heterozyklus, Alkylaryl, substituiertes Alkylaryl, Zykloalkyl, substituiertes Zykloalkyl, oder CH2CO2alkyl, wobei R7 und R8 gleich oder unterschiedlich sein kƶnnen.
- R is -CH = CH-R2, -Cā”C-R2, -C (R 2 ) = CH 2 , -C (R 2 ) = C (R 3), -CH = NR 2 , -C (R 2 ) = N-R 3 , a 4-7 C-ring system with or without substitution, a 4-7 nitrogen heterocycle with or without substitution, or a C 2 to C 8 chain with 1 to 5 double or triple bonds with substitutions selected from R1, R2, or R3 , in which
- -R 1 is H, -R, -NO 2, -CN, halide substituent, -N 3, -C1-8 alkyl, - (CH 2) n CO 2 R 2, -C2-8 alkenyl-CO 2 R 2, -O (CH 2 ) nCO 2 R 2 , -C (O) NR 2 R 3, -P (O) (OR 2 ) 2 , alkyl substituted tetrazol-5-yl, - (CH 2 ) n O (CH 2 ) n aryl, -NR 2 R 3, - (CH 2) n OR 2, - (CH 2) n SR2, -N (R2) C (O) R3, -S (O 2) NR2R3, -N (R2) S (O 2) R 3, - (CHR 2) n NR2R3 , -C (O) R 3, (CH 2 ) n, N (R 3) C (O) R 3, -N (R 2 ) CR 2 R 3, substituted or unsubstituted (CH 2 ) n -cycloalkyl, substituted or unsubstituted (CH 2 ) n-phenyl, or -cycle; where n is a number greater than 1;
- -R2 is H, halide substituent, alkyl, haloalkyl, - (CH 2) n-phenyl, - (CH2) 1-3-biphenyl, - (CH 2) 1-4-Ph-N (SO 2 -C 1 -2-alkyl) 2, -CO (CHR1) n OR1, - (CHR1) n-heterocycle, - (CHR1) n-NH-CO-R1, - (CHR1) n-NH-SO 2 R1, - ( CHR1) n-Ph-N (SO2 -C1-2 alkyl) 2, - (CHR1) n C (O) (CHR1) -NHR1, - (CHR1) n C (S) (CHR1) -NHR1, - (CH 2 ) nO (CH 2 ) n CH 3 , -CF 3 , -C 2 -C 5 acyl, - (CHR 1) n OH, - (CHR 1) n CO 2 R 1 , - (CHR 1) nO-alkyl, - (CHR 1) nO- (CH 2 ) nO-alkyl, - (CHR 1) n -S -alkyl, - (CHR 1) nS (O) -alkyl, - (CHR 1) nS (O 2 ) -alkyl, - (CHR 1) nS (O 2 ) -NHR 3 , - (CHR 3 ) n N 3 , - (CHR 3) n NHR 4, a C 2 to C 8 chain alkene chain having 1 to 5 double bonds, a C 2 to C 8 chain alkyne chain having 1 to 5 triple bonds, substituted or unsubstituted - (CHR3) n heterocycle, substituted or unsubstituted saturated or unsaturated - (CHR3) n cycloalkyl; where n is a number greater than 1 and R1 and R3 may be the same or different;
- -R3 is H, -OH, -CN, substituted alkyl, - C 2 to C 8 alkenyl, substituted or unsubstituted cycloalkyl, -N (R 1) R 2, saturated or unsaturated C 5 to C 7 heterocycle or heterobicycycle of 4 to 7 C atoms, -NR1, -NR2, -NR1R2 consisting of a saturated or unsaturated heterocycle or a heterocycle of 4 to 7 C atoms;
- -R 4 is H, - (CH 2) n OH, -C (O) ORS, -C (O) SR5, - (CH 2) n C (O) NR6R7, -OC (O) -O-R6, an amino acid or a peptide; where n is a number between 0 and 4;
- -R5 is H,
- -R6 is -C (R7) - (CH2) nOC (O) -R 8, - (CH 2) n C (R7) -OC (O) R8, - (CH 2) n C (R7) -OC (O) -O-R8, or-C (R7) - (CH2) nOC (O) -O-R8; where n is a number between 0 and 4; and
- R 7 and R 8 are each H, alkyl, substituted alkyl, aryl, substituted aryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, heterocycle, substituted heterocycle, alkylaryl, substituted alkylaryl, cycloalkyl, substituted cycloalkyl, or CH 2 CO 2 alkyl, where R7 and R8 may be the same or different.
ErfindungsgemĆ¤Ć ist es weiter mƶglich, alle mƶglichen Kombinationen der vorstehend als zugehƶrig zu i., ii. oder iii. genannten Substanzen und/oder deren Derivate einzusetzen.According to the invention, it is further possible to use all possible combinations of those mentioned above as belonging to i., Ii. or iii. to use said substances and / or derivatives thereof.
In einerweiteren AusfĆ¼hrungsform der Erfindung ist die Tensidzubereitung dadurch gekennzeichnet, dass sie ferner mindestens einen weiteren Inhaltsstoff umfasst, der ausgewƤhlt ist aus der Gruppe bestehend aus GerĆ¼ststoff (Builder), Persauerstoffverbindung, Bleichaktivator, nichtwƤssriges Lƶsungsmittel, SƤure, wasserlƶsliches Salz, Verdickungsmittel, desinfizierender Inhaltsstoff sowie Kombinationen hiervon.In another embodiment of the invention, the surfactant preparation is characterized by further comprising at least one other ingredient selected from the group consisting of builder, peroxygen compound, bleach activator, nonaqueous solvent, acid, water soluble salt, thickener, disinfecting ingredient, and the like Combinations thereof.
Das HinzufĆ¼gen von einem oder mehreren der weiteren Inhaltsstoff(e) erweist sich als vorteilhaft, da hierdurch eine weiter verbesserte Reinigungsleistung und/oder Desinfektion erreicht wird. Vorzugsweise beruht die verbesserte Reinigungsleistung und/oder Desinfektion auf einem synergistischen Zusammenwirken von mindestens zwei Inhaltsstoffen. Insbesondere durch die Kombination der enthaltenen Lipase und/oder des enthaltenen Phosphonats mit einem der nachstehend beschriebenen GerĆ¼ststoffe (Builder) und/oder mit einer der nachstehend beschriebenen Persauerstoffverbindungen und/oder mit einem der nachstehend beschriebenen Bleichaktivatoren und/oder mit einem der nachfolgend beschriebenen nichtwƤssrigen Lƶsungsmittel und/oder mit einer der nachfolgend beschriebenen SƤuren und/oder mit einem der nachstehend beschriebenen wasserlƶslichen Salze und/oder mit einem der nachfolgend beschriebenen Verdickungsmittel und/oder mit einem der nachfolgend beschriebenen desinfizierenden Inhaltsstoffe kann eine solche Synergie erreicht werden.The addition of one or more of the further ingredient (s) proves to be advantageous, as this further improved cleaning performance and / or disinfection is achieved. Preferably, the improved cleaning performance and / or disinfection is based on a synergistic interaction of at least two ingredients. In particular, by the combination of the lipase and / or phosphonate contained therein with one of the builders described below and / or with one of the peroxygen compounds described below and / or with one of the bleach activators described below and / or with one of the nonaqueous solvents described below and / or with one of the acids described below and / or with one of the water-soluble salts described below and / or with one of the thickening agents described below and / or with one of the disinfecting ingredients described below, such a synergy can be achieved.
Als GerĆ¼ststoffe (Builder), die in der Tensidzubereitung enthalten sein kƶnnen, sind insbesondere Silikate, Aluminiumsilikate (insbesondere Zeolithe), Carbonate, Salze organischer Di- und PolycarbonsƤuren sowie Mischungen dieser Stoffe zu nennen.Builders which may be present in the surfactant preparation include, in particular, silicates, aluminum silicates (in particular zeolites), carbonates, salts of organic di- and polycarboxylic acids and mixtures of these substances.
Organische GerĆ¼ststoffe, welche in der Tensidzubereitung vorhanden sein kƶnnen, sind beispielsweise die in Form ihrer Natriumsalze einsetzbaren PolycarbonsƤuren, wobei unter PolycarbonsƤuren solche CarbonsƤuren verstanden werden, die mehr als eine SƤurefunktion tragen. Beispielsweise sind dies CitronensƤure, AdipinsƤure, BernsteinsƤure, GlutarsƤure, ĆpfelsƤure, WeinsƤure, MaleinsƤure, FumarsƤure, ZuckersƤuren, AminocarbonsƤuren, NitrilotriessigsƤure (NTA), MethylglycindiessigsƤure (MGDA) und deren Abkƶmmlinge sowie Mischungen aus diesen. Bevorzugte Salze sind die Salze der PolycarbonsƤuren wie CitronensƤure, AdipinsƤure, BernsteinsƤure, GlutarsƤure, WeinsƤure, ZuckersƤuren und Mischungen aus diesen.Organic builders which may be present in the surfactant preparation are, for example, the polycarboxylic acids which can be used in the form of their sodium salts, polycarboxylic acids meaning those carboxylic acids which carry more than one acid function. These are, for example, citric acid, adipic acid, succinic acid, glutaric acid, malic acid, tartaric acid, maleic acid, fumaric acid, sugar acids, aminocarboxylic acids, nitrilotriacetic acid (NTA), methylglycine diacetic acid (MGDA) and derivatives thereof and mixtures thereof. Preferred salts are the salts of polycarboxylic acids such as citric acid, adipic acid, succinic acid, glutaric acid, tartaric acid, sugar acids and mixtures thereof.
Als GerĆ¼ststoffe sind weiter polymere Polycarboxylate geeignet. Dies sind beispielsweise die Alkalimetallsalze der PolyacrylsƤure oder der PolymethacrylsƤure, zum Beispiel solche mit einer relativen MolekĆ¼lmasse von 600 bis 750.000 g / mol.As builders further polymeric polycarboxylates are suitable. These are, for example, the alkali metal salts of polyacrylic acid or polymethacrylic acid, for example, those having a molecular weight of 600 to 750,000 g / mol.
Geeignete Polymere sind insbesondere Polyacrylate, die bevorzugt eine MolekĆ¼lmasse von 1.000 bis 15.000 g / mol aufweisen. Aufgrund ihrer Ć¼berlegenen Lƶslichkeit kƶnnen aus dieser Gruppe wiederum die kurzkettigen Polyacrylate, die Molmassen von 1.000 bis 10.000 g / mol, und besonders bevorzugt von 1.000 bis 5.000 g / mol, aufweisen, bevorzugt sein.Suitable polymers are in particular polyacrylates, which preferably have a molecular weight of from 1,000 to 15,000 g / mol. Because of their superior solubility, the short-chain polyacrylates, which have molecular weights of from 1,000 to 10,000 g / mol, and particularly preferably from 1,000 to 5,000 g / mol, may again be preferred from this group.
Geeignet sind weiterhin copolymere Polycarboxylate, insbesondere solche der AcrylsƤure mit MethacrylsƤure und der AcrylsƤure oder MethacrylsƤure mit MaleinsƤure. Zur Verbesserung der Wasserlƶslichkeit kƶnnen die Polymere auch AllylsulfonsƤuren, wie AllyloxybenzolsulfonsƤure und MethallylsulfonsƤure, als Monomer enthalten.Also suitable are copolymeric polycarboxylates, in particular those of acrylic acid with methacrylic acid and of acrylic acid or methacrylic acid with maleic acid. To improve the water solubility, the polymers may also contain allylsulfonic acids, such as allyloxybenzenesulfonic acid and methallylsulfonic acid, as a monomer.
Bevorzugt werden allerdings lƶsliche GerĆ¼ststoffe, wie beispielsweise CitronensƤure, oder Acrylpolymere mit einer Molmassen von 1.000 bis 5.000 g / mol bevorzugt in der flĆ¼ssigen Tensidzubereitung eingesetzt.However, preference is given to using soluble builders, such as, for example, citric acid, or acrylic polymers having a molar mass of from 1,000 to 5,000 g / mol, preferably in the liquid surfactant preparation.
Bei den fĆ¼r polymere Polycarboxylate angegebenen Molmassen handelt es sich im Sinne dieser Schrift um gewichtsmittlere Molmassen Mw der jeweiligen SƤureform, die grundsƤtzlich mittels Gelpermeationschromatographie (GPC) bestimmt wurden, wobei ein UV-Detektor eingesetzt wurde. Die Messung erfolgte dabei gegen einen externen PolyacrylsƤure-Standard, der aufgrund seiner strukturellen Verwandtschaft mit den untersuchten Polymeren realistische Molgewichtswerte liefert. Diese Angaben weichen deutlich von den Molgewichtsangaben ab, bei denen PolystyrolsulfonsƤuren als Standard eingesetzt werden. Die gegen PolystyrolsulfonsƤuren gemessenen Molmassen sind in der Regel deutlich hƶher als die in dieser Schrift angegebenen Molmassen.For the purposes of this document, the molecular weights stated for polymeric polycarboxylates are weight-average molecular weights M w of the particular acid form, which were determined in principle by means of gel permeation chromatography (GPC), a UV detector being used. The measurement was carried out against an external polyacrylic acid standard, which provides realistic molecular weight values due to its structural relationship with the polymers investigated. These data differ significantly from the molecular weight data in which Polystyrene sulfonic acids are used as standard. The molar masses measured against polystyrenesulfonic acids are generally significantly higher than the molecular weights specified in this document.
Derartige organische Buildersubstanzen kƶnnen gewĆ¼nschtenfalls in Mengen bis zu 40 Gew.-%, insbesondere bis zu 25 Gew.-% und vorzugsweise von 1 Gew.-% bis 8 Gew.-% enthalten sein. Mengen nahe der genannten Obergrenze werden vorzugsweise in pastenfƶrmigen oder flĆ¼ssigen, insbesondere wasserhaltigen, Tensidzubereitungen eingesetzt.If desired, such organic builder substances may be present in amounts of up to 40% by weight, in particular up to 25% by weight and preferably from 1% by weight to 8% by weight. Amounts close to the stated upper limit are preferably used in paste-form or liquid, in particular water-containing, surfactant preparations.
Als fĆ¼r den Einsatz in erfindungsgemƤĆen Tensidzubereitungen geeignete Persauerstoffverbindungen kommen insbesondere organische PersƤuren beziehungsweise persaure Salze organischer SƤuren, wie PhthalimidopercapronsƤure, PerbenzoesƤure oder Salze der DiperdodecandisƤure, Wasserstoffperoxid und unter den Waschbedingungen Wasserstoffperoxid abgebende anorganische Salze, zu denen Perborat, Percarbonat, Persilikat und/oder Persulfat wie Caroat gehƶren, in Betracht. Falls eine Zubereitung Persauerstoffverbindungen enthƤlt, sind diese in Mengen von vorzugsweise bis zu 50 Gew.-%, insbesondere von 5 Gew.-% bis 30 Gew.-%, vorhanden. Der Zusatz geringer Mengen bekannter Bleichmittelstabilisatoren wie beispielsweise von Phosphonaten, Boraten beziehungsweise Metaboraten und Metasilikaten sowie Magnesiumsalzen wie Magnesiumsulfat kann zweckdienlich sein.Peroxygen compounds which are suitable for use in surfactant preparations according to the invention are, in particular, organic peracids or persalts of organic acids, such as phthalimidopercaproic acid, perbenzoic acid or salts of diperdodecanedioic acid, hydrogen peroxide and inorganic salts which release hydrogen peroxide under the washing conditions, such as perborate, percarbonate, persilicate and / or persulphate Caroat belong into consideration. If a preparation contains peroxygen compounds, they are present in amounts of preferably up to 50% by weight, especially from 5% to 30% by weight. The addition of small amounts of known bleach stabilizers such as phosphonates, borates or metaborates and metasilicates and magnesium salts such as magnesium sulfate may be useful.
Als Bleichaktivatoren kƶnnen Verbindungen, die unter Perhydrolysebedingungen aliphatische PeroxocarbonsƤuren mit vorzugsweise 1 bis 10 C-Atomen, insbesondere 2 bis 4 C-Atomen, und/oder gegebenenfalls substituierte PerbenzoesƤure ergeben, eingesetzt werden. Geeignet sind Substanzen, die O- und/oder N-Acylgruppen der genannten C-Atomzahl und/oder gegebenenfalls substituierte Benzoylgruppen tragen. Bevorzugt sind mehrfach acylierte Alkylendiamine, insbesondere Tetraacetylethylendiamin (TAED), acylierte Triazinderivate, insbesondere 1,5-Diacetyl-2,4-dioxohexahydro-1,3,5-triazin (DADHT), acylierte Glykolurile, insbesondere Tetraacetylglykoluril (TAGU), N-Acylimide, insbesondere N-Nonanoylsuccinimid (NOSI), acylierte Phenolsulfonate, insbesondere n-Nonanoyl- oder Isononanoyloxybenzolsulfonat (n- bzw. iso-NOBS), CarbonsƤureanhydride, insbesondere PhthalsƤureanhydrid, acylierte mehrwertige Alkohole, insbesondere Triacetin, Ethylenglykoldiacetat, 2,5-Diacetoxy-2,5-dihydrofuran und Enolester sowie acetyliertes Sorbitol und Mannitol beziehungsweise deren beschriebene Mischungen (SORMAN), acylierte Zuckerderivate, insbesondere Pentaacetylglukose (PAG), Pentaacetylfruktose, Tetraacetylxylose und Octaacetyllactose sowie acetyliertes, gegebenenfalls N-alkyliertes Glucamin und Gluconolacton, und/oder N-acylierte Lactame, beispielsweise N-Benzoylcaprolactam. Die hydrophil substituierten Acylacetale und die Acyllactame werden ebenfalls bevorzugt eingesetzt. Auch Kombinationen konventioneller Bleichaktivatoren kƶnnen eingesetzt werden. Derartige Bleichaktivatoren kƶnnen, insbesondere bei Anwesenheit obengenannter Wasserstoffperoxid-liefernder Bleichmittel, im Ć¼blichen Mengenbereich, vorzugsweise in Mengen von 0,5 Gew.-% bis 10 Gew.-%, insbesondere 1 Gew.-% bis 8 Gew.-%, bezogen auf die gesamte Tensidzubereitung, enthalten sein, fehlen bei Einsatz von PercarbonsƤure als alleinigem Bleichmittel jedoch vorzugsweise ganz.As bleach activators, it is possible to use compounds which, under perhydrolysis conditions, give aliphatic peroxycarboxylic acids having preferably 1 to 10 C atoms, in particular 2 to 4 C atoms, and / or optionally substituted perbenzoic acid. Suitable substances are those which carry O- and / or N-acyl groups of the stated C atom number and / or optionally substituted benzoyl groups. Preference is given to polyacylated alkylenediamines, in particular tetraacetylethylenediamine (TAED), acylated triazine derivatives, in particular 1,5-diacetyl-2,4-dioxohexahydro-1,3,5-triazine (DADHT), acylated glycolurils, in particular tetraacetylglycoluril (TAGU), N- Acylimides, in particular N-nonanoylsuccinimide (NOSI), acylated phenolsulfonates, in particular n-nonanoyl or isononanoyloxybenzenesulfonate (n- or iso-NOBS), carboxylic anhydrides, in particular phthalic anhydride, acylated polyhydric alcohols, in particular triacetin, ethylene glycol diacetate, 2,5-diacetoxy- 2,5-dihydrofuran and enol esters and also acetylated sorbitol and mannitol or mixtures thereof (SORMAN), acylated sugar derivatives, in particular pentaacetylglucose (PAG), pentaacetylfruktose, tetraacetylxylose and octaacetyllactose as well as acetylated, optionally N-alkylated glucamine and gluconolactone, and / or N- acylated lactams, for example N-benzoyl-caprolactam. The hydrophilic substituted acyl acetals and the acyl lactams are also preferably used. Also combinations of conventional bleach activators can be used. Such bleach activators can, in particular in the presence of the abovementioned hydrogen peroxide-producing bleach, in the usual amount range, preferably in amounts of from 0.5 wt .-% to 10 wt .-%, in particular 1 wt .-% to 8 wt .-%, based on However, the total surfactant preparation, be contained when using percarboxylic acid as the sole bleach, but preferably completely.
ZusƤtzlich zu den konventionellen Bleichaktivatoren oder an deren Stelle kƶnnen auch Sulfonimine und/oder bleichverstƤrkende Ćbergangsmetallsalze beziehungsweise Ćbergangsmetallkomplexe als sogenannte Bleichkatalysatoren enthalten sein.In addition to the conventional bleach activators or in their place, sulfone imines and / or bleach-enhancing transition metal salts or transition metal complexes may also be present as so-called bleach catalysts.
Die erfindungsgemƤĆen Tensidzubereitungen sind flĆ¼ssig und enthalten vorzugsweise Wasser als Hauptlƶsungsmittel. Daneben oder alternativ kƶnnen der Tensidzubereitung nichtwƤssrige Lƶsungsmittel zugesetzt werden. Geeignete nichtwƤssrige Lƶsungsmittel umfassen ein- oder mehrwertige Alkohole, Alkanolamine oder Glykolether, sofern sie im angegebenen Konzentrationsbereich mit Wasser mischbar sind. Vorzugsweise werden die Lƶsungsmittel ausgewƤhlt aus Ethanol, n-Propanol, i-Propanol, Butanolen, Glykol, Propandiol, Butandiol, Glycerin, Diglykol, Propyldiglycol, Butyldiglykol, Hexylenglycol, Ethylenglykolmethylether, Ethylenglykolethylether, Ethylenglykolpropylether, Ethylenglykolmono-n-butylether, Diethylenglykolmethylether, Diethylenglykolethylether, Propylenglykolmethylether, Propylenglykolethylether, Propylenglykolpropylether, Dipropylenglykolmonomethylether, Dipropylenglykolmonoethylether, Diisopropylenglykolmonomethylether, Di-isopropylenglykolmonoethylether, Methoxytriglykol, Ethoxytriglykol, Butoxytriglykol, 1-Butoxyethoxy-2-propanol, 3-Methyl-3-methoxybutanol, Propylenglykol-t-butylether, Di-n-octylether sowie Mischungen dieser Lƶsungsmittel. Es ist allerdings bevorzugt, dass die Tensidzubereitung ein Polyol als nicht-wƤssriges Lƶsungsmittel enthƤlt. Das Polyol kann insbesondere Glycerin, 1,2-Propandiol, 1,3-Propandiol, Ethylenglycol, Diethylenglycol und/oder Dipropylenglycol umfassen. Insbesondere bevorzugt enthƤlt die Tensidzubereitung eine Mischung aus einem Polyol und einem einwertigen Alkohol. NichtwƤssrige Lƶsungsmittel kƶnnen in der Tensidzubereitung in Mengen zwischen 0,5 und 15 Gew.-%, bevorzugt aber unter 12 Gew.-% und eingesetzt werden.The surfactant preparations according to the invention are liquid and preferably contain water as the main solvent. In addition or alternatively, non-aqueous solvents may be added to the surfactant preparation. Suitable non-aqueous solvents include mono- or polyhydric alcohols, alkanolamines or glycol ethers, provided that they are miscible with water in the specified concentration range. Preferably, the solvents are selected from ethanol, n-propanol, i-propanol, butanols, glycol, propanediol, butanediol, glycerol, diglycol, propyldiglycol, butyldiglycol, hexylene glycol, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol propyl ether, ethylene glycol mono-n-butyl ether, diethylene glycol methyl ether, diethylene glycol ethyl ether, Propylene glycol methyl ether, propylene glycol ethyl ether, propylene glycol propyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, diisopropylene glycol monomethyl ether, di-isopropylene glycol monoethyl ether, methoxytriglycol, ethoxytriglycol, butoxytriglycol, 1-butoxyethoxy-2-propanol, 3-methyl-3-methoxybutanol, propylene glycol t-butyl ether, di-n-octyl ether, and the like Mixtures of these solvents. However, it is preferred that the surfactant formulation contain a polyol as a nonaqueous solvent. The polyol may in particular comprise glycerol, 1,2-propanediol, 1,3-propanediol, ethylene glycol, diethylene glycol and / or dipropylene glycol. Most preferably, the surfactant formulation contains a mixture of a polyol and a monohydric alcohol. Non-aqueous solvents may be used in the surfactant preparation in amounts of between 0.5 and 15% by weight, but preferably below 12% by weight.
Zur Einstellung eines gewĆ¼nschten, sich durch die Mischung der Ć¼brigen Komponenten nicht von selbst ergebenden pH-Werts kƶnnen die Tensidzubereitungen system- und umweltvertrƤgliche SƤuren, insbesondere CitronensƤure, EssigsƤure, WeinsƤure, ĆpfelsƤure, MilchsƤure, GlykolsƤure, BernsteinsƤure, GlutarsƤure und/oder AdipinsƤure, aber auch MineralsƤuren, insbesondere SchwefelsƤure, oder Basen, insbesondere Ammonium- oder Alkalihydroxide, enthalten. Derartige pH-Regulatoren sind in den Tensidzubereitungen in Mengen von vorzugsweise nicht Ć¼ber 20 Gew.-%, insbesondere von 1,2 Gew.-% bis 17 Gew.-%, enthalten.To set a desired, not by the mixture of the other components resulting in self-added pH, the surfactant formulations systemic and environmentally acceptable acids, especially citric acid, acetic acid, tartaric acid, malic acid, lactic acid, glycolic acid, succinic acid, glutaric acid and / or adipic acid, but Also, mineral acids, in particular sulfuric acid, or bases, in particular ammonium or alkali metal hydroxides. Such pH regulators are present in the surfactant preparations in amounts of preferably not more than 20% by weight, in particular from 1.2% by weight to 17% by weight.
Eine Tensidzubereitung im Sinne der Erfindung kann weiterhin ein oder mehrere wasserlƶsliche Salze enthalten, die beispielsweise zur ViskositƤtseinstellung dienen. Es kann sich dabei um anorganische und/oder organische Salze handeln. Einsetzbare anorganische Salze sind dabei vorzugsweise ausgewƤhlt aus der Gruppe umfassend farblose wasserlƶsliche Halogenide, Sulfate, Sulfite, Carbonate, Hydrogencarbonate, Nitrate, Nitrite, Phosphate und/oder Oxide der Alkalimetalle, der Erdalkalimetalle, des Aluminiums und/oder der Ćbergangsmetalle; weiterhin sind Ammoniumsalze einsetzbar. Besonders bevorzugt sind dabei Halogenide und Sulfate der Alkalimetalle; vorzugsweise ist das anorganische Salz daher ausgewƤhlt aus der Gruppe umfassend Natriumchlorid, Kaliumchlorid, Natriumsulfat, Kaliumsulfat sowie Gemische derselben. Einsetzbare organische Salze sind beispielsweise farblose wasserlƶsliche Alkalimetall-, Erdalkalimetall-, Ammonium-, Aluminium- und/oder Ćbergangsmetallsalze der CarbonsƤuren. Vorzugsweise sind die Salze ausgewƤhlt aus der Gruppe umfassend Formiat, Acetat, Propionat, Citrat, Malat, Tartrat, Succinat, Malonat, Oxalat, Lactat sowie Gemische derselben.A surfactant preparation according to the invention may further contain one or more water-soluble salts which serve, for example, for adjusting the viscosity. These may be inorganic and / or organic salts. Useful inorganic salts are preferably selected from the group consisting of colorless water-soluble halides, sulfates, sulfites, carbonates, bicarbonates, nitrates, nitrites, phosphates and / or oxides of the alkali metals, alkaline earth metals, aluminum and / or transition metals; Furthermore, ammonium salts can be used. Particularly preferred are halides and sulfates of the alkali metals; Preferably, therefore, the inorganic salt is selected from the group comprising sodium chloride, potassium chloride, sodium sulfate, potassium sulfate and mixtures thereof. Useful organic salts are, for example, colorless water-soluble alkali metal, alkaline earth metal, ammonium, aluminum and / or transition metal salts of the carboxylic acids. Preferably, the salts are selected from the group comprising formate, acetate, propionate, citrate, malate, tartrate, succinate, malonate, oxalate, lactate and mixtures thereof.
Zur Verdickung kann eine erfindungsgemƤĆe Tensidzubereitung ein oder mehrere Verdickungsmittel enthalten. Bevorzugt ist das Verdickungsmittel ausgewƤhlt aus der Gruppe umfassend Xanthan, Guar, Carrageenan, Agar-Agar, Gellan, Pektin, Johannisbrotkernmehl und Mischungen daraus. Diese Verbindungen sind auch in Gegenwart von anorganischen Salzen effektive Verdickungsmittel. In einer besonders bevorzugten AusfĆ¼hrungsform enthƤlt die Tensidzubereitung Xanthan als Verdickungsmittel, da Xanthan auch in Gegenwart von hohen Salzkonzentrationen effektiv verdickt und eine makroskopische Auftrennung der kontinuierlichen Phase verhindert. ZusƤtzlich stabilisiert das Verdickungsmittel die kontinuierliche, tensidarme Phase und verhindert eine makroskopische Phasenseparation.For thickening, a surfactant preparation according to the invention may contain one or more thickeners. Preferably, the thickener is selected from the group comprising xanthan, guar, carrageenan, agar-agar, gellan, pectin, locust bean gum and mixtures thereof. These compounds are effective thickeners even in the presence of inorganic salts. In a particularly preferred embodiment, the surfactant formulation contains xanthan gum as a thickener because xanthan effectively thickened even in the presence of high salt concentrations and prevents macroscopic separation of the continuous phase. In addition, the thickener stabilizes the continuous, low surfactant phase and prevents macroscopic phase separation.
Alternativ oder ergƤnzend kƶnnen auch (Meth)AcrylsƤure(co)polymere als Verdickungsmittel eingesetzt werden. Geeignete Acryl- und Methacryl(co)polymere umfassen beispielsweise die hochmolekularen mit einem Polyalkenylpolyether, insbesondere einem Allylether von Saccharose, Pentaerythrit oder Propylen, vernetzten Homopolymere der AcrylsƤure (INCI-Bezeichnung gemĆ¤Ć "International Dictionary of Cosmetic Ingredients" der "The Cosmetic, Toiletry and Fragrance Association (CTFA)": Carbomer), die auch als Carboxyvinylpolymere bezeichnet werden. Solche PolyacrylsƤuren sind unter anderem unter den Handelsnamen PolygelĀ® und CarbopolĀ® erhƤltlich. Weiterhin sind beispielsweise folgende AcrylsƤure-Copolymere geeignet: (i) Copolymere von zwei oder mehr Monomeren aus der Gruppe der AcrylsƤure, MethacrylsƤure und ihrer einfachen, vorzugsweise mit C1-4-Alkanolen gebildeten, Ester (INCI Acrylates Copolymer), die beispielsweise unter den Handelsnamen AculynĀ®, AcusolĀ® oder TegoĀ® Polymer erhƤltlich sind; (ii) vernetzte hochmolekulare AcrylsƤure-Copolymere, zu denen etwa die mit einem Allylether der Saccharose oder des Pentaerythrits vernetzten Copolymere von C10-30-Alkylacrylaten mit einem oder mehreren Monomeren aus der Gruppe der AcrylsƤure, MethacrylsƤure und ihrer einfachen, vorzugsweise mit C1-4-Alkanolen gebildeten, Ester (INCI Acrylates/C10-30 Alkyl Acrylate Crosspolymer) gehƶren und die beispielsweise unter dem Handelsnamen CarbopolĀ® erhƤltlich sind. Weitere geeignete Polymere sind (Meth)AcrylsƤure(co)polymere des Typs SokalanĀ®.Alternatively or additionally, it is also possible to use (meth) acrylic acid (co) polymers as thickeners. Suitable acrylic and methacrylic (co) polymers include, for example, the high molecular weight homopolymers of acrylic acid crosslinked with a polyalkenyl polyether, in particular an allyl ether of sucrose, pentaerythritol or propylene (INCI name according to "International Dictionary of Cosmetic Ingredients" of "The Cosmetic, Toiletry and Fragrance Association (CTFA) ": carbomer), also referred to as carboxyvinyl polymers. Such polyacrylic acids are available, inter alia, under the trade names PolygelĀ® and CarbopolĀ®. Furthermore, for example, the following acrylic acid copolymers are suitable: (i) copolymers of two or more monomers from the group of acrylic acid, methacrylic acid and their simple, preferably formed with C 1-4 alkanols, esters (INCI acrylates copolymer), for example, among the Trade names AculynĀ®, AcusolĀ® or TegoĀ® Polymer are available; (ii) crosslinked high molecular weight acrylic acid copolymers, such as those crosslinked with an allyl ether of sucrose or pentaerythritol copolymers of C 10-30 alkyl acrylates with one or more Monomers from the group of acrylic acid, methacrylic acid and their simple, preferably with C 1-4 alkanols formed ester (INCI acrylates / C 10-30 alkyl acrylate crosspolymer) include and are available, for example, under the trade name CarbopolĀ®. Other suitable polymers are (meth) acrylic acid (co) polymers of the SokalanĀ® type.
Es kann bevorzugt sein, dass die erfindungsgemƤĆe Tensidzubereitung ein (Meth)AcrylsƤure(co)polymer in Kombination mit einem weiteren Verdickungsmittel, vorzugsweise Xanthan, enthƤlt. Die Tensidzubereitung kann 0,05 bis 1,5 Gew.-% und vorzugsweise 0,1 bis 1 Gew.-%, jeweils bezogen auf die gesamte Tensidzubereitung, Verdickungsmittel enthalten. Die Menge an eingesetztem Verdickungsmittel ist dabei abhƤngig von der Art des Verdickungsmittels und dem gewĆ¼nschten Grad der Verdickung.It may be preferred that the surfactant preparation according to the invention contains a (meth) acrylic acid (co) polymer in combination with a further thickener, preferably xanthan. The surfactant preparation can contain from 0.05 to 1.5% by weight and preferably from 0.1 to 1% by weight, based in each case on the total surfactant preparation, of thickening agent. The amount of thickener used depends on the type of thickener and the desired degree of thickening.
Unter einem desinfizierenden Inhaltsstoff werden insbesondere Inhaltsstoffe verstanden, die eine antimikrobielle oder antivirale Wirksamkeit besitzen, also Keime abtƶten. Die keimabtƶtende Wirkung ist dabei abhƤngig von dem Gehalt des desinfizierenden Inhaltsstoffes in der Tensidzubereitung, wobei die keimabtƶtende Wirkung mit abnehmendem Gehalt an desinfizierendem Inhaltsstoff bzw. zunehmender VerdĆ¼nnung der Tensidzubereitung abnimmt.In particular, ingredients which have an antimicrobial or antiviral activity, ie kill germs, are understood to be a disinfectant ingredient. The germicidal effect is dependent on the content of the disinfecting ingredient in the surfactant preparation, wherein the germicidal effect decreases with decreasing content of disinfecting ingredient or increasing dilution of the surfactant preparation.
Ein bevorzugter desinfizierender Inhaltsstoff ist Ethanol oder Propanol. Diese einwertigen Alkohole werden aufgrund ihrer Lƶsemitteleigenschaften und ihrer keimtƶtenden Wirkung hƤufig in Desinfektionsmitteln und auch in Reinigungsmitteln allgemein eingesetzt. Dabei umfasst der Begriff "Propanol" sowohl das 1-Propanol (n-Propanol) als auch das 2-Propanol ("Isopropanol"). Ethanol und/oder Propanol ist beispielsweise in einer Menge von insgesamt 10 bis 65 Gew.-%, vorzugsweise 25 bis 55 Gew.-% in der Tensidzubereitung enthalten. Ein weiterer bevorzugter desinfizierender Inhaltsstoff ist Teebaumƶl. Hierbei handelt es sich um das Ƥtherische Ćl des Australischen Teebaums (Melaleuca alternifolia), einem in New South Wales und Queensland beheimateten immergrĆ¼nen Strauch aus der Gattung Myrtenheiden (Melaleuca), sowie weiterer Teebaum-Arten aus verschiedenen Gattungen (z.B. Baeckea, Kunzea und Leptospermum) in der Familie der MyrtengewƤchse (Myrtaceae). Das Teebaumƶl wird durch Wasserdampfdestillation aus den BlƤttern und Zweigspitzen dieser BƤume gewonnen und ist ein Gemisch aus ca. 100 Substanzen; zu den Hauptbestandteilen zƤhlen (+)-Terpinen-4-ol, Ī±-Terpinen, Terpinolen, Terpineol, Pinen, Myrcen, Phellandren, p-Cymen, Limonen und 1,8-Cineol. Teebaumƶl ist beispielsweise in einer Menge von 0,05 bis 10 Gew.-%, vorzugsweise 0,1 bis 5,0 Gew.-%, in der viruziden Behandlungslƶsung enthalten. Ein weiterer bevorzugter desinfizierender Inhaltsstoff ist MilchsƤure. Die MilchsƤure oder 2-HydroxypropionsƤure ist ein GƤrungsprodukt, das von verschiedenen Mikroorganismen erzeugt wird. Sie ist schwach antibiotisch aktiv. MilchsƤure ist beispielsweise in Mengen von bis zu 10 Gew.-%, vorzugsweise 0,2 bis 5,0 Gew.-% in der Tensidzubereitung enthalten.A preferred disinfecting ingredient is ethanol or propanol. These monohydric alcohols are commonly used in disinfectants and detergents because of their solvent properties and their germicidal activity. The term "propanol" includes both the 1-propanol (n-propanol) and the 2-propanol ("isopropanol"). Ethanol and / or propanol, for example, in an amount of from 10 to 65 wt .-%, preferably 25 to 55 wt .-% in the surfactant preparation. Another preferred disinfecting ingredient is tea tree oil. These are the essential oil of the Australian Tea Tree (Melaleuca alternifolia), a native of New South Wales and Queensland evergreen shrub of the genus Myrtenheiden (Melaleuca), and other tea tree species from different genera (eg Baeckea, Kunzea and Leptospermum) in the family of myrtle family (Myrtaceae). The tea tree oil is obtained by steam distillation from the leaves and branch tips of these trees and is a mixture of about 100 substances; its main constituents include (+) - terpinene-4-ol, Ī±-terpinene, terpinolene, terpineol, pinene, myrcene, phellandrene, p-cymene, limonene and 1,8-cineole. Tea tree oil is contained, for example, in an amount of 0.05 to 10% by weight, preferably 0.1 to 5.0% by weight, in the virucidal treatment solution. Another preferred disinfecting ingredient is lactic acid. The lactic acid or 2-hydroxypropionic acid is a fermentation product produced by various microorganisms. She is weakly active in antibiotics. Lactic acid is for example, in amounts of up to 10 wt .-%, preferably 0.2 to 5.0 wt .-% in the surfactant preparation.
Weitere desinfizierende Inhaltsstoffe sind beispielsweise Wirkstoffe aus den Gruppen der Alkohole, Aldehyde, antimikrobiellen SƤuren bzw. deren Salze, CarbonsƤureester, SƤureamide, Phenole, Phenolderivate, Diphenyle, Diphenylalkane, Harnstoffderivate, Sauerstoff-, Stickstoff-Acetale sowie Formale, Benzamidine, Isothiazole und deren Derivate wie Isothiazoline und Isothiazolinone, Phthalimidderivate, Pyridinderivate, antimikrobiellen oberflƤchenaktiven Verbindungen, Guanidine, antimikrobiellen amphoteren Verbindungen, Chinoline, 1,2-Dibrom-2,4-dicyanobutan, lodo-2-propynyl-butyl-carbamat, lod, lodophore und Peroxide. Hierunter bevorzugte Wirkstoffe werden vorzugsweise ausgewƤhlt aus der Gruppe umfassend 1,3-Butandiol, Phenoxyethanol, 1,2-Propylenglykol, Glycerin, UndecylensƤure, ZitronensƤure, MilchsƤure, BenzoeesƤure, SalicylsƤure, Thymol, 2-Benzyl-4-chlorphenol, 2,2'-Methylen-bis-(6-brom-4-chlorphenol), 2,4,4'-Trichlor-2'-hydroxydiphenylether, N-(4-Chlorphenyl)-N-(3,4-dichlorphenyl)-harnstoff, N,N'-(1,10-decandiyldi-1-pyridinyl-4-yliden)-bis-(1-octanamin)-dihydrochlorid, N,N'-Bis-(4-Chlorphenyl)-3,12-diimino-2,4,11,13-tetraazatetradecandiimidamid, quaternƤre oberflƤchenaktive Verbindungen, Guanidine. Bevorzugte oberflƤchenaktive quaternƤre Verbindungen enthalten eine Ammonium-, Sulfonium-, Phosphonium-, Jodonium- oder Arsoniumgruppe. Weiterhin kƶnnen auch desinfizierende Ƥtherische Ćle eingesetzt werden, die gleichzeitig fĆ¼ eine Beduftung der viruziden Behandlungslƶsung sorgen. Besonders bevorzugte Wirkstoffe sind jedoch ausgewƤhlt aus der Gruppe umfassend SalicylsƤure, quaternƤre Tenside, insbesondere Benzalkoniumchlorid, PeroxoVerbindungen, insbesondere Wasserstoffperoxid, Alkalimetallhypochlorit sowie Gemische derselben. Ein solcher weiterer desinfizierender Inhaltsstoff ist beispielsweise in einer Menge von 0,01 bis 1 Gew.-%, vorzugsweise 0,02 bis 0,8 Gew.-%, insbesondere 0,05 bis 0,5 Gew.-%, besonders bevorzugt 0,1 bis 0,3 Gew.-%, ƤuĆerst bevorzugt 0,2 Gew.-% in der Tensidzubereitung enthalten.Further disinfectant ingredients are, for example, active compounds from the groups of alcohols, aldehydes, antimicrobial acids or their salts, carboxylic esters, acid amides, phenols, phenol derivatives, diphenyls, diphenylalkanes, urea derivatives, oxygen, nitrogen acetals and formals, benzamidines, isothiazoles and derivatives thereof such as isothiazolines and isothiazolinones, phthalimide derivatives, pyridine derivatives, antimicrobial surface active compounds, guanidines, antimicrobial amphoteric compounds, quinolines, 1,2-dibromo-2,4-dicyanobutane, iodo-2-propynyl-butyl-carbamate, iodine, iodophores and peroxides. Among these, preferred active ingredients are selected from the group comprising 1,3-butanediol, phenoxyethanol, 1,2-propylene glycol, glycerol, undecylenic acid, citric acid, lactic acid, benzoic acid, salicylic acid, thymol, 2-benzyl-4-chlorophenol, 2,2 '. -Methylene bis (6-bromo-4-chlorophenol), 2,4,4'-trichloro-2'-hydroxydiphenyl ether, N- (4-chlorophenyl) -N- (3,4-dichlorophenyl) -urea, N , N '- (1,10-decanediyldi-1-pyridinyl-4-ylidene) bis (1-octanamine) dihydrochloride, N, N'-bis (4-chlorophenyl) -3,12-diimino-2 , 4,11,13-tetraazatetradecandiimidamide, quaternary surface active compounds, guanidines. Preferred quaternary surface active compounds contain an ammonium, sulfonium, phosphonium, iodonium or arsonium group. Furthermore, disinfectant essential oils can be used, which at the same time provide for a scenting of the virucidal treatment solution. However, particularly preferred active compounds are selected from the group comprising salicylic acid, quaternary surfactants, in particular benzalkonium chloride, peroxo compounds, in particular hydrogen peroxide, alkali metal hypochlorite and mixtures thereof. Such another disinfecting ingredient is, for example, in an amount of 0.01 to 1 wt .-%, preferably 0.02 to 0.8 wt .-%, in particular 0.05 to 0.5 wt .-%, particularly preferably 0 , 1 to 0.3 wt .-%, most preferably 0.2 wt .-% in the surfactant preparation.
FlĆ¼ssige erfindungsgemƤĆe Tensidzubereitungen in Form von Ć¼bliche Lƶsungsmittel enthaltenden Lƶsungen werden in der Regel durch einfaches Mischen der Inhaltsstoffe, die in Substanz oder als Lƶsung in einen automatischen Mischer gegeben werden kƶnnen, hergestellt.Liquid surfactant preparations according to the invention in the form of customary solvent-containing solutions are generally prepared by simply mixing the ingredients, which can be added in bulk or as a solution in an automatic mixer.
ErfindungsgemƤĆe Tensidzubereitungen kƶnnen als enzymatische Bestandteile ausschlieĆlich eine Lipase enthalten wie beschrieben. Alternativ kƶnnen sie auch weitere hydrolytische Enzyme oder andere Enzyme in einer fĆ¼r die Wirksamkeit der Tensidzubereitung zweckmƤĆigen Konzentration enthalten. In einer weiteren AusfĆ¼hrungsform der Erfindung umfasst die Tensidzubereitung daher mindestens ein weiteres Enzym. Prinzipiell sind diesbezĆ¼glich alle im Stand der Technik fĆ¼r diese Zwecke etablierten Enzyme einsetzbar. Als weitere Enzyme bevorzugt einsetzbar sind alle Enzyme, die in einer erfindungsgemƤĆen Tensidzubereitung eine katalytische AktivitƤt entfalten kƶnnen, insbesondere eine Protease, Amylase, Cellulase, Hemicellulase, Mannanase, Pektinase, Tannase, Xylanase, Xanthanase, Ć-Glucosidase, Carrageenase, Perhydrolase, Oxidase, Oxidoreduktase oder eine weitere Lipase, sowie deren Gemische. Weitere Enzyme sind in der Tensidzubereitung vorteilhafterweise jeweils in einer Gesamtmenge von 1 x 10-8 bis 5 Gew.-% bezogen auf aktives Protein enthalten. Zunehmend bevorzugt ist jedes weitere Enzym in einer Menge von 1 x 10-7 -3 Gew.-%, von 0,00001-1 Gew.-%, von 0,00005-0,5 Gew.-%, von 0,0001 bis 0,1 Gew.-% und besonders bevorzugt von 0,0001 bis 0,05 Gew.-% in erfindungsgemƤĆen Tensidzubereitungen enthalten, bezogen auf aktives Protein. Besonders bevorzugt zeigen die Enzyme synergistische Reinigungsleistungen gegenĆ¼ber bestimmten Anschmutzungen oder Flecken, d.h. die in der Tensidzubereitung enthaltenen Enzyme unterstĆ¼tzen sich in ihrer Reinigungsleistung gegenseitig. Ganz besonders bevorzugt liegt ein solcher Synergismus vor zwischen der enthaltenen Lipase und einem weiteren Enzym der erfindungsgemƤĆen Tensidzubereitung, darunter insbesondere zwischen der Lipase und einer Protease und/oder einer Amylase und/oder einer Mannanase und/oder einer Cellulase und/oder einer Pektinase. Synergistische Effekte kƶnnen nicht nur zwischen verschiedenen Enzymen, sondern auch zwischen einem oder mehreren Enzymen und weiteren Inhaltsstoffen der erfindungsgemƤĆen Tensidzubereitung auftreten.Surfactant preparations according to the invention may contain as enzymatic constituents exclusively a lipase as described. Alternatively, they may also contain other hydrolytic enzymes or other enzymes in a concentration useful for the effectiveness of the surfactant formulation. In a further embodiment of the invention, therefore, the surfactant preparation comprises at least one further enzyme. In principle, all the enzymes established in the prior art for this purpose can be used in this regard. Preferred as further enzymes all enzymes which can develop a catalytic activity in a surfactant preparation according to the invention can be used, in particular a protease, amylase, cellulase, hemicellulase, mannanase, pectinase, tannase, xylanase, xanthanase, .beta.-glucosidase, carrageenase, perhydrolase, oxidase, oxidoreductase or another Lipase, as well as their mixtures. Further enzymes are advantageously contained in the surfactant preparation, in each case in a total amount of from 1 Ć 10 -8 to 5% by weight, based on active protein. More preferably, each further enzyme is in an amount of 1 x 10 -7 -3 wt%, from 0.00001 to 1 wt%, from 0.00005 to 0.5 wt%, from 0.0001 to 0.1 wt .-% and particularly preferably from 0.0001 to 0.05 wt .-% in inventive surfactant preparations, based on active protein. Particularly preferably, the enzymes show synergistic cleaning performance against certain stains or stains, ie the enzymes contained in the surfactant preparation support each other in their cleaning performance. Very particular preference is given to such synergism between the lipase contained and another enzyme of the surfactant preparation according to the invention, including in particular between the lipase and a protease and / or an amylase and / or a mannanase and / or a cellulase and / or a pectinase. Synergistic effects can occur not only between different enzymes, but also between one or more enzymes and other ingredients of the surfactant preparation according to the invention.
Unter den Proteasen sind solche vom Subtilisin-Typ bevorzugt. Beispiele hierfĆ¼r sind die Subtilisine BPN' und Carlsberg, die Protease PB92, die Subtilisine 147 und 309, die Alkalische Protease aus Bacillus lentus, Subtilisin DY und die den Subtilasen, nicht mehr jedoch den Subtilisinen im engeren Sinne zuzuordnenden Enzyme Thermitase, Proteinase K und die Proteasen TW3 und TW7. Subtilisin Carlsberg ist in weiterentwickelter Form unter dem Handelsnamen AlcalaseĀ® von der Firma Novozymes A/S, Bagsvaard, DƤnemark, erhƤltlich. Die Subtilisine 147 und 309 werden unter den Handelsnamen EsperaseĀ®, beziehungsweise SavinaseĀ® von der Firma Novozymes vertrieben. Von der Protease aus Bacillus lentus DSM 5483 leiten sich die unter der Bezeichnung BLAPĀ® gefĆ¼hrten Protease-Varianten ab. Weitere brauchbare Proteasen sind beispielsweise die unter den Handelsnamen DurazymĀ®, RelaseĀ®, EverlaseĀ®, NafizymĀ®, NatalaseĀ®, KannaseĀ® und OvozymeĀ® von der Firma Novozymes, die unter den Handelsnamen, PurafectĀ®, PurafectĀ® OxP, PurafectĀ® Prime, ExcellaseĀ® und ProperaseĀ® von der Firma Genencor, das unter dem Handelsnamen ProtosolĀ® von der Firma Advanced Biochemicals Ltd., Thane, Indien, das unter dem Handelsnamen WuxiĀ® von der Firma Wuxi Snyder Bioproducts Ltd., China, die unter den Handelsnamen ProleatherĀ® und Protease PĀ® von der Firma Amano Pharmaceuticals Ltd., Nagoya, Japan, und das unter der Bezeichnung Proteinase K-16 von der Firma Kao Corp., Tokyo, Japan, erhƤltlichen Enzyme. Besonders bevorzugt eingesetzt werden auch die Proteasen aus Bacillus gibsonii und Bacillus pumilus, die offenbart sind in den internationalen Patentanmeldungen
ErfindungsgemĆ¤Ć konfektionierbare Amylasen sind beispielsweise die Ī±-Amylasen aus Bacillus licheniformis, aus Bacillus amyloliquefaciens oder aus Bacillus stearothermophilus sowie insbesondere auch deren fĆ¼r den Einsatz in Wasch- oder Reinigungsmitteln verbesserte Weiterentwicklungen. Das Enzym aus Bacillus licheniformis ist von dem Unternehmen Novozymes unter dem Namen TermamylĀ® und von dem Unternehmen Danisco/Genencor unter dem Namen PurastarĀ®ST erhƤltlich. Weiterentwicklungsprodukte dieser Ī±-Amylase sind von dem Unternehmen Novozymes unter den Handelsnamen DuramylĀ® und TermamylĀ®ultra, von dem Unternehmen Danisco/Genencor unter dem Namen PurastarĀ®OxAm und von dem Unternehmen Daiwa Seiko Inc., Tokyo, Japan, als KeistaseĀ® erhƤltlich. Die Ī±-Amylase von Bacillus amyloliquefaciens wird von dem Unternehmen Novozymes unter dem Namen BANĀ® vertrieben, und abgeleitete Varianten von der Ī±-Amylase aus Bacillus stearothermophilus unter den Namen BSGĀ® und NovamylĀ®, ebenfalls von dem Unternehmen Novozymes. Desweiteren sind fĆ¼r diesen Zweck die Ī±-Amylase aus Bacillus sp. A 7-7 (DSM 12368) und die Cyclodextrin-Glucanotransferase (CGTase) aus Bacillus agaradherens (DSM 9948) hervorzuheben. Ebenso sind Fusionsprodukte aller genannten MolekĆ¼le einsetzbar. DarĆ¼ber hinaus sind die unter den Handelsnamen FungamylĀ® von dem Unternehmen Novozymes erhƤltlichen Weiterentwicklungen der Ī±-Amylase aus Aspergillus niger und A. oryzae geeignet. Weitere vorteilhaft einsetzbare Handelsprodukte sind beispielsweise die Amylase-LTĀ® und StainzymeĀ® oder Stainzyme ultraĀ® bzw. Stainzyme plusĀ®, letztere ebenfalls von dem Unternehmen Novozymes. Auch durch Punktmutationen erhƤltliche Varianten dieser Enzyme kƶnnen erfindungsgemĆ¤Ć eingesetzt werden. Besonders bevorzugte Amylasen sind offenbart in den internationalen Offenlegungsschriften
Beispiele fĆ¼r zusƤtzliche erfindungsgemĆ¤Ć konfektionierbare Lipasen oder Cutinasen, die insbesondere wegen ihrer Triglycerid-spaltenden AktivitƤten enthalten sind, aber auch, um aus geeigneten Vorstufen in situ PersƤuren zu erzeugen, sind die ursprĆ¼nglich aus Humicola lanuginosa (Thermomyces lanuginosus) erhƤltlichen, beziehungsweise weiterentwickelten Lipasen, insbesondere solche mit dem AminosƤureaustausch D96L. Sie werden beispielsweise von der Firma Novozymes unter den Handelsnamen LipolaseĀ®, LipolaseĀ®Ultra, LipoPrimeĀ®, LipozymeĀ® und LipexĀ® vertrieben. Desweiteren sind beispielsweise die Cutinasen einsetzbar, die ursprĆ¼nglich aus Fusarium solani pisi und Humicola insolens isoliert worden sind. Von der Firma Genencor sind beispielsweise die Lipasen beziehungsweise Cutinasen einsetzbar, deren Ausgangsenzyme ursprĆ¼nglich aus Pseudomonas mendocina und Fusarium solanii isoliert worden sind. Als weitere wichtige Handelsprodukte sind die ursprĆ¼nglich von der Firma Gist-Brocades vertriebenen PrƤparationen M1 LipaseĀ® und LipomaxĀ® und die von der Firma Meito Sangyo KK, Japan, unter den Namen Lipase MY-30Ā®, Lipase OFĀ® und Lipase PLĀ® vertriebenen Enzyme zu erwƤhnen, ferner das Produkt LumafastĀ® von der Firma Genencor.Examples of additional lipases or cutinases which can be synthesized according to the invention, which are contained in particular because of their triglyceride-cleaving activities, but also in order to generate in situ peracids from suitable precursors, are the lipases which are originally obtainable from Humicola lanuginosa (Thermomyces lanuginosus) or further developed, in particular those with the amino acid exchange D96L. They are sold for example by the company Novozymes under the trade names LipolaseĀ®, LipolaseĀ®Ultra, LipoPrimeĀ®, LipozymeĀ® and LipexĀ®. Furthermore, for example, the cutinases can be used, which were originally isolated from Fusarium solani pisi and Humicola insolens. From the company Genencor are For example, the lipases or cutinases can be used whose initial enzymes were originally isolated from Pseudomonas mendocina and Fusarium solanii. Other important commercial products are the preparations M1 Lipase.RTM. And Lipomax.RTM. Originally sold by Gist-Brocades and the enzymes marketed by Meito Sangyo KK, Japan, under the name Lipase MY-30Ā®, Lipase OFĀ® and Lipase PLĀ® to mention also the product LumafastĀ® from the company Genencor.
ErfindungsgemƤĆe Wasch- oder Reinigungsmittel kƶnnen ferner Cellulasen enthalten, je nach Zweck als reine Enzyme, als EnzymprƤparationen oder in Form von Mischungen, in denen sich die einzelnen Komponenten vorteilhafterweise hinsichtlich ihrer verschiedenen Leistungsaspekte ergƤnzen. Zu diesen Leistungsaspekten zƤhlen insbesondere BeitrƤge zur PrimƤrwaschleistung, zur SekundƤrwaschleistung des Mittels (Antiredepositionswirkung oder Vergrauungsinhibition) und Avivage (Gewebewirkung), bis hin zum AusĆ¼ben eines "stone washed"-Effekts.Detergents or cleaning agents according to the invention may also contain cellulases, depending on the purpose, as pure enzymes, as enzyme preparations or in the form of mixtures in which the individual components advantageously supplement each other in terms of their various performance aspects. These performance aspects include, in particular, contributions to the primary washing performance, the secondary washing performance of the composition (anti-redeposition effect or graying inhibition) and softening (fabric effect), up to the exercise of a "stone washed" effect.
ErfindungsgemĆ¤Ć konfektionierbare Cellulasen (Endoglucanasen, EG) umfassen beispielsweise die pilzliche, Endoglucanase(EG)-reiche Cellulase-PrƤparation beziehungsweise deren Weiterentwicklungen, die von dem Unternehmen Novozymes unter dem Handelsnamen CelluzymeĀ® angeboten wird. Die ebenfalls von dem Unternehmen Novozymes erhƤltlichen Produkte EndolaseĀ® und CarezymeĀ® basieren auf der 50 kD-EG, beziehungsweise der 43 kD-EG aus Humicola insolens DSM 1800. Weitere einsetzbare Handelsprodukte dieses Unternehmens sind CellusoftĀ®, RenozymeĀ® und CellucleanĀ®. Weiterhin einsetzbar sind beispielsweise Cellulasen, die von dem Unternehmen AB Enzymes, Finnland, unter den Handelsnamen EcostoneĀ® und BiotouchĀ® erhƤltlich sind, und die zumindest zum Teil auf der 20 kD-EG aus Melanocarpus basieren. Weitere Cellulasen von dem Unternehmen AB Enzymes sind EconaseĀ® und EcopulpĀ®. Weitere geeignete Cellulasen sind aus Bacillus sp. CBS 670.93 und CBS 669.93, wobei die aus Bacillus sp. CBS 670.93 von dem Unternehmen Danisco/Genencor unter dem Handelsnamen PuradaxĀ® erhƤltlich ist. Weitere verwendbare Handelsprodukte des Unternehmens Danisco/Genencor sind "Genencor detergent cellulase L" und IndiAgeĀ®Neutra. Auch durch Punktmutationen erhƤltliche Varianten dieser Enzyme kƶnnen erfindungsgemĆ¤Ć eingesetzt werden. Besonders bevorzugte Cellulasen sind Thielavia terrestris Cellulasevarianten, die in der internationalen Offenlegungsschrift
Ferner kƶnnen insbesondere zur Entfernung bestimmter Problemanschmutzungen weitere Enzyme eingesetzt sein, die unter dem Begriff Hemicellulasen zusammengefasst werden. Hierzu gehƶren beispielsweise Mannanasen, Xanthanlyasen, Xanthanasen, Pektinlyasen (=Pektinasen), Pektinesterasen, Pektatlyasen, Xyloglucanasen, Xylanasen, Pullulanasen und Ī²-Glucanasen. DiesbezĆ¼glich geeignete Enzyme sind beispielsweise unter den Namen GamanaseĀ® und Pektinex ARĀ® von der Firma Novozymes, unter dem Namen RohapecĀ® B1L von der Firma AB Enzymes und unter dem Namen PyrolaseĀ® von der Firma Diversa Corp., San Diego, CA, USA erhƤltlich. Die aus Bacillus subtilis gewonnene Ī²-Glucanase ist unter dem Namen CerefloĀ® von der Firma Novozymes erhƤltlich. ErfindungsgemĆ¤Ć besonders bevorzugte Hemicellulasen sind Mannanasen, welche beispielsweise unter den Handelsnamen MannawayĀ® von dem Unternehmen Novozymes oder PurabriteĀ® von dem Unternehmen Genencor vertrieben werden.Furthermore, in particular for the removal of certain problem soiling, further enzymes can be used, which are summarized by the term hemicellulases. These include, for example, mannanases, xanthan lyases, xanthanases, pectin lyases (= pectinases), pectin esterases, pectate lyases, xyloglucanases, xylanases, pullulanases and Ī²-glucanases. Suitable enzymes for this purpose are available, for example, under the name GamanaseĀ® and Pektinex ARĀ® from Novozymes, under the name RohapecĀ® B1L from AB Enzymes and under the name PyrolaseĀ® from Diversa Corp., San Diego, CA, USA , The Ī²-glucanase obtained from Bacillus subtilis is available under the name CerefloĀ® from Novozymes. Hemicellulases which are particularly preferred according to the invention are mannanases which are sold, for example, under the trade names MannawayĀ® by the company Novozymes or PurabriteĀ® by the company Genencor.
Zur Erhƶhung der bleichenden Wirkung kann eine erfindungsgemƤĆe Tensidzubereitung auch Oxidoreduktasen, beispielsweise Oxidasen, Oxygenasen, Katalasen (die bei niedrigen H2O2-Konzentrationen als Peroxidase reagieren), Peroxidasen, wie Halo-, Chloro-, Bromo-, Lignin-, Glucose- oder Manganperoxidasen, Dioxygenasen oder Laccasen (Phenoloxidasen, Polyphenoloxidasen) enthalten. Als geeignete Handelsprodukte sind DeniliteĀ® 1 und 2 der Firma Novozymes zu nennen. Als vorteilhaft einsetzbare Beispielsysteme fĆ¼r eine enzymatische Perhydrolyse wird auf die Anmeldungen
Die erfindungsgemĆ¤Ć einzusetzenden Enzyme kƶnnen ferner zusammen mit Begleitstoffen, etwa aus der Fermentation, oder mit Stabilisatoren konfektioniert sein und in einer derartigen Konfektionierungsform in eine erfindungsgemƤĆe Tensidzubereitung eingearbeitet werden.The enzymes to be used according to the invention may also be formulated together with accompanying substances, for example from the fermentation, or with stabilizers and incorporated in such a formulation in a surfactant preparation according to the invention.
Einen weiteren Erfindungsgegenstand stellt die Verwendung einer erfindungsgemƤĆen Tensidzubereitung zur Entfernung von Anschmutzungen, insbesondere von lipase-sensitiven Anschmutzungen, auf Textilien oder harten OberflƤchen, d.h. zur Reinigung von Textilien oder von harten OberflƤchen, dar. Denn erfindungsgemƤĆe Tensidzubereitungen kƶnnen, insbesondere auf Grund der enthaltenen Kombination von Phosphonat und Lipase, vorteilhaft dazu verwendet werden, um von Textilien oder von harten OberflƤchen entsprechende Verunreinigungen zu beseitigen. AusfĆ¼hrungsformen dieses Erfindungsgegenstandes stellen beispielsweise die HandwƤsche, die manuelle Entfernung von Flecken von Textilien oder von harten OberflƤchen oder die Verwendung im Zusammenhang mit einem maschinellen Verfahren dar. Alle Sachverhalte, GegenstƤnde und AusfĆ¼hrungsformen, die fĆ¼r erfindungsgemƤĆe Tensidzubereitungen beschrieben sind, sind auch auf diesen Erfindungsgegenstand anwendbar. Daher wird an dieser Stelle ausdrĆ¼cklich auf die Offenbarung an entsprechender Stelle verwiesen mit dem Hinweis, dass diese Offenbarung auch fĆ¼r die vorstehende erfindungsgemƤĆe Verwendung gilt. Entsprechendes gilt fĆ¼r die Verwendung einer erfindungsgemƤĆen Tensidzubereitung zur Desinfektion.A further subject of the invention is the use of a surfactant preparation according to the invention for the removal of stains, in particular of lipase-sensitive stains, on textiles or hard surfaces, ie for the cleaning of textiles or of hard surfaces. For example, surfactant preparations according to the invention may be used, in particular because of the combination of phosphonate and lipase, advantageously in order to remove impurities from textiles or from hard surfaces. Embodiments of this subject invention include, for example, hand washing, manual removal of stains from textiles or hard surfaces, or use in conjunction with a machine process. All aspects, articles, and embodiments described for surfactant formulations of the invention are also applicable to this subject of the invention , Therefore, reference is made at this point expressly to the disclosure in the appropriate place with the statement that this disclosure also applies to the above inventive use. The same applies to the use of a surfactant preparation according to the invention for disinfection.
Einen weiteren Erfindungsgegenstand stellt ein Verfahren zur Reinigung von Textilien oder harten OberflƤchen oder zur Desinfektion dar, wobei in mindestens einem Verfahrensschritt eine erfindungsgemƤĆe Tensidzubereitung angewendet wird.A further subject of the invention is a process for the cleaning of textiles or hard surfaces or for disinfection, wherein in at least one process step a surfactant preparation according to the invention is used.
Ein weiterer Gegenstand der Erfindung ist ein Verfahren, insbesondere eine Wasch-, Reinigungs-oder Desinfektionsverfahren, in dem eine Waschflotte, die ein Phosphonat und eine Lipase, die natĆ¼rlicherweise in einem Mikroorganismus vorhanden ist, wobei der Mikroorganismus Rhizopus oryzae oder Mucorjavanicus ist, umfasst, mit einer lipase-sensitiven Anschmutzung oder einem Keim auf einem Textil oder einer harten OberflƤche in Kontakt gebracht wird.The invention furthermore relates to a process, in particular a washing, cleaning or disinfecting process, in which a wash liquor which comprises a phosphonate and a lipase which is naturally present in a microorganism, the microorganism being Rhizopus oryzae or Mucorjavanicus, is contacted with a lipase-sensitive soil or germ on a textile or hard surface.
Hierunter fallen sowohl manuelle als auch maschinelle Verfahren, wobei maschinelle Verfahren aufgrund ihrer prƤziseren Steuerbarkeit, was beispielsweise die eingesetzten Mengen und Einwirkzeiten angeht, bevorzugt sind. Verfahren zur Reinigung von Textilien zeichnen sich im Allgemeinen dadurch aus, dass eine oder mehrere reinigungsaktive Substanzen auf das Reinigungsgut aufgebracht und nach der Einwirkzeit abgewaschen werden. Insbesondere wird das Reinigungsgut mit der Tensidzubereitung oder der durch sie gebildeten Waschflotte behandelt, vorzugsweise fĆ¼r eine bestimmte Mindestdauer, beispielsweise 5, 10, 15, 20, 25, 30, 40, 50 oder 60 Minuten. Entsprechendes gilt fĆ¼r Verfahren zur Reinigung von allen anderen Materialien als Textilien, insbesondere von harten OberflƤchen. Bei Desinfektionsverfahren wird der abzutƶtende Keim mit der Tensidzubereitung bzw. der durch sie gebildeten Waschflotte in Kontakt gebracht, vorzugsweise fĆ¼r eine bestimmte Mindestdauer, beispielsweise 5, 10, 15, 20, 25, 30, 40, 50 oder 60 Minuten. Alle denkbaren Wasch-, Reinigungs- oder Desinfektionsverfahren kƶnnen in wenigstens einem der Verfahrensschritte um die Anwendung einer erfindungsgemƤĆen Tensidzubereitung beziehungsweise um die Anwendung einer erfindungsgemƤĆen Lipase in Kombination mit einem Phosphonat bereichert werden und stellen dann AusfĆ¼hrungsformen der vorliegenden Erfindung dar. Alle Sachverhalte, GegenstƤnde und AusfĆ¼hrungsformen, die fĆ¼r erfindungsgemƤĆe Tensidzubereitungen beschrieben sind, sind auch auf diese ErfindungsgegenstƤnde anwendbar. Daherwird an dieser Stelle ausdrĆ¼cklich auf die Offenbarung an entsprechender Stelle verwiesen mit dem Hinweis, dass diese Offenbarung auch fĆ¼r die vorstehenden erfindungsgemƤĆen Verfahren gilt.This includes both manual and mechanical processes, with mechanical processes being preferred on account of their more precise controllability, for example with regard to the quantities and reaction times used. Processes for cleaning textiles are generally characterized in that one or more cleaning-active substances are applied to the items to be cleaned and washed off after the action time. In particular, the cleaning product is treated with the surfactant preparation or the wash liquor formed by it, preferably for a certain minimum duration, for example 5, 10, 15, 20, 25, 30, 40, 50 or 60 minutes. The same applies to processes for cleaning all other materials than textiles, especially hard surfaces. In disinfection process, the germ to be killed is brought into contact with the surfactant preparation or the wash liquor formed by it, preferably for a certain minimum duration, for example 5, 10, 15, 20, 25, 30, 40, 50 or 60 minutes. All conceivable washing, cleaning or disinfection methods can be enriched in at least one of the method steps to the application of a surfactant preparation according to the invention or to the application of a lipase according to the invention in combination with a phosphonate and then provide embodiments of All facts, objects and embodiments described for surfactant preparations according to the invention are also applicable to these subjects of the invention. Therefore, reference is made at this point expressly to the disclosure in the appropriate place with the note that this disclosure also applies to the above inventive method.
In einer bevorzugten AusfĆ¼hrungsform ist ein erfindungsgemƤĆes Verfahren dadurch gekennzeichnet, dass die Lipase in der Waschflotte in einer Konzentration von 0,0000003 bis 0,0004 Gew.-%, bevorzugt von 0,0000005 bis 0,0003 Gew.-% vorliegt, wobei die Angaben auf Aktivprotein in der Waschflotte bezogen sind. In einerweiteren bevorzugten AusfĆ¼hrungsform ist ein erfindungsgemƤĆes Verfahren dadurch gekennzeichnet, dass es bei einer Temperatur zwischen 10Ā°C und 80Ā°C, bevorzugt zwischen 10Ā°C und 70Ā°C und besonders bevorzugt zwischen 20Ā°C und 60Ā°C durchgefĆ¼hrt wird.In a preferred embodiment, a method according to the invention is characterized in that the lipase is present in the wash liquor in a concentration of 0.0000003 to 0.0004 wt .-%, preferably from 0.0000005 to 0.0003 wt .-%, wherein the Details are based on active protein in the wash liquor. In a further preferred embodiment, a method according to the invention is characterized in that it is carried out at a temperature between 10 Ā° C and 80 Ā° C, preferably between 10 Ā° C and 70 Ā° C and more preferably between 20 Ā° C and 60 Ā° C.
ErfindungsgemĆ¤Ć vorgesehene Lipasen sind vorteilhaft in erfindungsgemƤĆen Tensidzubereitungen sowie Verfahren, insbesondere Wasch-, Reinigungs- oder Desinfektionsverfahren, einsetzbar. Sie kƶnnen also vorteilhaft dazu verwendet werden, um in entsprechenden Zubereitungen eine lipolytische AktivitƤt bereitzustellen.Lipases provided according to the invention are advantageously usable in surfactant preparations according to the invention and processes, in particular washing, cleaning or disinfection processes. They can therefore be used advantageously to provide lipolytic activity in corresponding preparations.
Einen weiteren Gegenstand der Erfindung stellt daher die Verwendung einer Lipase, die natĆ¼rlicherweise in einem Mikroorganismus vorhanden ist, wobei der Mikroorganismus Rhizopus oryzae oder Mucorjavanicus ist, zur Bereitstellung einer lipolytischen AktivitƤt in einer flĆ¼ssigen Tensidzubereitung, welche ferner ein Phosphonat umfasst, dar.Another object of the invention, therefore, is the use of a lipase naturally present in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucorjavanicus, for providing a lipolytic activity in a liquid surfactant preparation further comprising a phosphonate.
Ein weiterer Gegenstand der Erfindung ist die Verwendung einer Lipase, die natĆ¼rlicherweise in einem Mikroorganismus vorhanden ist, wobei der Mikroorganismus Rhizopus oryzae oder Mucor javanicus ist, zur Entfernung von lipase-sensitiven Anschmutzungen auf Textilien oder harten OberflƤchen oder zur Desinfektion in einer Waschflotte, welche ferner ein Phosphonat umfasst.Another object of the invention is the use of a lipase, which is naturally present in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucor javanicus, for the removal of lipase-sensitive stains on textiles or hard surfaces or for disinfection in a wash liquor, which further comprises a phosphonate.
Alle Sachverhalte, GegenstƤnde und AusfĆ¼hrungsformen, die fĆ¼r erfindungsgemƤĆe Tensidzubereitungen und/oder erfindungsgemƤĆe Verfahren beschrieben sind, sind auch auf die genannten Verwendungen anwendbar. Daherwird an dieser Stelle ausdrĆ¼cklich auf die Offenbarung an entsprechender Stelle verwiesen mit dem Hinweis, dass diese Offenbarung auch fĆ¼r die vorstehenden erfindungsgemƤĆen Verwendungen gilt.All facts, subjects and embodiments described for surfactant preparations and / or methods according to the invention are also applicable to the mentioned uses. Therefore, reference is made at this point expressly to the disclosure in the appropriate place with the statement that this disclosure also applies to the above uses according to the invention.
FĆ¼r dieses Beispiel wurden standardisiert verschmutze Textilien eingesetzt, die von dem Center For Testmaterials (CFT, Vlaardingen, Niederlande) bezogen worden waren. Dabei wurden folgende Anschmutzungen und Textilien verwendet:
- A: RuĆ/Mineralƶl auf Baumwolle: Produkt Nr. C-01 erhƤltlich von CFT;
- B: RuĆ/Olivenƶl auf Baumwolle: Produkt Nr. C-02 erhƤltlich von CFT;
- C: Pigment/ĆI auf Baumwolle: Produkt Nr. C-09 erhƤltlich von CFT ;
- D: Hautfett (Sebum)/Kohlenschwarz,auf Baumwolle: Produkt Nr. C-S-32 erhƤltlich von CFT.
- A: carbon black / mineral oil on cotton: Product No. C-01 available from CFT;
- B: carbon black / olive oil on cotton: Product No. C-02 available from CFT;
- C: Pigment / oil on cotton: Product No. C-09 available from CFT;
- D: Skin fat (sebum) / carbon black, on cotton: Product No. CS-32 available from CFT.
Mit diesem Testmaterial wurden verschiedene Waschmittel auf ihre Reinigungsleistung hin untersucht. DafĆ¼r wurden die AnsƤtze fĆ¼r 30 Minuten bei Temperaturen von 40Ā°C gewaschen. Die Dosierung lag bei 3,5 Gramm des Waschmittels pro Liter Waschflotte. Es wurde mit Stadtwasser mit einer WasserhƤrte von etwa 16Ā° deutscher HƤrte gewaschen.With this test material, various detergents were examined for their cleaning performance. For this, the batches were washed for 30 minutes at temperatures of 40 Ā° C. The dosage was 3.5 grams of detergent per liter of wash liquor. It was washed with city water with a water hardness of about 16 Ā° German hardness.
Als Waschmittel-Basis-Rezeptur diente ein Phosphonat-haltiges FlĆ¼ssigwaschmittel folgender Zusammensetzung (alle Angaben in Gewichts-Prozent): 0,3-0,5% Xanthan, 0,2-0,4% AntiSchaummittel, 6-7% Glycerin, 0,3-0,5% Ethanol, 4-7% FAEOS (Fettalkoholethersulfat), 24-28% nichtionische Tenside, 1% BorsƤure, 1-2% Natriumcitrat (Dihydrat), 2-4% Soda, 14-16% Kokosnuss-FettsƤuren, 0,5% HEDP (1-Hydroxyethan-1,1-diphosphonsƤure), 0-0,4% PVP (Polyvinylpyrrolidon), 0-0,05% optischer Aufheller, 0-0,001% Farbstoff, Rest demineralisiertes Wasser.The detergent base formulation used was a phosphonate-containing liquid detergent of the following composition (all figures in percent by weight): 0.3-0.5% xanthan gum, 0.2-0.4% anti-foaming agent, 6-7% glycerol, 0 , 3-0.5% ethanol, 4-7% FAEOS (fatty alcohol ether sulfate), 24-28% nonionic surfactants, 1% boric acid, 1-2% sodium citrate (dihydrate), 2-4% soda, 14-16% coconut oil. Fatty acids, 0.5% HEDP (1-hydroxyethane-1,1-diphosphonic acid), 0-0.4% PVP (polyvinylpyrrolidone), 0-0.05% optical brightener, 0-0.001% dye, balance demineralized water.
Diese Waschmittel-Basis-Rezeptur wurde fĆ¼r die verschiedenen Versuchsreihen aktivitƤtsgleich zu 0,35 Gew.-% Lipex 100L (LipaseprƤparation des Unternehmens Novozymes (Ansatz 4 als Referenz) mit folgenden Lipasen versetzt: Lipase M-AP10Ā® (Ansatz 1), Lipase LEĀ® (Ansatz 2) und Lipase FĀ® (auch Lipase JVĀ®; Ansatz 3), alle erhƤltlich von dem Unternehmen Amano Pharmaceuticals.This detergent base formulation was added to the following series of lipases for the various series of experiments in an activity-identical manner to 0.35% by weight of Lipex 100L (lipase preparation from Novozymes (batch 4 as reference): Lipase M-AP10Ā® (batch 1), Lipase LE Ā® (batch 2) and Lipase FĀ® (also Lipase JVĀ®, batch 3), all available from Amano Pharmaceuticals.
Nach dem Waschen wurde der WeiĆheitsgrad der gewaschenen Textilien gemessen. Die Messung erfolgte an einem Spektrometer Minolta CM508d (Lichtart D65, 10Ā°). Das GerƤt wurde zuvor mit einem mitgelieferten WeiĆstandard kalibriert. Die erhaltenen Ergebnisse sind die Differenzremissionen zwischen einem Waschvorgang mit einem Waschmittel enthaltend die jeweilige Lipase und einem parallel durchgefĆ¼hrten Kontrollwaschgang mit einem Waschmittel ohne Lipase. Die Ergebnisse sind in der nachfolgenden Tabelle 1 zusammengestellt und erlauben einen unmittelbaren RĆ¼ckschluss auf den Beitrag des jeweils enthaltenen Enzyms zur Reinigungsleistung des verwendeten Mittels.
Es wird deutlich, dass erfindungsgemƤĆe Tensidzubereitungen (AnsƤtze 1 bis 3) sehr gute Reinigungsleistungen zeigen, die gegenĆ¼ber der Referenz (Ansatz 4) verbessert sind.It is clear that surfactant preparations according to the invention (batches 1 to 3) show very good cleaning performances, which are improved over the reference (batch 4).
- <110> Henkel AG & Co. KGaA<110> Henkel AG & Co. KGaA
- <120> FlĆ¼ssige Tensidzubereitung enthaltend Lipase und Phosphonat<120> Liquid surfactant preparation containing lipase and phosphonate
- <130> H 08918 (PT018327)<130> H 08918 (PT018327)
-
<150>
DE 102010063743.2
<151> 2010-12-21<150>DE 102010063743.2
<151> 2010-12-21 - <160> 1<160> 1
- <170> PatentIn version 3.3<170> PatentIn version 3.3
-
<210> 1
<211> 269
<212> PRT
<213> Rhizopus oryzae<210> 1
<211> 269
<212> PRT
<213> Rhizopus oryzae - <400> 1 <400> 1
Claims (10)
- A liquid surfactant preparation comprising a phosphonate and a lipase that exists naturally in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucor javanicus.
- The surfactant preparation according to claim 1, characterized in that the phosphonate is selected from the group consisting of 1-hydroxyethane-1,1-diphosphonic acid (HEDP), aminotrimethylene phosphonic acid (ATMP), nitrilotrimethylene phosphonic acid (NTMP), diethylenetriaminepentamethylene phosphonic acid (DTPMP, DETPMP or DTPNT), ethylenediaminetetramethylene phosphonic acid (EDTMP), 2-phosphonobutane-1,2,4-tricarboxylic acid (PBS-AM) as well as combinations thereof.
- The surfactant preparation according to claim 1 or 2, characterized in that the lipase possesses an amino acid sequence that is at least 80 % identical to the amino acid sequence listed in SEQ ID NO. 1.
- The surfactant preparation according to one of claims 1 to 3, characterized in that the phosphonate is comprised in an amount of 0.01 to 4 wt %, and/or the lipase is comprised in an amount of 1 x 10-8 to 5 wt %, based on active protein.
- The surfactant preparation according to one of claims 1 to 4, characterized in that it is a washing agent, cleaning agent or disinfectant.
- The surfactant preparation according to one of claims 1 to 5, characterized in that it additionally comprises a component selected fromi. an anionic and/or polyanionic substance, and/orii. a cationic and/or polycationic substance, and/oriii. a substance that possesses hydroxyl and/or polyhydroxyl group(s).
- The surfactant preparation according to one of claims 1 to 6, characterized in that it additionally comprises at least one additional ingredient selected from the group consisting of builder, peroxygen compound, bleach activator, non-aqueous solvent, acid, water-soluble salt, thickener, disinfecting ingredient as well as combinations thereof, and/or that it contains at least one additional enzyme, in particular a protease, amylase, cellulase, hemicellulase, mannanase, pectinase, tannase, xylanase, xanthanase, Ī²-glucosidase, carrageenase, perhydrolase, oxidase, oxidoreductase or a lipase, and preferably their mixtures.
- A method for cleaning fabrics or hard surfaces or for disinfection, wherein a surfactant preparation according to one of claims 1 to 7 is used in at least one process step.
- A method, in particular a washing, cleaning or disinfection method, in which a washing liquor that contains a phosphonate and a lipase that exists naturally in a microorganism, is brought into contact with a lipase-sensitive soil or a germ on a fabric or on a hard surface, wherein said microorganism is Rhizopus oryzae or Mucor javanicus.
- Use of a lipase that exists naturally in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucor javanicus, so as to provide a lipolytic activity in a liquid surfactant preparation that additionally comprises a phosphonate, or so as to remove lipase-sensitive soils on fabrics or hard surfaces or for disinfection in a washing liquor that additionally comprises a phosphonate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL11805804T PL2655587T3 (en) | 2010-12-21 | 2011-12-13 | Liquid surfactant preparation containing lipase and phosphonate |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102010063743A DE102010063743A1 (en) | 2010-12-21 | 2010-12-21 | Liquid surfactant preparation containing lipase and phosphonate |
PCT/EP2011/072513 WO2012084582A1 (en) | 2010-12-21 | 2011-12-13 | Liquid surfactant preparation containing lipase and phosphonate |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2655587A1 EP2655587A1 (en) | 2013-10-30 |
EP2655587B1 true EP2655587B1 (en) | 2017-05-10 |
Family
ID=45464508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11805804.9A Active EP2655587B1 (en) | 2010-12-21 | 2011-12-13 | Liquid surfactant preparation containing lipase and phosphonate |
Country Status (9)
Country | Link |
---|---|
US (1) | US20130266552A1 (en) |
EP (1) | EP2655587B1 (en) |
KR (1) | KR101928587B1 (en) |
DE (1) | DE102010063743A1 (en) |
ES (1) | ES2634512T3 (en) |
HU (1) | HUE035746T2 (en) |
MX (1) | MX2013007116A (en) |
PL (1) | PL2655587T3 (en) |
WO (1) | WO2012084582A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10731110B2 (en) | 2013-12-20 | 2020-08-04 | Novozymes A/S | Compositions and processes for treatment with lipases |
CN105849121B (en) | 2014-01-22 | 2020-12-29 | čÆŗē»“äæ”å ¬åø | Polypeptides having lipase activity and polynucleotides encoding same |
DE102017202034A1 (en) | 2017-02-09 | 2018-08-09 | Henkel Ag & Co. Kgaa | Lipases with increased thermostability |
EP3772540A1 (en) | 2019-08-08 | 2021-02-10 | Henkel AG & Co. KGaA | Lipases with increased thermostability |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2706778B2 (en) | 1988-03-07 | 1998-01-28 | 天éč£½č¬ ę Ŗå¼ä¼ē¤¾ | Oil and fat reforming method |
EP0443063A1 (en) | 1990-02-22 | 1991-08-28 | Henkel Research Corporation | Pseudomonas lipase gene, vectors for the expression thereof, production of the lipase by transformed microorganisms and uses of this enzyme |
DE69133633D1 (en) | 1991-06-11 | 2010-07-08 | Genencor Int | Cellulase compositions having a deficiency of type CBH I component-containing detergent compositions |
CN101955921A (en) | 1995-03-17 | 2011-01-26 | čÆŗę²å„ę¢ å ¹ęéå ¬åø | Novel endoglucanases |
EP0857216B1 (en) | 1995-10-17 | 2014-09-10 | AB Enzymes Oy | Cellulases, the genes encoding them and uses thereof |
DE69735767T2 (en) | 1996-09-17 | 2007-04-05 | Novozymes A/S | cellulase |
AU734264B2 (en) | 1996-11-15 | 2001-06-07 | Ecolab Inc. | Cleaning method for polyethylene terephthalate containers |
DE19713852A1 (en) * | 1997-04-04 | 1998-10-08 | Henkel Kgaa | Activators for peroxygen compounds in detergents and cleaning agents |
US7312062B2 (en) | 1998-11-27 | 2007-12-25 | Novozymes A/S | Lipolytic enzyme variants |
MXPA01009706A (en) | 1999-03-31 | 2002-05-14 | Novozymes As | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same. |
AU2452101A (en) | 1999-12-23 | 2001-07-03 | Pharmacia & Upjohn Company | Assays and methods of diagnosis and treatment based on use of sodium channels astargets for amyloid beta or its aggregates |
JP4907834B2 (en) | 2000-08-04 | 2012-04-04 | ććć¹ć³ć»ć¦ć¼ćØć¹ć»ć¤ć³ć³ć¼ćć¬ć¼ććć | Mutant EGIII cellulase, DNA encoding such EGIII composition and method for obtaining the same |
US20030050211A1 (en) * | 2000-12-14 | 2003-03-13 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Enzymatic detergent compositions |
WO2002099091A2 (en) | 2001-06-06 | 2002-12-12 | Novozymes A/S | Endo-beta-1,4-glucanase from bacillus |
DE10131441A1 (en) | 2001-06-29 | 2003-01-30 | Henkel Kgaa | A new group of alpha amylases and a method for identifying and obtaining new alpha amylases |
DE10163748A1 (en) | 2001-12-21 | 2003-07-17 | Henkel Kgaa | New glycosyl hydrolases |
AU2003302905A1 (en) * | 2002-12-11 | 2004-06-30 | Novozymes A/S | Detergent composition comprising endo-glucanase |
DE10260903A1 (en) | 2002-12-20 | 2004-07-08 | Henkel Kgaa | New perhydrolases |
DK2664670T3 (en) | 2003-12-03 | 2015-07-27 | Danisco Us Inc | perhydrolase |
DE102004029475A1 (en) | 2004-06-18 | 2006-01-26 | Henkel Kgaa | New enzymatic bleaching system |
DE102006038448A1 (en) | 2005-12-28 | 2008-02-21 | Henkel Kgaa | Enzyme-containing cleaning agent |
DE102006022224A1 (en) | 2006-05-11 | 2007-11-15 | Henkel Kgaa | Subtilisin from Bacillus pumilus and detergents and cleaners containing this new subtilisin |
DE102007003143A1 (en) * | 2007-01-16 | 2008-07-17 | Henkel Kgaa | New alkaline protease from Bacillus gibsonii and detergents and cleaners containing this novel alkaline protease |
-
2010
- 2010-12-21 DE DE102010063743A patent/DE102010063743A1/en not_active Withdrawn
-
2011
- 2011-12-13 HU HUE11805804A patent/HUE035746T2/en unknown
- 2011-12-13 EP EP11805804.9A patent/EP2655587B1/en active Active
- 2011-12-13 PL PL11805804T patent/PL2655587T3/en unknown
- 2011-12-13 KR KR1020137015919A patent/KR101928587B1/en active IP Right Grant
- 2011-12-13 ES ES11805804.9T patent/ES2634512T3/en active Active
- 2011-12-13 WO PCT/EP2011/072513 patent/WO2012084582A1/en active Application Filing
- 2011-12-13 MX MX2013007116A patent/MX2013007116A/en not_active Application Discontinuation
-
2013
- 2013-06-20 US US13/922,509 patent/US20130266552A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
PL2655587T3 (en) | 2017-10-31 |
EP2655587A1 (en) | 2013-10-30 |
ES2634512T3 (en) | 2017-09-28 |
WO2012084582A1 (en) | 2012-06-28 |
KR20130135272A (en) | 2013-12-10 |
US20130266552A1 (en) | 2013-10-10 |
KR101928587B1 (en) | 2018-12-12 |
DE102010063743A1 (en) | 2012-06-21 |
MX2013007116A (en) | 2013-08-27 |
HUE035746T2 (en) | 2018-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2478097B1 (en) | Stable liquid washing or cleaning agent containing a protease | |
EP3260537B1 (en) | Storage-stable liquid washing or cleaning agent containing protease and cellulase | |
EP2569409B1 (en) | Storage-stable liquid detergent or cleaning agent containing protease and lipase | |
DE102014018149A1 (en) | Solid washing and cleaning agent with amylase | |
EP2598624A2 (en) | Stabilized liquid tenside preparation comprising enzymes | |
EP2652131A1 (en) | Storage-stable liquid washing or cleaning agent containing protease and amylase | |
EP2756064A2 (en) | Method for adapting a hydrolytic enzyme to a component that stabilizes the hydrolytic enzyme | |
DE102020205400A1 (en) | Highly alkaline laundry detergent with protease | |
EP3230443B1 (en) | Detergents and cleaning agents comprising a combination of amylase and protease | |
WO2011036198A1 (en) | Stabilized enzymatic composition | |
EP2655587B1 (en) | Liquid surfactant preparation containing lipase and phosphonate | |
EP2598626A2 (en) | Stabilized liquid tenside preparation comprising enzymes | |
DE102020205381A1 (en) | Highly alkaline laundry detergent with protease | |
DE102019210806A1 (en) | Laundry detergent with a Bacillus gibsonii protease | |
EP2640818B1 (en) | Stabilized liquid surfactant composition comprising enzym | |
WO2023232193A1 (en) | Detergents and cleaning agents with an improved enzyme stability | |
WO2023232192A1 (en) | Detergent and cleaning agent with improved enzyme stability | |
WO2023232194A1 (en) | Detergents and cleaning agents with an improved enzyme stability | |
EP2598622A2 (en) | Stabilized liquid tenside preparation comprising enzymes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20130522 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20140606 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C11D 3/386 20060101AFI20170109BHEP |
|
INTG | Intention to grant announced |
Effective date: 20170202 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 892339 Country of ref document: AT Kind code of ref document: T Effective date: 20170515 Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502011012230 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20170510 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2634512 Country of ref document: ES Kind code of ref document: T3 Effective date: 20170928 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170811 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170810 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170910 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170810 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 7 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20171212 Year of fee payment: 7 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502011012230 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20180213 |
|
REG | Reference to a national code |
Ref country code: HU Ref legal event code: AG4A Ref document number: E035746 Country of ref document: HU |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: HU Payment date: 20171218 Year of fee payment: 7 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171213 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20171231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171213 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171231 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171231 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171231 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20181211 Year of fee payment: 8 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 892339 Country of ref document: AT Kind code of ref document: T Effective date: 20171213 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171213 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170510 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181214 Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170510 Ref country code: CZ Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191213 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191213 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PL Payment date: 20221202 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20230227 Year of fee payment: 12 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230530 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231220 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20231228 Year of fee payment: 13 Ref country code: FR Payment date: 20231221 Year of fee payment: 13 Ref country code: DE Payment date: 20231214 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PL Payment date: 20231130 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20240126 Year of fee payment: 13 |